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ABSTRACT
Timothy Wessler: Mathematical Modeling of Biological Processes at the
Cellular, Tissue, and System Levels
(Under the direction of M. Gregory Forest)
In this work, mathematical modeling is used in conjunction with in vivo and in vitro experiments
to investigate disparate biological phenomena at various scales, including cell rounding, virus trapping,
and drug delivery. First, a rapid change in cell morphology from a spread to a rounded state is
modeled. This transition reveals a several-fold greater cell surface than is required to enclose a
perfectly round object of the same volume, and an open question is how this extra surface is stored.
A Hamiltonian model, where the energy cost is minimized, is used to address this question and
reproduce statistics of the surface morphology. Next, antibody attachments and detachments to
pathogens moving through a biological environment are modeled. Experiments demonstrate that a
pathogen with absolutely no affinity to mucus can become trapped in a mucus network in the presence
of antibodies. Antibodies and mucus work cooperatively to trap pathogens by tethering the pathogen
to the mucus via the antibody. Both a continuum reaction-diffusion model and a stochastic model
are used to simulate the pathogen and antibody movement and binding kinetics. This work generates
many important insights into the design of antibodies that use trapping to protect against foreign
pathogens infecting underlying tissue. Finally, the movement of a nanoparticle drug from organ to
organ throughout the body is modeled. Covalently attaching polyethylene glycol (PEG) to a drug
helps maintain an adequately high concentration in the blood. However, the anti-PEG antibodies
increasingly common throughout the population attach to PEG and accelerate the elimination of
PEGylated drugs. A possible strategy to temporarily lower the concentration of free anti-PEG
antibodies is to introduce free PEG that will bind to free anti-PEG antibodies, thus depleting their
numbers before the PEGylated drug treatment begins. This work uses a compartment model with
local dynamics at different scales within different compartments to model the organ-specific changes
in concentrations of the PEGylated drug, the free PEG, and the anti-PEG antibodies, as well as the
iii
binding kinetics. The results lay out guidelines for a nanoparticle PEGylated drug therapy.
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2.1 Transition from spread to rounded states and localization of F-actin and
myosin in the cortex of a typical rounded cell and cortical structure. A.
Merged DIC and fluorescence image of spread Swiss 3T3 fibroblasts stably transfected
with Lifeact-RFP (green) cells with clearly visible signal from stress fibers. Cell
outlines traced from image. Bar = 20µm. B. Image of the same cell after trypsin-
induced detachment. The white outline shows the former spread shape. Yellow arrow
points to the rounded cell. C. Cartoon compares the radius of a sphere required to
accommodate the cell volume from the spread state (R = 50µm) versus the rounded
state (R = 13µm) for the cell on the left. D. Distribution of spread and rounded cell
areas. E. Distribution of rounded cell radii. F. DIC and confocal fluorescence images
of rounded CHO cell stably expressing GFP-Lifeact (green) and RFP-MLC (red) Bar
= 5 µm. G. Transmission electron microscopy image of GFP immunogold staining of
rounded CHO cells with stable expression of Lifeact-GFP. Black dots which represent
gold particles show the position of actin filaments. Bar = 1 µm. H. Inset shows
outlined region in G at higher magnification. Arrow points to F-actin immediately
underlying the plasma membrane in BLiPs: arrowhead points to the F-actin in the
cortex closer toward center of the cell. Bar = 0.5 µm. . . . . . . . . . . . . . . . . . . 8
2.2 The discrete geometric model. A. Two layer cortex model (left) and its bead-
spring representation with notations employed (right). B. Folded geometries as a
function of the fold number and the excess surface ratio. C. A portion of a model cell
with BLiPs at steady state where the gold line represents the cortex. D. The shape
of three single folds extracted from simulations for initial excess ratio, ER = 4 with
different numbers of folds, N: 20 (blue), 40 (red) and 50 (yellow). E. The shape of
three single folds extracted from simulations for number of folds N = 40 with different
initial excess ratio, ER: 6 (blue), 4 (red), 2 (yellow). All calculated shapes were scaled
to have the same unit area inside the outer perimeter. The bending energy (BE) is
presented for each configuration. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.3 Morphology of rounded cells. A. Fluorescence, DIC and merged images of rounded
CHO cells stably transfected with Lifeact-GFP. B. Fluorescence, DIC and merged
images taken near the equatorial plane of a rounded CHO cell with the fluorescence
signal coming from the PH domain of PLC-delta fused to EGFP that marks the inner
leaflet of the plasma membrane (Bar = 5 µm). C. Scanning electron microscope image
of the rounded state (Bar = 5 µm). D. BLiP radii distribution for N = 7096 BLiPs. 13
2.4 BLiPs morphology generated by seed-and-growth models. A. A realization
of the Voronoi diagram. The seeds and boundaries of Voronoi cells are shown in
blue; the Voronoi polygons are shown in red. B. A realization of the "seed and
growth" model. C. Magnified view of rectangle in (B). D. Distribution of BLiP sizes:
Voronoi model (green bars) and "seed and growth" model (red bars) normalized using
the assumption that average rounded cell radius is 8 um; the blue line shows the
experimentally obtained distribution. E. For the "seed and growth" model, plots
of%surface area stored in BLiPs and%of total volume stored in BLiPs as a function of
the number of BLiPs. F. A cross-section of "seed and growth" model. G. Transmission
electron micrograph of a section of a rounded cell (Bar = 2 µm) for comparison to F. 16
2.5 Schematic for the phase field formulation of a cell in an aqueous medium.
φ1, φ2, φ3, represent volume fractions of the external aqueous medium, the nematic
cortex as schematically depicted by the crosshatched region and the cytosol, respec-
tively, with φ1 + φ2 + φ3 = 1. The entire computational domain is denoted as Ω.
The cell surface is defined by the level sets φ1 = φ2 = 0.5, while the cortex-cytosol
interface is defined by φ2 = φ3 = 0.5. Note that we penalize coexistence of three phases. 17
xii
2.6 Application of the phase field model to 2D target images. A. Proof of
principle of the 2D phase field simulation. From left to right, convergence from
circular initial data to a target cell surface morphology with 25 uniform, equally
spaced, "BLiPs". B. Convergence of a 2D phase field simulation to a 2D, TEM image
of a representative cell surface morphology. The red curve in panels 1-3 is the cell
surface obtained from a 2D TEM micrograph, which serves as the target of the phase
field model. The black contours in each panel are the initial data (left panel) which
evolves to the actual cell surface in the phase field simulation. The green contours
depict the interface between the cortex and interior cytosol. In the right panel, the
F-actin filament orientational distribution within the nematic cortex is superimposed,
as predicted by the phase field model. In these simulations, the Flory order parameter,√
h1/h2 is set to 1. C. Phase field predictions of the pressure distribution. D. the first
invariant (trace) of the dominant stored stress, the Ericksen stress, for the converged
stationary morphology shown in B, right panel. E. A blow-up of the trace of the
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CHAPTER 1
Introduction
A reliable mathematical model is an invaluable complement to biological experiments that would
otherwise be impossible to perform due to cost or limits on technology. In that spirit, this work
describes models that expand or focus the experimental possibilities for three distinct biological
problems: the precise changes in cell morphology that accompany changes in cell state, the importance
of antibody binding in mucosal immunology, and the particulars of nanoparticle drug delivery.
First, I present previously published research which uses mathematical modeling to complement
wet lab experiments to investigate the morphology of cells with an excess of surface area. It is
reformatted here from PLOS Computational Biology. Due to limits in technology, it is impossible to
determine the mechanism responsible for the organization and storage of excess cell surface during
cell rounding with wet lab experiments alone. Hence, the PLOS Computational Biology paper
includes both mathematical modeling and experimental results. My main contribution to the paper
was related to 2d Hamiltonian model. I wrote and ran the code, as well as helped design the model
and analyze the results. The paper is found in Chapter 2, and Chapter 3 expands upon on this work.
Next, I include previously published work showing the potency of mucosal trapping of HIV by
antibodies. It is reformatted here from ACS Infectious Diseases. In order to determine the optimum
antibody-mucus affinity for protecting against HIV infection, the effects of changing the binding
properties of the antibodies were simulated. Modeling that determines the best choice for these
numerous properties and then engineering the ideal antibody is favorable to designing numerous
antibodies for expensive and time-consuming clinical trials. Furthermore, certain experiments can’t
be performed directly, especially when dealing with highly intractable sexually transmitted diseases.
Hence, mathematical modeling was essential to simulating the ability of theoretical antibodies to
protect against the spread of HIV. The ACS Infectious Diseases paper simulated numerous different
antibodies, and the results were compared the antibodies that do exist. It includes two models for
two different approaches (a stochastic approach and a continuum approach) for solving the same
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problem, which we verified converge to give the same results. I was responsible for the continuum
model. The paper is reproduced here as Chapter 4, with Chapter 5 including extended work on this
subject.
Finally, I give an overview of a nanoparticle drug delivery model, which is in work to be submitted.
Since drug treatments require extensive testing that is expensive, mathematical modeling is a powerful
tool to help direct treatments before testing. This research simulates a drug treatment strategy that
draws on previous research on animal in vivo experimental results. I helped design the model and
performed all simulations. Chapter 6 includes the discussion on this topic.
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CHAPTER 2
Modeling the Excess Cell Surface Stored in a Complex Morphology of
Bleb-Like Protrusions1
2.1 Introduction
Cells maintain their structural integrity while being flexible enough to adopt a variety of shapes.
In general, it is the cytoskeleton of eukaryotic cells that drives shape transformation leading to cell
movement and provides the structural support to the cytoplasm and the means to resist external
forces. The periphery of cells, consisting of the plasma membrane (PM) and the actomyosin cortex,
is highly dynamic to accommodate shape change. The plasma membrane (PM) consists of a high
density of proteins [1] embedded in a phospholipid bilayer of 5-10 nm thickness, with a very limited
ability to extend without rupture [2, 3] but highly amenable to bending [4–6]. The thin (50-500
nm) layer of cytoskeleton structure immediately subjacent to the plasma membrane, known as the
cell cortex, consists of a dense F-actin network that is cross-linked by actin binding proteins and
is amenable to contractility mediated by myosin motors. Interposed between the cortex and the
PM is a thin spectrin-actin network, forming a "fishnet" with a mesh size of ∼100 nm [7,8]. This
structure is anchored both to the PM and cortex by adaptor proteins. In the following, we term the
plasma membrane and spectrin-actin network as the "cell surface".
Previously we [9] suggested that most dynamical shape changes exhibited by non-spread (rounded)
cells originate from a membrane-cortex folding-unfolding process and an excess of cell surface area is
a necessary requirement for such changes. We investigated the dynamics of periodically protruding
cells and hypothesized that the plasma membrane and thin cortical layer remain coupled during
all stages of shape transformation. We also assumed that densely compressed cell surface folds and
1This chapter previously appeared as an article in PLOS Computational Biology. The original citation is as follows:
Maryna Kapustina, Denis Tsygankov, Jia Zhao, Timothy Wessler, Xiaofeng Yang, Alex Chen, Nathan Roach, Timothy
C. Elston, Qi Wang, Ken Jacobson, M. Gregory Forest. "Modeling the Excess Cell Surface Stored in a Complex
Morphology of Bleb-Like Protrusions," PLoS Comput Biol, 12 no. 3 (2016): e1004841
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small protrusions could be kept intact by the underlying actin-myosin network residing in the cortex
proper. While this notion may be applicable to many shape transitions occurring in non-spread
cells, in this paper we reconsider this hypothesis in context of one of the most drastic changes of cell
shape: the transformation from a fully spread to a rounded state.
If a cell transitions from a spread to rounded state while maintaining a constant volume, it will
experience an excess of surface area over the minimum needed to cover the enclosed volume. Because
this process typically happens rapidly (∼30s-), there is insufficient time for excess membrane to
be internalized by endocytosis. Thus, another mechanism for storing surface area at the plasma
membrane must exist. Indeed, there is significant evidence from both electron and fluorescence
microscopy that during the rounding process the cell surface adopts a tightly folded morphology
[9–12].
While there are a number of models for cell shape, most of them treat the cell surface as smooth
[13–17] and do not take into account the possibility that rounded cells store excess surface area in
a dense distribution of bleb-like protrusions (BLiPs). Thus, new modeling approaches are needed
to understand the dynamics of cell shape changes that involve active use of this surface storage.
We introduce three complementary modeling approaches, each incorporating the concept of excess
surface area. The first approach is a 2D model based on a thin cell surface structure that is coupled
to a thicker, contractile actomyosin layer. This model allows us to investigate the folding of the
excess surface and to estimate the bending energy in different configurations. The second approach is
a random "seed and growth" model that produces 3D morphologies consistent with the distributions
of BLiP size and number estimated from scanning electron micrographs. This model yields insight
into how large numbers of BLiPs are efficiently packed on the cell periphery.
The third approach is a multi-compartment phase field model. By faithfully capturing the
physical properties of the cortex, cytosol, and cell surface, the model predicts the stress and pressure
distributions associated with a highly folded 2D morphology and a dense distribution of 3D BLIPs.
Phase field models have been widely used to study complex systems comprised of distinct material
phases and their adjacent interfaces. When the separate material phases are immiscible, the phase
field approach is to prescribe a finite thickness of a "diffuse" interface within which there is a mixture
of the two materials [18,19]. The phase field method is an alternative to sharp interface methods; in
both methods the shape and evolution of the sharp versus diffuse interface are part of the solution.
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For every pair of adjacent material components, a phase field variable is introduced that interpolates
from one material phase to the other through the finite thickness boundary. Phase field models
have been employed to describe shapes of lipid bilayer vesicles in which the surface tension and
Helfrich bending energy are approximated using a bulk energy defined within the diffuse interfacial
layer [19]. Phase field models have been applied to many interfacial problems including liquid drops,
multiphase complex fluids [20], and fractures in solid-state materials [21].
The phase field model simulations achieve separate goals. From either a 2D transmission electron
micrograph or a 3D image reconstruction of the cell morphology, the model "learns" the spontaneous
curvature functional of the rounded, BLiP-rich, morphology. Since the phase field model faithfully
captures material properties of each cellular compartment, the model converges to the cell target
morphology while constructing self-consistent stress and isotropic pressure distributions for the cell
surface, cortex and cytoplasm, as well as estimating the nematic orientation within the cortex.
Storage of excess cell surface in folds or bleb-like protrusions at the periphery is likely to be
important for a variety of rapid cell shape changes, taking place over a time scale of a few minutes or
less, such as those that occur in forms of amoeboid migration or either within or in the transitions
between the phases of mitosis. It seems likely that rapid cell shape changes can be accomplished more
quickly by calling upon a reserve of excess membrane stored in the BLiP distributions rather than
relying on extensive membrane-cortex remodeling and exocytosis. Thus, the theoretical approaches
presented here should be applicable in a number of different biological contexts.
2.2 Results
2.2.1 Cell rounding produces an accumulation of excess surface at the cell periphery
When spread cells (Fig 2.1A) are chemically detached from an underlying substrate, they rapidly
transition to a rounded state on a characteristic time scale of ∼30-60s (Fig 2.1B). Numerous studies
suggest that in media with constant osmolarity, cell volume is stable [3, 22]. We estimated cell
volume by reconstructing 3D geometries from Z-stacks of spinning disc fluorescence images of cells
undergoing rounding. The mean volume for Chinese hamster ovary (CHO) cells in the spread state is
6.5± 2.82× 103µm3, while the mean volume in the rounded state is 5.7± 2.30× 103µm3, indicating
a slight decrease in cell volume after rounding. Because this slight decrease in cell volume would
only increase excess surface area, in all our models, we assume that cell volume remains constant
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during rounding.
The surface area of a spread cell is estimated as twice the area measured from images to account
for dorsal and ventral surfaces. In reality cells are not completely flat and have more surface area due
to finite thickness, particularly around the nucleus. Therefore, we are underestimating the surface
area of a spread cell. In the rounded state, the minimal surface area needed to enclose the measured
cell volume can be found by assuming the cell is spherical and calculating the radius. For example,
the cell 1 in Fig 2.1A has a surface area of ∼31000 µm2 while the surface area needed to enclose the
rounded state is only ∼ 2200 µm2. Therefore after rounding, this cell has ∼14 times more surface
area than is required to enclose its volume. This image presents an extreme case of surface area
excess. For cell 2 in Fig 2.1A, which is less spread before detachment, an excess surface area of
about five times the required amount is accumulated following rounding. It is important to note
that the amount of excess surface area that is accumulated during rounding depends on cell type
and characteristics of the spreading and detachment for individual cells. Using DIC and fluorescence
microscopy, we studied populations of cells before and after detachment, and individual cells rounding
during trypsinization. The histogram in Fig 2.1C presents the distribution of surface areas for spread
CHO cells (blue bars; population mean = 4310± 3600µm2, N = 199) and cells immediately after
rounding (red bars; population mean = 892 ± 284µm2, N = 1646). The distribution of rounded
cell sizes is narrow with majority of cell radii (Fig 2.1E) being between 7 and 9.5 µm (mean =
8.36 ± 1.24µm; N = 1646). Separate experiments, where we followed the change in morphology
of individual cells during rounding, demonstrated that for CHO cells the average excess surface,
defined as the ratio of spread cell area to that required to smoothly cover a sphere with radius
corresponding to that of the rounded cell, accumulated due to detachment and rounding is 3.8± 2.06
with maximum value of 12 (N = 99).
To gain insight into how much excess surface area can be stored in BLiPs, we first consider the
case of a rounded cell uniformly covered with equally sized spherical BLiPs.
It is easy to show (S1 Appendix) that as spherical BLiPs become smaller, more excess surface
area can be accommodated. The maximum possible surface excess that can be stored in the equally
sized spherical BLiPs is 5 (in the limit of BLiP radius r → 0). The fact that we observed rounded
cells with the surface excess as high as 14, means that cells utilize a more efficient packing strategy.
Also no limits on the surface excess ratio would be imposed if we did not require BLiPs to be
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spherical, but rather allow for an arbitrarily high curvature of the surface, as occurs, for example, in
tubules. Yet, the majority of BLiPs appear to be rounded immediately after detachment. These
considerations suggest that the actual morphology of the folded cell surface is dictated by a balance
between the necessity to pack tightly a very large number of BLiPs and the necessity to generate,
regulate, and maintain significant surface curvature.
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Figure 2.1: Transition from spread to rounded states and localization of F-actin and
myosin in the cortex of a typical rounded cell and cortical structure. A. Merged DIC and
fluorescence image of spread Swiss 3T3 fibroblasts stably transfected with Lifeact-RFP (green) cells
with clearly visible signal from stress fibers. Cell outlines traced from image. Bar = 20µm. B. Image
of the same cell after trypsin-induced detachment. The white outline shows the former spread shape.
Yellow arrow points to the rounded cell. C. Cartoon compares the radius of a sphere required to
accommodate the cell volume from the spread state (R = 50µm) versus the rounded state (R =
13µm) for the cell on the left. D. Distribution of spread and rounded cell areas. E. Distribution of
rounded cell radii. F. DIC and confocal fluorescence images of rounded CHO cell stably expressing
GFP-Lifeact (green) and RFP-MLC (red) Bar = 5 µm. G. Transmission electron microscopy image
of GFP immunogold staining of rounded CHO cells with stable expression of Lifeact-GFP. Black
dots which represent gold particles show the position of actin filaments. Bar = 1 µm. H. Inset shows
outlined region in G at higher magnification. Arrow points to F-actin immediately underlying the
plasma membrane in BLiPs: arrowhead points to the F-actin in the cortex closer toward center of
the cell. Bar = 0.5 µm.
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2.2.2 Cortex architecture informs the 2D discrete geometric model
To better understand the process of packing cell surface excess into a convoluted surface
morphology, we constructed a 2D geometric model designed to produce BLiPs. We hypothesize
that the cell surface and underlying contractile cortex form a two-layer structure that is coupled at
certain fixed points. The first layer, which we term the cell surface, is passive and consists of the
plasma membrane and membrane- associated cytoskeleton. This layer is assumed to be similar to
the spectrin-actin network that is coupled to the plasma membrane of red cells [23]. Such structures
have been shown by Kusumi and co-workers to exist in many other cell types [8]. The membrane
associated cytoskeleton has been termed the membrane skeleton fence [8]. It is basically a very
thin filamentous meshwork that provides a "fishnet" with a mesh size of approximately 100 nm
immediately underlying the PM. This layer is coupled to the plasma membrane via adaptor proteins
including the ankyrin and ERM families as well as by interactions of the membrane skeleton fence
with lipids in the inner monolayer of the PM. The layer is thought to be passive undergoing only
thermal motions, serving to anchor some transmembrane proteins and restrict the free diffusion of
others. We assume that this thin layer is coupled via adaptor proteins to a thicker, active contractile
layer containing actin and myosin. This view of the cortex-cell surface couple is consistent with that
advanced by Charras et al (2006) [24] in the context of spontaneously blebbing cells.
Additional evidence for this structure comes by imaging employing confocal and electron mi-
croscopy. Fig 2.1F shows a confocal image of the actin-myosin cortex in rounded cells as visualized
with GFP-lifeact and RFP-myosin merged with a DIC image of the same cell. The green signal for
Lifeact marks F-actin filaments associated with the folded morphology of the cell periphery and this
fluorescent signal originates from both the thin layer immediately subjacent to the membrane and
the thicker contractile layer. The fluorescent signal from myosin (red) shows that this protein is
localized mainly to a thin circle located below the BLiPs and more toward the cell interior. Fig 2.9
presents Z-stack images of the same cell. From this image, it is clearly visible that the convoluted
morphology covers the whole cell. Fig 2.1G and 2.1H shows immunogold TEM images of GFP-lifeact
where F-actin is seen underlying BLiPs (arrow) and also in a layer closer toward the center of the
cell (arrowhead).
To construct the 2D geometric model introduced qualitatively above, we implement a two-layer
architecture in a 2D bead-spring model of the cell membrane and cortex (model description in
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Methods). The bead-spring model consists of two-layers (Fig 2.2A and Fig 2.10), where one layer
(outer layer) represents the membrane and underlying actin mesh (i.e. the cell surface) and the
other layer (inner layer) represents the actomyosin-rich contractile cortex. In each layer, beads are
connected pairwise by springs and contact points serve to connect the two layers. By minimizing
the bending energy we explored the steady-state shapes of BLiPs generated during cell rounding
when the cell is rapidly presented with a substantial excess surface. For simplicity we define excess
surface ratio (ER) as a ratio of perimeters of the surface layer and contracted cortex. Here we define
a normalized total bending energy (E) as for
E =
∮
s
κ2ds ≈ L
N
N∑
i=1
κ2i (2.1)
where κ is the local curvature measured between two neighboring beads, L is the perimeter, and N
is the number of beads in the outer layer [25–29].
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Figure 2.2: The discrete geometric model. A. Two layer cortex model (left) and its bead-spring
representation with notations employed (right). B. Folded geometries as a function of the fold
number and the excess surface ratio. C. A portion of a model cell with BLiPs at steady state where
the gold line represents the cortex. D. The shape of three single folds extracted from simulations for
initial excess ratio, ER = 4 with different numbers of folds, N: 20 (blue), 40 (red) and 50 (yellow).
E. The shape of three single folds extracted from simulations for number of folds N = 40 with
different initial excess ratio, ER: 6 (blue), 4 (red), 2 (yellow). All calculated shapes were scaled to
have the same unit area inside the outer perimeter. The bending energy (BE) is presented for each
configuration.
The number of contact points determines the number of folds (M). In the simulation the total
Hamiltonian of the two-layer system is minimized with the result that a folded configuration of
outer layer is produced. Fig 2.2B shows the resulting shapes as a function of both M and ER.
Fig 2.2C shows a portion of a model cell with BLiPs at steady state where the gold line represents
the contractile part of the cortex with contact points. While the appearance of folds is expected,
the shape of folds and the bending energy stored in each configuration is of particular interest.
Fig 2.2D gives a comparison of the fold configuration for several different sets of parameters with
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the calculated bending energy for each shape. Inspection of the fold shapes shows that in order to
accommodate more surface, the folds tend to develop long necks. (Note that in case where there is
heterogeneity in the size of folds, this effect would allow small folds to grow under larger ones, an
effect that permits accommodation of more excess surface.) The smallest possible bending energy
will be achieved when ER = 1 and M= 0 (no surface excess and no BLiPs). For a given value of ER,
the energy increases with the number of BLiPs (Fig 2.2D and Fig 2.10). However, the bending energy
is decreasing while the excess surface ratio is increasing. Although this result looks counterintuitive,
it can be explained. The local curvature is the inverse of local radius. Folds with a longer perimeter
have bigger inner radii which substantially decreases bending energy with the square of local radius
(Fig 2.2D and Fig 2.11). Thus, morphologies with longer perimeters corresponding to larger ERs
will have lower energy compared to the shapes with the same number of folds but with shorter
perimeters (i.e. smaller ERs). The analysis of the area which is stored inside the folds (i.e., volume
in 3D) shows that for the same surface excess, more area is stored in folds when the number of folds
used for accommodation of this surface surplus is smaller (Fig 2.11D).
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Figure 2.3: Morphology of rounded cells. A. Fluorescence, DIC and merged images of rounded
CHO cells stably transfected with Lifeact-GFP. B. Fluorescence, DIC and merged images taken near
the equatorial plane of a rounded CHO cell with the fluorescence signal coming from the PH domain
of PLC-delta fused to EGFP that marks the inner leaflet of the plasma membrane (Bar = 5 µm). C.
Scanning electron microscope image of the rounded state (Bar = 5 µm). D. BLiP radii distribution
for N = 7096 BLiPs.
2.2.3 BLiP size measurements
At the resolution achievable by standard fluorescence microscopy, the convoluted cell surface
often appears as a thickening of membrane and cortical stains (Fig 2.3A and 3B). However, surface
morphology can be imaged at higher resolution using both scanning (SEM) and thin-section
transmission (TEM) electron micrographs (Figs 2.3C and 2.1H, respectively). At this scale, bleb-like
protrusions (BLiPs) and other cell surface protuberances are clearly visible. Note that only fully
spread cells have a smooth surface essentially devoid of protrusions (Fig 2.12).
To determine length, area and volume metrics of BLiPs, we manually segmented SEM images of
cells that were fixed after rounding (Fig 2.13). Each protrusion was approximated as a sphere and
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the area of the protrusion visible on the image was interpreted as a two dimensional projection of
that sphere. We calculated the radius that corresponds to a projection of that size, and consider it
as the radius of the BLiP. The distributions of BLiP radii derived from 10 SEM images (25 cells)
that include 7096 BLiPs is presented in Fig 2.3D. We find that the distribution of radii is skewed
with a preponderance of small BLiPs and a decreasing frequency of larger BLiPs. The mean BLiP
radius is R = 0.25 µm with a median of 0.22 µm and mode of 0.19 µm.
It is important to mention that during the processes of detachment and rounding some part of
the cell surface can be lost due to incomplete detachment from the substrate or because it remains
in retraction fibers. However, the area remaining in retraction fibers is quite small. Using SEM
images from cells that spread for 24 h and rounded 5 minutes before fixation, we estimated that the
surface area that might be stored in retraction fibers represents between ∼0.5-5% of the cell surface
area in the spread state.
2.2.4 BLiP packing on the cell periphery
To investigate how the large number of BLiPs required to accommodate the excess cell surface
are packed on the cell periphery, we constructed two models. As a plausible starting point, we
employed a Voronoi approach, in which a spherical ball of radius R =
√
S/4pi contains the surface
area, S of the spread cell before detachment and rounding; n seed point locations are randomly
sampled from a uniform spatial distribution on the ball. The ball is then partitioned by a Voronoi
tessellation according to the n seed points (Fig 2.4A) such that any point in each Voronoi cell is
closer to the parent seed point than any other seed point. The area of each Voronoi cell is then
determined. In this configuration, we assumed that, upon the cell rounding to its final state with
the "BLiPed" morphology, each Voronoi cell of area v morphs into a spherical BLiP with radius
r =
√
ν/4pi. Fig 2.4D demonstrates that, constructed in this way, the distribution of BLiP radii has
a well-defined length scale with the bell-shape distribution, which is not consistent with the skewed
distribution of experimental data. This result arises from the fact that Voronoi cells corresponding
to two very closely positioned seeds are not necessarily small themselves, as might be expected from
two closely positioned BLiPs.
In order to mitigate this effect, we introduce an alternative 3D "seed and growth" model (Fig 2.4B
and 2.4C), in which BLiP radii are proportional to spacing between randomly distributed seeds. In
this model, spheres are generated from each seed point by increasing their radii at a uniform rate.
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Simultaneously, the locations of the seed points are moved outward radially at the same rate, so
that the spheres always remain tangent to the cell. When one sphere encounters another, it stops
growing. When all spheres have stopped growth, a spherical cell coated by different sized BLiPs is
produced (Fig 2.4B). The resulting BLiP radius distribution in Fig 2.4D is more consistent with the
experimental distribution than that produced by the Voronoi model. The generated structure is also
consistent with SEM image data, which show approximately spherical BLiPs largely covering the cell
but with some areas devoid of BLiPs. We reproduced 2D cross-sectional views from the simulated
3D geometries (Fig 2.4F); these show similarity to the thin section TEM images of rounded cells
(Fig 2.4G) where some of the BLiPs appear to be detached from the cell body because BLiPs are
not always sectioned through their centers.
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Figure 2.4: BLiPs morphology generated by seed-and-growth models. A. A realization of
the Voronoi diagram. The seeds and boundaries of Voronoi cells are shown in blue; the Voronoi
polygons are shown in red. B. A realization of the "seed and growth" model. C. Magnified view of
rectangle in (B). D. Distribution of BLiP sizes: Voronoi model (green bars) and "seed and growth"
model (red bars) normalized using the assumption that average rounded cell radius is 8 um; the
blue line shows the experimentally obtained distribution. E. For the "seed and growth" model, plots
of%surface area stored in BLiPs and%of total volume stored in BLiPs as a function of the number
of BLiPs. F. A cross-section of "seed and growth" model. G. Transmission electron micrograph of a
section of a rounded cell (Bar = 2 µm) for comparison to F.
In the "seed and growth" model, a larger number of BLiPs results in a higher surface area excess
ratio (Fig 2.4E) and a smaller percentage of the cell volume stored within the BLiPs, which is
consistent with our simplified estimations based on an 2D equal-sized BLiP distribution. In principle,
BLiPs that are not of equal size could allow a more efficient packing of excessive cell surface (with
smaller BLiPs filling the space between larger ones), which is important for accommodating very
high excess ratios (>5). However, in this model the packing is still inefficient because it always
generates areas devoid of BLiPs. A potential improvement to our model might be to incorporate
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stochastic seeding of new BLiPs and occasional "shrinking" BLiPs that are in contact, so that BLiPs
are dynamic and continue to adjust themselves toward the most efficient filling of the available space.
Such a "seed, growth, and shrinking" model would be consistent with the BLiP dynamics observed
in our experiments, but is beyond the scope of the current paper. Another potential improvement
would be to make final BLiP size proportional to the rate of expansion of the BLiP; this has been
found to be the case in an earlier study of blebbing cells [30].
Figure 2.5: Schematic for the phase field formulation of a cell in an aqueous medium.
φ1, φ2, φ3, represent volume fractions of the external aqueous medium, the nematic cortex as
schematically depicted by the crosshatched region and the cytosol, respectively, with φ1 +φ2 +φ3 = 1.
The entire computational domain is denoted as Ω. The cell surface is defined by the level sets
φ1 = φ2 = 0.5, while the cortex-cytosol interface is defined by φ2 = φ3 = 0.5. Note that we penalize
coexistence of three phases.
2.2.5 A phase field model can learn the spontaneous curvature of the cell surface from
2D transmission electron micrographs or 3D image reconstructions
The preceding models help build mechanistic intuition, yet, while predictive, they do not capture
all of the essential physics of the rounded phenotype. In order to approach this goal, we formulated
2D and 3D phase field models for a cell immersed in the aqueous extracellular environment. The
model is formulated in 3 space dimensions (3D), but it also restricts to 2D for purposes of modeling
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a cell cross-section. In our case, we have three phases (exterior aqueous medium, cortex, interior
cytosol) and two diffuse interfaces. The external aqueous medium and interior cytosol are modeled as
viscous fluids with specified viscosities and the cortex is modeled as a nematic (liquid crystal) gel [31].
The first diffuse (i.e., finite thickness) interface is what we have termed the cell surface, consisting of
the plasma membrane and very thin underlying filamentous "fishnet", that separates the aqueous
medium and the cortex proper. As described below in Methods, a particular level set function in the
phase field formulation will afford our definition of the "cell surface". The second diffuse interface is
the cortex-cytosol transition layer. Fig 2.5 is a 2D schematic of a 3D cell cross-section with individual
components and diffuse interfaces labeled, along with the phase variables defined below. (We do not
explicitly model the nucleus within the cytoplasm for this paper since we are primarily concerned
with the stationary rounded morphology.) A more complete mechanical formulation giving the total
system free energy in terms of its components is found in Methods.
2.2.6 Phase field modeling of a 2D cell surface morphology with excess "perimeter"
We summarize the key numerical results of the phase field modeling of a 2D cell surface morphology
due to an imposed excess arc length enclosing the 2D area. We require a 2D image of the membrane
morphology, taken from 2D transmission electron micrographs. From the image file, we posit an
initial smooth membrane boundary, and then evolve the phase field model while adjusting the
spontaneous curvature function C1 until the model converges to the image dataset. We first illustrate
the ability of the phase field model to match an arbitrary specified 2D boundary by "learning" the
spontaneous curvature function; the results are shown in Fig 2.6A for an illustrative benchmark in
which the cell perimeter contains 25 regularly spaced, uniform "BLiPs". (In 2D, this is achieved
by superimposing the appropriate Fourier mode on a circle.) Next, we used as input the actual
periphery of a rounded cell from a 2D transmission electron micrograph (TEM) image. The results
in Fig 2.6B show the convergence of the phase field membrane morphology to the TEM image, where
the nematic phase ordering (representing F-actin orientation) in the cortex is depicted. This result
assumes tangential anchoring condition of F-actin at both cortical diffuse interfaces.
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Figure 2.6: Application of the phase field model to 2D target images. A. Proof of principle
of the 2D phase field simulation. From left to right, convergence from circular initial data to a
target cell surface morphology with 25 uniform, equally spaced, "BLiPs". B. Convergence of a
2D phase field simulation to a 2D, TEM image of a representative cell surface morphology. The
red curve in panels 1-3 is the cell surface obtained from a 2D TEM micrograph, which serves as
the target of the phase field model. The black contours in each panel are the initial data (left
panel) which evolves to the actual cell surface in the phase field simulation. The green contours
depict the interface between the cortex and interior cytosol. In the right panel, the F-actin filament
orientational distribution within the nematic cortex is superimposed, as predicted by the phase
field model. In these simulations, the Flory order parameter,
√
h1/h2 is set to 1. C. Phase field
predictions of the pressure distribution. D. the first invariant (trace) of the dominant stored stress,
the Ericksen stress, for the converged stationary morphology shown in B, right panel. E. A blow-up
of the trace of the Ericksen stress inside the dashed yellow rectangular domain in D. The color bars
for C, D, and E are in units of Pascals.
Fig 2.6C- 2.6E shows the phase field predictions of the pressure distribution (C) and the first
invariant of the dominant stored stress, the Ericksen stress, for the converged stationary morphology
(D,E) shown in Fig 2.6B. These results reveal the orders of magnitude as well as spatial localization
of pressure and stored stress for the target 2D morphology.
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2.2.7 Phase field recapitulation of 3D BLiP morphologies and associated stress maps
A 3D simulation is depicted in Fig 2.7 to demonstrate the capability of our phase field model to
converge to a target 3D cell surface morphology. The excess surface area ratio for this illustration is
s0 = 3. Because it is impossible to reproduce a full 3D morphology of a rounded cell from a single
scanning electron micrograph, we use the "seed and growth" model to simulate a 3D cell surface
target. This model (Fig 2.4) provides a 3D surface morphology consistent with the measured BLiP
size distribution data; therefore, we posit the output image from this model as the target morphology
for the 3D phase field simulation. As shown earlier in 2D and here in Fig 2.7 in 3D, the phase
field model converges to the target 3D morphology from an initial posited surface, while satisfying
the volume and excess surface area constraints. The model does so by iterating the spontaneous
curvature function until all constraints are satisfied; once converged, the model then yields the
pressure and stresses within the cell surface and cortex that are self-consistent with the 3D surface
morphology and constitutive properties of the exterior and cell compartments.
In Fig 2.7A, the target cell morphology is shown. The evolution of cell morphology, from an initial
rounded cell guess to the target cell shape, is provided in (Fig 2.7B and 2.7C). Fig 2.7D depicts 2D
projections in three mutually orthogonal planes of the cell surface morphology as well as the cortical
layer and interior cytosol domains, displaying the values of the phase field variables for each domain.
In Fig 2.7E and 2.7F the model predictions for hydrostatic pressure distributions and stored stress
in the same orthogonal planar sections for the stationary morphology are given correspondingly. The
pressure values are not unreasonable (e.g. a 1 mm depth of water at atmospheric pressure exerts a
hydrostatic pressure of 9.8 Pa). The pressure is low and positive in the external aqueous medium
and cytosol; therefore, an inward pressure is exerted from the external medium to the cell surface
and an outward pressure from the cell interior (cytoplasm) to the cortex. The pressure is negative in
the plasma membrane and cortical layer meaning that this layer experiences an inward compressive
pressure from the external aqueous medium and cytosol. The highest (compressive) pressures arise in
the cell surface "interphase" nearby high curvature BLiPs, with about an order of magnitude lower
values within the cortical layer itself. These stationary pressure gradients suggest a propensity for
fluid absorption from the exterior aqueous medium into the cortex phase and cell surface interface.
It is important to note that our simulations assume a stationary morphology, and the pressure and
stress distributions are a consequence of the stationary assumption. In reality, these morphologies
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are non-stationary, and in particular there is flow of the cytoplasm that fills the BLiPs. The new
balance of pressure and stress will then dictate the directional flux and flow of the external aqueous
medium and cytosol through the various cell compartments.
The 3D orientational distributions of cortical actin-filaments, comprising the nematic cortical
phase, are given in Fig 2.8A; planar 2D slices are shown at the specified positions in Fig 2.1B- 2.8D.
These figures convey the degree and direction of order within the F-actin filaments of the cortex,
and their strong correlation with the cell surface morphology. Note that cortical F-actin is assumed
to prefer parallel alignment at both cortical interfaces for this illustration of the 3D phase field
model. The anchoring energy at the interfaces together with the presumed strength of the nematic
potential are responsible for the relatively high degree of alignment of the F-actin; these parameters
are tunable to match experimental data on nematic order within the cortex.
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Figure 2.7: Phase field simulation showing convergence to a target 3D cell morphology
image. (A) The target 3D cell morphology. (B) The assumed initial data for the cell surface. (C)
The converged cell surface from the phase field simulation. (D) 2D planar slices at z = 0.5, y =
0.5 and x = 0.5, respectively, of the converged 3D phase field simulation shown in C. The color bar
depicts level sets of the cortical phase variable φ2 to delineate the cortex (red is the level set φ2 = 1)
from the pure external aqueous medium and pure interior cytosol (both blue since φ2 = 0), while
both diffuse interfaces are depicted by the color interpolation between these level sets of φ2. (E)
Corresponding pressure distributions (units of Pa) in the 2D slices shown in (D). (F) Distribution of
the trace of the Ericksen stress (units of Pa) in the 2D slices shown in (D). The color bar for E, F is
in units of Pa. For these calculations the Flory order parameter is set to 1.
The nematic order was changed by varying Flory order parameter from 1 to values approaching 0.
The results of these simulations are shown in Fig 2.14 which shows the nematic order superimposed
on the 3D morphology for order parameters that range from 1.0 to 0.01. Cross-sections taken at
three orthogonal planes are shown in Fig 2.15. Note that the values assumed for K (the Franck
elastic constant), and h1 and h2 will not significantly affect the pressure or the Ericksen stress
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of the stationary morphology; this is because the dominant contribution to the Ericksen stress is
from spatial gradients of the level set function φ1 = 1/2 that defines the cell surface. As shown in
Figs 2.14 and 2.7, h1 and h2 only affect the nematic order of the stationary state and K does not
affect any of the predictions for the stationary morphology. However, for dynamic processes, these
parameter values will strongly dictate the results of the simulation.
Figure 2.8: The orientational distribution of F-actin filaments in the nematic cortex for
the steady state cell morphology associated with the 3D target morphology of Fig 2.7.
Since the Flory order parameter is unknown, for illustrative purposes we impose its maximum value
of 1 in this simulation, and impose lower values in the Figs 2.14 and 2.15. (A) 3D view; (B-D) 2D
planar projections of the nematic director field in the cortex in the x = 0.5, y = 0.5, z = 0.5 planes,
respectively. The color bar shows the magnitude of nematic director, where |p| = 1 denotes nematic
phase and |p| = 0 denotes the isotropic phase.
2.3 Discussion
Using comparative measurements of many individual cells in two distinct configurations, spread
on a substrate versus in a rounded state detached from the substrate, we showed that the cell surface
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area in the rounded state is highly convoluted and far exceeds the surface area of a sphere that
would enclose the volume of the cortex, cytosol and nucleus. We analyzed the size and distribution
of bleb-like protrusions (BLiPs) on the cell periphery that served as storage for the excess of surface
area. We then developed three complementary modeling approaches that incorporate the concept of
excess surface area on rounded cells in different ways.
Employing a 2D discrete geometric model, we tested whether the two-layer composition of the
cortex, with the outer layer termed the cell surface, giving the local shape of the BLiPs and the
inner layer responsible for contraction, is sufficient to reproduce the highly folded surface observed
after rounding. This model demonstrated that morphologies with longer perimeters corresponding
to larger ERs will have lower energy compared to the shapes with the same number of folds but
with shorter perimeters (i.e. smaller ERs). This result predicts that during cell rounding, larger
folds, which are energetically more favorable, should appear early in the process. On the other hand,
smaller folds will appear later because it can require time to build structures that will support the
higher curvature folds. Indeed, several preliminary experiments in which cells are detached and
imaged appear to support this notion. In the early stages of rounding, big folds often appear on
the cell surface but, as time goes on, the cell breaks the large folds into the smaller ones. This
is supported by the fact that we see a prevalence of small BLiPs in the distribution of fold sizes
from the SEM and fluorescence imaging. It is also possible that smaller BLiPs are required as the
cell approaches a rounded, steady state because the large folds stored too much of the cell volume
(Fig 2.11D) which could disrupt normal cell functioning. In addition, the ability to create smaller
folds would be advantageous in storing large surface excesses in that small BLiPs could form under
larger ones for more efficient packing.
Our 3D random "seed and growth" model of BLiPs approximated the BLiP number density and
size distribution from 3D scanning electron micrographs. The model provided insight into the SEM
image analysis that revealed skewed size distributions of the BLiPs, with a preponderance of small-
scale features and successively fewer large-scale protuberances. Moreover, this model demonstrates
that efficient packing of BLiPs requires that heterogeneity of BLiP sizes is needed to recapitulate 3D
morphologies.
To begin to capture the physical properties underlying the convoluted morphology of the rounded
cell, we introduced a generalized phase field formulation. The model accounted for the cell surface as
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a diffuse interface between the exterior aqueous phase and the interior cortical phase and cytoplasm.
In the model, the cell surface is equipped with a Helfrich bending elastic energy that includes
a spontaneous curvature function that encodes the bending energy associated with the BLiPs.
The spontaneous curvature function is a consequence of molecular components (the spectrin-actin
"fishnet") that mediate the attachment between the cell surface and cortex. However, this molecular
information is implicit at this stage of the phase field model, with future extensions aimed at coupling
these molecular origins of the spontaneous curvature. At this juncture, our multi-compartment,
phase field model accepts 2D or 3D images of the cell morphology as input targets and "learns"
the membrane curvature of that target morphology. Since each cell compartment is endowed with
constitutive properties, the phase field model predicts physical consequences of the target morphology
throughout the cell compartments, restricted for this study to input stationary morphologies. In
particular, the model predicts pressure and stress distributions that are concentrated within the cell
surface diffuse interface and highly correlated with membrane-cortex interface gradients associated
with BLiPs. In future model developments, when the dynamics of the rounded phenotype are
introduced, the pressure-stress distributions will evolve in time, and the consequences of constitutive
properties of each compartment will dominate the evolution, unlike the stationary predictions where
viscous and nematic stresses relax to zero.
How do these three distinct approaches relate to one another? We postulate that cell surface
regions rich in adaptor proteins bind the cell surface to the cortex, inheriting the mean curvature
of the cortex. We have termed these regions attachment or contact points. Although the species
composing these regions have not been identified, presumably they would belong to groups such as
the ERM family of cytoskeletal-membrane adaptors as previously suggested in [24]. Moreover, one
would expect that these contact points would be transient and regulatable leading to more dynamic
behavior than we capture in the current models. Domains with less binding proteins allow the cell
surface to detach from the contractile part of cortex forming BLiPs. We assume in our models that
the distribution of binding protein species dictates the surface morphology, which in turn dictates
the spontaneous curvature function. In the discrete geometric Hamiltonian model, the binding sites
forming the attachments between the cell surface and the cortex are explicitly modeled, leading to
an induced cell surface morphology.
In the phase field model, we choose the level set φ1 = 0.5 to define and match the surface
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morphology captured in 2D micrographs or reconstructed in 3D using the seed-and-growth model.
Thus discrete Hamiltonian and phase field modeling approaches are complementary: the discrete
Hamiltonian model is based on postulated attachment points that determine morphology, whereas the
phase field model, in which specific molecular features are coarse-grained, is based on a spontaneous
curvature function specific to and constructed from the morphology itself. In 3D, micrographs are
not sufficient to provide a 3D image file due to significant occluded cell surface. Thus, we used
images produced by seed-and-growth model that yields 3D images of the surface morphology that
are statistically consistent with the measured 3D BLiP distribution data from scanning electron
microscopy images. The phase field model then uses the 3D surface construction as an imposed target
morphology, and the model evolution adapts the spontaneous curvature function until the target
morphology is reached. The phase field model then predicts the stationary stresses and energies
within the cell surface and cortex self-consistent with that surface morphology. It is important to
note the stationary aspect of the model predictions which identify stress contributions that are due to
spatial gradients of the fitted membrane morphology. Indeed, since the model simulation converges
to the input stationary morphology, the stored stresses due to nematic elasticity all relax and are
negligible. I.e., the stress components are insensitive to the nematic parameters, and are dominated
by the gradients of the level set function φ1 = 0.5 learned from the morphology. The power of the
model will be further revealed when we investigate the dynamics of the highly convoluted morphology,
where nematic parameters and constitutive properties of all compartments will then have significance.
It will be important from a biological standpoint to learn the bounds on these parameters.
An additional caveat is that the models presented are purely mechanical or steric in nature. It is
certainly possible that active processes other than cortical contraction, giving rise to cortical tension
[32] during rounding could play a role even in the short time span of cell rounding from a spread
state. For example, in our model, we did not include the actin polymerization process explicitly
although but it is true that smaller BLiPs, which are the majority of the population, have higher
bending energy so that they require stronger cortical support perhaps requiring additional actin
nucleation and polymerization [33] on short time scales.
Highly convoluted surface morphologies are often apparent in three-dimensional tissue contexts
and in cells that are not fully spread on a two-dimensional surface. The storage of the cell surface in
folds or bleb-like protrusions at the cell periphery is likely to be crucial to a variety of rapid cell
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shape changes such as those that occur in cell migration. It seems more feasible and energetically
favorable that rapid cell shape changes can be accomplished quickly by calling upon and pulling
out the excess surface stored in the BLiP distributions as an alternative to large scale endo- and
exocytosis accompanied by membrane-cortex remodeling. Although the results presented here are
derived for stationary BLiP-laden morphologies, these models form the foundation for future studies
of cell surface dynamics regulated by coupling to reaction-diffusion kinetics of various molecular
species. These kinetics can be expected to be controlled by signal transduction in many cases. The
theoretical approaches presented here should find application in a number of different biological
contexts.
2.4 Methods
2.4.1 Development of the discrete geometric model
The bead-spring model consists of two-layers (Fig 2.2A), where one layer (outer layer) represents
the membrane and underlying actin mesh (i.e. the cell surface) and the other layer (inner layer)
represents the myosin-rich contractile cortex. Within each layer, beads are connected pairwise by
springs. Special contact points serve to connect the two layers via springs. At the beginning of
simulation both layers have the same perimeter. During the simulation the inner layer (cortex)
shrinks in order to reach the target enclosed area with smaller perimeter, imitating cortex contraction.
The presence of contact points between two layers enforces outer layer bending (Fig 2.10). Although
the more correct definition of the excess surface ratio is ε2D = L¯2piR¯ = L¯/2
√
piATotal, where L¯ is the
perimeter of the surface layer and R¯ is the radius of the circle that would enclose the area inside this
surface layer (Atotal), for the simplicity we define excess surface as a ratio between the perimeters of
surface layer and contracted cortex.
Let the surface layer with the perimeter L be represented by N beads (Fig 2.10), with the
notational convention that bead 0 corresponds to bead N (representing a closed contour). Then the
Hamiltonian for this outer layer of beads and springs (i.e. the cell surface) is:
Hout = c1
N∑
i=1
κ2i + c2
N∑
i=1
(li − L¯/N)2, (2.2)
where κi is the local curvature of the surface at bead i; li is the length of the spring between beads i
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and i+ 1; c1 and c2 are free parameters that define relative contributions of the energy terms. The
first term in Eq 2 is the energy cost for bending the surface layer. The second term ensures that the
outer layer does not significantly stretch or contract during the simulated process. c1 and c2 are
chosen with c2  c1 so that as the system approaches a steady (minimum energy) state, the first
term tends to a configuration that minimizes curvature and the second term tends to zero.
The Hamiltonian of the inner, contractile layer (i.e. the cortex) is:
Hin = c3
M∑
j=1
p2j + c4(A− A¯)2, (2.3)
where M is the number of beads in the inner cortex (M < N); pj is the length of the spring between
inner beads j and j + 1; A is the area of the polygon formed by the inner beads with perimeter
P ; A is the target area; and c3 and c4 are scaling parameters that define relative contributions of
the energy terms. At the steady state this layer approaches the circular shape with A → A¯ and
j → 2
√
piA¯/M .
The total Hamiltonian of the two-layer system contains three additional terms:
Htot = Hout +Hinn +Hcontact +Hcross +Hself . (2.4)
Hcontact is the energy stored in the springs between inner and outer cortex contact points:
Hcontact = c5
p∑
i=1
||ti − τi||2, (2.5)
where ti denote the contact points on the outer cortex and τi denote the corresponding contact points
on the inner cortex. This term ensures that these contact points remain close. Hcross penalizes
crossing of outer cortex beads into the inner cortex polygon:
Hcross = c6
M∑
i=1
||ti − l¯||1pi∈Inn, (2.6)
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where Inn denotes the interior of the polygon formed by the points of the inner cortex, and the
indicator function 1pi∈Inn if the outer cortex point pi is in Inn and 0 if outside. ti denote the points
on the outer cortex and l¯ denotes the segment closest to each point. We calculate this function by
computing the point’s winding number. Lastly, Hself penalizes self-crossing of the outer polygon.
Let l¯ denote the line segment connecting beads i and i+ 1.
Hself = c7
∑
i 6=j
cross(l¯i, l¯j), (2.7)
where the function cross(l¯i, l¯j) = 1 if l¯i and l¯j cross and 0 if they do not. We let c7 =∞ with the
convention 0∞˙ = 0, effectively preventing any self-crossings of the outer cortex. In practice, this
condition is enforced by considering all other energy terms and keeping bead i fixed if l¯i crosses any
l¯j for any j 6= i in the next iteration. As the system approaches steady state each of these additional
terms tends to zero.
While the target area (A¯) constraint is more aptly applied to the outer layer, it is numerically
more feasible to apply the target area constraint to the inner layer Hamiltonian and to scale the final
simulated result by multiplying the coordinates of each point by a multiplicative factor to match the
target area. With this scaling the overall shapes of the "cell surface" and cortex do not change but
all simulated shapes get the same area inside their surface layer which includes cortex and folds.
2.4.2 The phase field approach
We introduce phase variables φi, i = 1,2,3 (Fig 2.5) that denote the volume fractions of phase 1
(the exterior aqueous medium surrounding the rounded cell), phase 2 (cortex) and phase 3 (interior
cytosol), respectively. Clearly, in any pure phase i, the respective φi = 1, whereas in diffuse interfaces
between phases i and j, φi + φj = 1, with φk = 0,k 6= i, j, and everywhere the total volume fraction
is 1. Thus in the external aqueous medium, φ1 = 1; in the F-actin rich, cell cortical layer, φ2 =
1; and in the interior cytoplasm, φ3 = 1. The phase boundaries are: the cell surface, as defined
above, that separates the external aqueous medium and cortical layer, where 0<φ1,φ2<1; and, the
transition layer between the cortex and interior cytosol where 0<φ2, φ3<1. For graphical purposes
and for matching 2D TEM and 3D simulated topology images from the seed and growth model, the
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cell surface is defined by the level sets φ1 = φ2 = 0.5, while the cortex-cytosol interface is defined by
φ2 = φ3 = 0.5. We do not allow all three phases to come into contact in this model, achieved by an
energy penalty term. Therefore the level set φ1 = 0.5, in domains where φ3 = 0, determines the cell
surface. Below, we illustrate how to constrain this level set function to match the experimentally
measured cell surface, in both shape and surface area.
We note that for this paper the external aqueous medium and interior cytosol are modeled as
viscous fluids with specified viscosities and the cortex is modeled as a nematic (liquid crystal) gel
[31]. Viscoelasticity of the interior cytoplasm is easily incorporated into our phase field formulation
[34], but for the purposes of the stationary morphology any stored elastic stress in the cell interior
relaxes to zero. Thus we simplify to a viscous cytosol for this paper.
The governing equations for the three phases and two diffuse interfaces are presented next. The
phase field method is an energy-based variational theory, comprised of free energy functionals for
each phase and diffusive interface.
Free energy. We denote the free energy of the cortex by Fp, where the subscript p is the nematic
director; the free energy for all interfacial tensions by FS , where S denotes surface energies; and the
free energy for the cell surface bending energy by FB, where B denotes bending. The cell surface
and the F-actin cortex may be bound or tethered, modeled by an orientational anchoring condition
that can be tuned between parallel and normal alignment of the cortex, and with an energy cost of
membrane-cortex anchoring denoted by Fanch. The membrane surface area and the cell volume are
assumed to be known from experimental measurements of the spread cell configuration and conserved
in the transition from spread to rounded configuration as discussed in the experimental section. The
phase transport equations for the phase variables in this paper are Cahn-Hilliard equations that
ensure the conservation of volume of each component and thereby conserve cell volume [18, 35].
Therefore, cell volume is encoded in the initial conditions and preserved in all simulations. To ensure
conservation of membrane surface area, we introduce an energy FSA that penalizes the departure
from the prescribed, measured, membrane surface area. Putting these contributions together, the
total free energy is given by the sum:
F = FS + FB + Fp + Fanch + FSA. (2.8)
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We now describe these energy terms in more detail. The interfacial surface energy contributions
are built into φ1 and φ2 at the external aqueous medium-cortex boundary (the cell surface) and
into φ2 and φ3 at the cortex-cytosol phase boundary. Each contribution is modeled by a standard
phase field approximation to the surface energy at the interface, consisting of an energy penalty for
conformational entropy together with the Ginzburg-Landau double well potential whose two minima
define the two adjacent phases, and finally an energy term that penalizes coexistence of the three
phases:
FS =
∫
Ω
3∑
i=1
3
√
2γis
(
ε
2
||∇φi||2 + 1
ε
φ2i (1− φi)2
)
+
γ123
2
3∏
i=1
φ2i dx, (2.9)
where γ1s and γ2s contribute the cell surface tension while γ2s and γ3s contribute surface tension for
the cortex-cytosol diffuse interface. Here γ123 is a parameter to penalize coexistence of the three
phases.
Since the membrane "surface" is represented by φ1 = 0.5 φ2 = 0.5, the bending elastic energy
FB of the cell surface is built into φ1, given by
FB =
∫
Ω
3
√
2γ1bε
(
∇2φ1 − 2
ε2
φ1(φ1 − 1)(2φ1 − 1− ε√
2
C1)
)2
dx, (2.10)
where γ1b parameterizes the bending rigidity of the bilayer membrane, and ε parameterizes the
interfacial thickness. The function C1 is the spontaneous curvature of the cell surface, a key element
of our model that warrants discussion. C1 is a proxy for the heterogeneous "fishnet" or membrane
skeleton coupled to the plasma membrane per se, as discussed above, that will be explicitly represented
by attachments between the plasma membrane and subjacent fishnet as discussed in the discrete
geometric model presented above. Regions with a relatively dense fishnet bind the membrane to
the cortex, inheriting the (relatively low) mean curvature of the cortex. Regions with a relatively
dilute fishnet allow the cell surface to detach from the cortex and in these domains, we surmise that
BLiPs form. In the absence of detailed molecular knowledge of the fishnet structure, we use either
2D micrographs of the cell surface morphology or 3D simulations of the cell surface morphology (see
the next paragraph) to instead construct the fishnet proxy, the spontaneous curvature function C1.
Note that the interplay between domains poor versus rich in the cell surface-cortex skeleton dictates
the surface morphology, which in turn dictates the spontaneous curvature function C1. We choose
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the level set φ1 = 0.5 to define and match the membrane morphology captured in 2D micrographs
and reconstructed from 3D micrographs.
The elastic energy associated with the (apolar) nematic gel model of the filamentous actin cortex
is described in terms of a direction p for the principal axis of orientation, while |p| is allowed to
vary between 0 for the isotropic phase and 1 for a perfectly aligned phase. (We have chosen to use
a generalized Leslie-Ericksen-Oseen-Frank model of the nematic cortex in this study, rather than
more complex models based on the second moment tensor of the F-actin orientational distribution.
The rationale is both for modeling simplicity and to minimize the set of constitutive parameters
for the cortex that require experimental measurement. The vector with direction p is the nematic
director and |p| is the scalar order parameter. The elastic energy of the cortex is then given by a
Frank-Oseen distortional energy together with a Landau- de Gennes bulk free energy,
Fp =
∫
Ω
1
2
φ22
(
K
2
||∇p||2 + h2
4
||p||4 − h1
2
||p||2
)
dx, (2.11)
where the prefactor φ22 restricts the nematic elastic energy to the cortex, K is the Frank elastic
constant (we assume the bend, splay and twist constants are equal in this paper), controlling
energy cost for orientational gradients within the actin-rich cortical network; and h1, h2 are model
parameters that control whether the equilibrium phase of the cortex is nematic (|p| 6= 0) or isotropic
(|p| = 0). In a spatially homogeneous state, where ∇p vanishes, the elastic energy for the cortex
favors stable minima of the bulk energy function: h2/4||p||4 − h1/2||p||2. For h2>0, the stable
minimizer of this function is given by the nematic state |p| =
√
h1/h2 when h1 > 0 and by the
isotropic state p, when h1 ≤ 0.
The anchoring energy of the nematic cortex with the cell membrane is given by
Fanch =
∫
Ω
α1
2
(p · ∇φ1)2 dx, (2.12)
where α1 parameterizes the strength of the anchoring potential, and α1 > 0 promotes tangential
anchoring while α1 < 0 promotes normal anchoring of the F-actin cortical network with the cell
surface.
The target surface area is s0S∗, where S∗ is the initial external surface area of the plasma
membrane (the rounded base morphology) and s0 is the excess surface area ratio. The excess
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membrane surface is enforced by an energy penalty for deviation of the simulated, model surface
area S(t) from the imposed target surface area. The energy penalty function is given by
FSA =
1
2
λS (S(t)− s0S∗)2 (2.13)
where λS weights this energy penalty relative to other energy contributions, and S(t) can be estimated
from the phase variable φ1 by an integral over the entire computational domain (see [36, 37] for the
rigorous argument):
S(t) =
∫
Ω
3
√
2
(
ε
2
||∇φ1||2 + 1
ε
φ21(1− φ1)2
)
dx (2.14)
We note that this variational energy model accepts the measured target for s0S∗, and the
microscopic images are used to fit C1 from 2D cell perimeters or 3D cell surface reconstructions. In
this way, any initial guesses for S follow the energy minimization dynamics toward the target surface
area, while C1 guides the cell surface morphology toward that of the experimental micrographs.
With the free energy functional for the multiphase cell and external aqueous medium outlined
above, a hydrodynamic phase field model is then derived. The details of the governing system of
equations, the numerical method, and the parameter values we employ in simulations are deferred to
the supplemental.
2.4.3 Cell culture
Swiss 3T3 cells (obtained from Tissue culture facility UNC Chapel Hill) were cultured in DMED
(Gibco) with 10% FBS(Gibco). CHO-wt cells (from ATTC) were grown in medium DMEM/F12
(Gibco) containing 10% FBS. CHO cells stably expressing Lifeact-GFP (the small 17-amino-acid
peptide, Lifeact, fused to green fluorescent protein, GFP) were obtained from the James Bear
laboratory (UNC-Chapel Hill). CHO-wt cells were transiently transfected by GFP-PH-delta domain
(gift from Con Beckers, UNC-CH) using Lipofectamine Plus reagent (Invitrogen) and images were
taken 24-48 hours after transfection.
2.4.4 Imaging
Light microscopy. For visualization of cell rounding and estimation of cell sizes, cells were
grown for 24 h on glass bottom dishes. At the beginning of experiment cells were imaged in spread
state and then were detached by trypsin under continuous microscope recording. After the cells
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rounded, medium was added to the dish cells were imaged. Images were acquired with a 60x oil
immersion objective using an Olympus FluoView1200 laser scanning confocal microscope employing
an environmental chamber.
Scanning electron microscopy. CHO cells were grown in cell culture flask and on two
coverslips for 24h. Cells from flask were detached by trypsin, spun down, resuspended in 2 mL
of culture media. 1 mL of resuspended cells was added to one of the coverslips with spread CHO
cells (50% confluency) and incubated for 20 min. Another coverslip containing spread CHO cells
was treated with trypsin under microscope observation to insure that the cells rounded but did not
completely detach. Both coverslips were fixed with a solution of 2.5% glutaraldehyde/HBSS, pH
7.4, for one hour at room temperature. Following three rinses with 0.15M sodium phosphate buffer,
pH 7.4 (PB), the cells were post-fixed in 1% osmium tetroxide in PBS for 30 minutes followed by
subsequent treatment with 2% tannic acid for 10 minutes and 1% osmium tetroxide in water for 10
minutes. The coverslips were dehydrated with ethanol (30%, 50%, 75%, 100%, 100%), transferred
to a Samdri-795 critical point dryer and dried using carbon dioxide as the transitional solvent
(Tousimis Research Corporation, Rockville, MD). Coverslips were mounted on aluminum planchets
with double-sided carbon adhesive and coated with 10nm of gold-palladium alloy (60 Au: 40 Pd,
Hummer X Sputter Coater, Anatech USA, Union City, CA). Images were taken using a Zeiss Supra
25 FESEM operating at 5kV, working distance of 5mm, and 10Î14m aperture (Carl Zeiss SMT Inc.,
Peabody, MA).
Transmission electron microscopy. CHO cells stably expressing Lifeact-GFP were grown to
confluency, detached by trypsin, spun down, resuspended in cell culture medium, transferred to a
glass bottom dish and incubated for 20 min. Cells were fixed with 4% paraformaldehyde/HBSS and
then underwent osmium treatment, dehydration, and resin infiltration steps with coverslip separation.
For immunoelectron microscopy, primary antibody (Cell Signaling #2956 (GFP[D5.1]XP Rabbit
mAb) and secondary goat anti-rabbit conjugated to 5nm or 15nm colloidal gold diluted 1:100 was
employed. After preliminary observation, 5nm Aulabeled grids were enhanced with Nanoprobes Gold
Enhance (#2113, Nanoprobes, Yaphank, NY) reagent for 3 minutes. Stained sections were observed
using a LEO EM910 electron microscope operating at 80kV (Carl Zeiss SMT, Inc., Peabody, MA)
and photographed using a Gatan Orius SC1000 CCD Digital Camera and Digital Micrograph 3.11.0
(Gatan, Inc., Pleasanton, CA).
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2.5 Supplemental material for "Modeling the excess cell surface stored in a
complex morphology of bleb-like protrusions"
2.5.1 The full set of coupled model equations
By postulating the linear momentum balance and incompressibility of the material system, the
governing system of equations is (recall the description of the total free energy F in the main text):

ρ(∂tv + v · ∇v) = −∇p+∇ · σ,
∇ · v = 0,
∂tφi +∇ · (vφi) = ∇ · (λi∇(µi −mu2)), i = 1, 3,
∂tp + v · ∇p−W · p = νD · p + λ−1p h,
(2.15)
where h = δFδp is known as the molecular field in the liquid crystal community [38], representing a
torque generated by the Frank-Oseen elastic energy, µi = δFδφi is the chemical potential with respect
to φi, given by
µ3 = 3
√
2γ3sε
(−∇2φ3 + f ′s(φ3))+ γ123φ21φ22φ3,
µ2 = 3
√
2γ2sε
(−∇2φ2 + f ′s(φ2))+ γ123φ21φ2φ23 + φ2(K2 (∇p)2 + h24 |p|4 − h12 |p|2
)
,
µ1 = 3
√
2γ1sε
(−∇2φ1 + f ′s(φ1))+ γ123φ1φ22φ23
+ 3
√
2γ1b
(∇4φ1f ′b(φ1)∇2φ1 −∇2fb(φ1) + f ′b(φ1)fb(φ1))− α1∇ · ((p · ∇φ1)p) ,
h = −K∇ · (φ
2
2
2
∇p) + φ
2
2
2
(2.16)
with fs(φ) = 1ε2φ
2(1 − φ)2 and fb(φ) = 1ε2φ(φ − 1)(2φ − 1 + ε√2C1), where C1 is the spontaneous
curvature functional defined in the main text and approximated from the phase field variable φ1
by (6) below. Here σ is the total extra stress, Wαβ = 12(∂βvα − ∂αvβ) is the vorticity tensor,
Dαβ =
1
2(∂βvα + ∂αvβ) is the rate of strain tensor, ν is a geometric parameter for the nematic gel,
and λp is a rotational relaxation time for the nematic director p. Here the total extra stress tensor
consists of three parts:
σ = σr + σd + σe, (2.17)
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where σr is the elastic stress corresponding to the motion of the nematic director p, σd is the viscous
stress associated to the solvent in the system, σe is the Ericksen stress, the stress associated to the
elastic interfacial force due to molecular convection. They are given specifically by the following:
σr = −ν
2
(ph+ hp) +
1
2
(ph− hp),
σd = 2ηD,
σeαβ =
(
f −
3∑
i=1
φiµi
)
δαβ −
3∑
i=1
∂f
∂(∂βφi)
∂αφi − ∂f
∂(∂βpγ)
∂αpγ ,
(2.18)
where η is the volume-averaged viscosity, η =
∑3
i=1 φiηi, with η1 the buffer viscosity, η2 the cortical
viscosity and η3 the cytosol viscosity. The divergence of the Ericksen stress yields the interfacial
forces ∇ · σe = −(∇p) · h−∑3i=1 φiµi.
2.5.2 How to fit the spontaneous curvature
Given the TEM (2d) micrograph, we convert the experimental image into gray scale, where each
pixel is represented by a number between 0 and 1 that represents the volume fraction of pure buffer,
denoted by φ1 (1 represents pure buffer, 0 represents cytosol and cortex). The plasma membrane is
the level set φ1 = 12 . Then, the figure is interpolated into either 256*256 pixels, or 128*128 pixels,
depending on the mesh size in the simulation. In a similar manner, for the 3D case, we use the data
generated by the seed-and-grow model. The data is stored in either a 2563 or 1283 matrix, with
each data point between 0 and 1, representing the volume fraction of pure buffer. All data are in
Cartesian coordinates.
Denote the unit outward normal vector of the plasma membrane {φ1 = 12} as n, which is denoted
within the phase field context by
n = − ∇φ1|∇φ1| . (2.19)
Then the interfacial curvature can be expressed as a function of the phase field variable φ1 via
[39]
C1 = −∇ · textbfn ≈ 1|∇φ1|
(
∇2φ1 − φ1(1− φ1)(1− 2φ1)
ε2
)
. (2.20)
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2.5.3 Table of Model Parameters
All parameters are summarized in Table 1, including references that cite the order of magnitude
for some, whereas the others are estimated.
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Symbol Description Nominal
Value
Unit Reference and Remarks
d Characteristic length scale 1× 10−5 m [15]
t0 Characteristic time scale 1 s [15]
ρ Cell density 1.1× 103 kg/m3 [40]
η1, η2, η3 Averaged viscosity 10.0 N · s/m2 10−3−1 [15] for cytosol,
100 [41] for cortex
γis, i = 1, 2, 3 Surface tension for the interface 5× 10−5 N/m [13]
γ Bending rigidity of cell mem-
brane
1×10−18 N ·m [42]
ε Thickness of the interface 5× 10−7 m model parameter
λ1, λ3 Motility parameter 1× 10−8 m3 ·s/kg model parameter
λp Time relaxation for the nematic
director p
1× 103 s [43]
s0 Excess surface area ratio 3 experiment measured
model parameter
λS Lagrange multiplier for excess
surface area constraint
2× 105 N/m3 model parameter
K elastic strength for cell cortex
(Frank elastic constraints)
10−11 N [44, 45]
h1, h2 Landau de Gennes nematic po-
tential parameters
2× 102 N/m2 model parameter
α1 Parallel anchoring strength 10−11 N assume the same with K
ν Nematic director tumbling pa-
rameter
1.2 rod-like flow-aligning
regime
Table 2.1: dimensional and dimensionless parameters
2.5.4 Numerical Schemes
We now present the semi-discrete numerical scheme as follows.
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Given the initial conditions (p0, φ01, φ02, φ03,v0 = 0, p0 = 0), having computed (pn, φn1 , φn2 , φn3 ,vn, pn)
for n ≥ 0, we compute (pn+1, φn+11 , φn+12 , φn+13 ,vn+1, pn+1) in the following sequence.
1. Step 1: update pn+1:

pn+1−pn
δt = v
n · ∇pn − 12
(
vn − (vn)T ) · pn − ν2 (vn + (vn)T ) · pn = − 1λphn+1,
hn+1 = −K∇ ·
(
(φn2 )
2
2 ∇pn+1
)
+
(φn2 )
2
2
(−h1 + h2||pn||2)pn+1,
∂pn+1
∂n |∂Ω = 0,
(2.21)
2. Step 2: update (φn+11 , φ
n+1
3 ):
φn+1i −φni
∂t +∇ · (vnφni ) = ∇ ·
(
λi∇(µn+1i − µn2 )
)
,
µn+13 = C3(φ
n+1
3 − φn3 ) + 3
√
2γ3sε
(−∇2φn+13 + f ′s(φn3 ))+ γ123(φ21φ22φ3)n,
µn2 = 3
√
2γ2sε
(−∇2φn+12 + f ′s(φn2 ))+ γ123(φ21φ2φ23)n
+φn2
(
K
2 (∇pn+1)2 + h24 ||pn+1||4 − h12 ||pn+1||2
)
,
µn+11 = C2(φ
n+1
1 − φn1 ) + 3
√
2γ1sε
(−∇2φn+11 + f ′s(φn1 ))+ γ123(φ1φ22φ23)n
+3
√
2γ1b
(∇4φn+11 − f ′b(φn1 )∇2φn1 −∇2fb(φn1 ) + f ′b(φn1 )fb(φn1 ))
−α1∇ ·
(
(pn+1 · ∇φn1 )pn+1
)
,
∂φn+1i
∂n |∂Ω = 0,
∂∇2φn+1i
∂n |∂Ω = 0,
∂µn+1i
∂n |∂Ω = 0
(2.22)
3. Step 3: update φn+12 :
φn+12 = 1− φn+11 − φn+13 (2.23)
4. Step 4: update (vn+1, pn+1):

ρ v˜
n+1−vn
δt + (v
n · ∇)v˜n+1 = η∇ · (v˜n+1 + (v˜n+1)T )−∇pn − φn∇µn+1 − hn+1∇pn
+∇ · (−a2 (pnhn+1 + hn+1pn) = 12(pnhn+1 − hn+1pn) + ζφn+12 φn+13 pn+1pn+1) ,
v˜n+1|∂Ω = 0.
(2.24)
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
vn+1−v˜n+1
δt = −∇(pn+1 − pn),
∇ · vn+1 = 0,vn+1|∂Ω = 0.
(2.25)
In the above, C2 and C3 are numerical stabilizing parameters [46]. The above scheme is
constructed by combining several effective approaches in the approximation of Cahn-Hilliard equations
[46], Navier-Stokes equations [47] and phase-field models [48,49].
The numerical scheme is further discretized in space central finite differences, and implemented
on graphic processing units (GPUs) using the CUDA interface. The Nvidia CUFFT, Thrust [50], as
well as CUSP [51] have been used to solve the linearized systems. The resultant solver is tested in
both time and space to ensure it is convergent and attains first order accuracy.
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Figure 2.9: Fluorescence and DIC imaging of rounded CHO cell stably expressing RFP-Myosin and
GFP-Lifeact. Images taken along Z direction from cell bottom with 1um step.
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Figure 2.10: Schematic of the computational progression from initial (i) to final state (iii) for the
geometric model. i.) Initial condition: both the cell surface perimeter, L, and cortex perimeter,
Pinitial, start out at identical, coincident positions enclosing area A. N contact points are equally
distributed around the perimeter. The inner yellow circle represents the target area, Atarget, to
which the cortex will shrink during the computation, imitating a two-dimensional cell rounding.
ii) A snapshot at the early stages of computation when inner layer already shrunk to target area
with perimeter, Pfinal. Because the inner and outer layers are connected via contact points, folds
(BLiPs) are formed around the 2D cell periphery but bending energy of folds is not minimized yet.
iii) The final steady state is achieved by minimizing the Hamiltonian (in effect, the curvature of the
outer, cell surface layer). In this configuration, contact points on the outer and inner layer meet and,
because curvature energy is minimized, the system ceases to further evolve.
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Figure 2.11: Three overlapping shapes, each has the same area and initial excess ratio ER=4. The
shapes were prescribed to have different number of folds: 20 (yellow), 40 (red), 50 (blue). The
blue shape has smaller local radius along the perimeter which results in higher bending energy. B.
Three overlapping shapes, each has the same area and number of folds, N=40. The shapes have
different initial excess ratio: 6 (yellow), 4 (red), 2 (blue). The blue shape has smaller local radius
along the perimeter which results in higher bending energy. C. Plot of bending energy for simulated
shapes with different ERs and number of folds. D. Plot of area stored in BLiPs for different shape
configurations.
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Figure 2.12: A SEM image of CHO cells. Part of cells was spread on glass bottom dish for 24 hours
and another part was detached and plated on the same dish 20min before fixation. Bar=10 µm
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Figure 2.13: Estimation of BLiPs sizes. A. SEM image of rounded CHO cells. B. Enlarged part of
image on A (yellow dotted line) with some BLiPs contoured as example of how radius was estimated.
Using ImageJ the area within each contour was measured and the radius was calculated assuming
that the measured area represents a great circle of BLiP. C. Distribution of BLiPs radii of all cells
on image A estimated as it shown on B.
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Figure 2.14: The black lines in (b)-(e) denote the direction and magnitude of the nematic director,
where |p| indicates the degree of order between 0 (isotropic) and 1 (maximum order). Here √h1/h2
prescribes the Flory order parameter of the nematic equilibrium. Here we choose h1 = 2× 102N/m2
and h2 = 2× 102, 8× 102, 2× 104, 2× 106N/m2, for (b)-(e) respectively.
46
Figure 2.15: 2D slices of the surface morphology and director orientation from Figure 2.1. (a-c)√
h1/h2=1; (d-f)
√
h1/h2=0.5; (g-i)
√
h1/h2=0.1.
2.6 Appendix for "Modeling the excess cell surface stored in a complex mor-
phology of bleb-like protrusions"
The possible surface excess that can be stored on the rounded cell with equally sized
spherical BLiPs.
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2.6.1 Membrane excess
Suppose a spread cell has volume V0 and membrane surface area S0. We define membrane excess
as ε = S0S , where S is the surface area of a sphere with volume V0. Thus,
ε =
S0
4pi
(
4pi
3V0
)2/3
(2.26)
2.6.2 Two dimensional case
In 2D, the definition of membrane excess becomes
ε =
P0
2pi
√
pi
A0
(2.27)
Let’s assume that a rounded cell has circular folds ("blisters") of radius r tightly covering the cell
body of radius R (Fig. 2.16). Then,
Figure 2.16: A rounded cell with circular folds of different radii tightly covering the cell body.
Total area:
piR2 +Npir2 = A0 (2.28)
Total perimeter:
2piR+N2pir = P0 = 2ε
√
piA0 (2.29)
where the number of folds is
N =
pi
arcsin
(
r
R+r
) (2.30)
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In the limit r << R,
N ≈ piR
r
(2.31)
and
piR2 + pi2rR = A0
piR+ pi2R = ε
√
piA0
so that
R =
ε
√
A0√
pi(1 + pi)
(2.32)
r =
√
A0
pi
√
pi
(
1 + pi
ε
− ε
1 + pi
)
(2.33)
N =
pi2ε2
(1 + pi)2 − ε2 (2.34)
Therefore, membrane excess can be accounted in the given geometry (r > 0) if
ε < (1 + pi) (2.35)
Since the integrated curvature of a circle is 2pir(1/r)2 = 2pir , the total curvature is
K = 2piR +N
2pi
r ≈ 2piR + 2pi
2R
r2
r→0(→1+pi)−−−−−−−−→∞
2.6.3 Three dimensional case
In 3D, ( 2.28)-( 2.35) become Total volume:
4
3
piR3 +N
4
3
pir3 = V0 (2.36)
Total surface area:
4piR2 +N4pir2 = S0 = 4piε
(
3V0
4pi
)2/3
(2.37)
The number of folds (for r << R):
N ≈ 4piR
2
pir2
= 4
R2
r2
(2.38)
From ( 2.36)-( 2.38) we find that
R =
√
ε
5
(
3V0
4pi
)1/3
(2.39)
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r =
1
4
(
3V0
4pi
)1/3 [5
ε
−
√
ε
5
]
(2.40)
N =
[
8ε
√
ε
5
√
5− ε√ε
]2
(2.41)
In this case, membrane excess can be accounted in the given geometry (r > 0) if
ε < 5
Numerical example:
Fig. 2.17 shows the dependence of R(ε), r(ε) and N(ε), according to equations ( 2.32)-( 2.34) for
A0 = 570µm
2 and equations ( 2.39)-( 2.41) for V0 = 10000µm3. Grey area corresponds to r between
0.5 and 1.0 µm.
Figure 2.17: Plots of R(ε), r(ε) and N(ε) in 2D and 3D.
Comment: the above arithmetic is valid only under assumption that the folds are circular
(spherical) with the same size. For such geometry the maximum membrane excess is 1 + pi (in
2D) and 5 (in 3D). In different geometry, such as sinusoidal folds (Fig. 2.18), the membrane excess
doesn’t have to be bound. However, this geometry requires higher integrated curvature. We can use
our discrete model, that minimizes curvature but is not limited to a specific geometry, to explore
different shapes as a function of membrane excess ε and the number of folds N .
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Figure 2.18: A rounded cell with sinusoidal folds.
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CHAPTER 3
3d cell rounding
3.1 Introduction
This work is a continuation of the work by Kapustina et al. [9] discussed in previous chapter. To
examine the dynamics of a cell during the transition from a spread to rounded morphology, we hope
to extend the 2d Hamiltonian model from Kapustina et al. [9] to 3d. In addition, we are developing
a numerical fluid solver that can simulate structures with a viscoelastic fluid on the inside of the cell
and a viscous fluid on the outside, which will be used in the cell rounding simulation.
3.1.1 Energy function
Similar to the work done by Kapustina et al. 2016 [52], the morphology of the rounded cell will
be that which minimizes the following energy function:
Etot = Evol + ESA + Ecurv
where Evol is a function of any deviation from the target (initial) volume, ESA is a function of any
deviation from the target (initial) surface area, and Ecurv is a measure of the bending energy of the
entire surface.
3.1.2 Point initialization and energy calculation
In order to model the surface of the cell, a discretized sphere will be used, ideally with the
distance between a point and all of its nearest neighbors to be the same for every point. Since
there are only 5 regular polyhedra (Platonic solids), it is impossible to have perfectly equally spaced
points. However, there is some code by Anton Semechko found online for discretizing a sphere with
M points, which can be used to initialize the points on the outer layer. The total energy cost of each
state can be calculated by computing the energy of each of these M points on the discretized sphere.
Let’s look at a point on the surface, call it pk, which will have Nk=5 to 7 neighbors. In order to
illustrate how to calculate the energy for a single point without a loss of generality, let’s look at the
example case that pk has 6 neighboring points (Nk = 6) and label them n1, ..., n6 (see figure 3.1).
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Figure 3.1: Point pk with its 6 neighbors.
As will be shown later, calculation of the curvature also requires that we look at all of the faces
(triangles) that point pk is a vertex of, along with all of the faces (triangles) that share sides with the
faces that point pk is a vertex of (see figure 3.2). In this example case, since there are 6 neighbors,
Nk = 6, and there are 6 faces that point pk is a vertex of, and, consequently, 6 more faces that
share a side with any of the points neighboring point pk. We’ll call the 6 faces that pk is a vertex of
f1, f2, f3, f4, f5, f6, and we’ll call the 6 secondary faces f7, f8, f9, f10, f11, f12, where f1 will share a
side with fNk+1 = f7, f2 will share a side with fNk+2 = f8, etc. We will name the 6 new points that
are required to form these 6 new secondary faces s1, ..., s6.
Figure 3.2: Point pk with its 6 neighboring faces and 6 secondary points.
Since all the labels in figure 3.2 must be found for each point pk, an algorithm was written that
will do so after the sphere is discretized. Fig 3.3a is an image of a discretized sphere with M=1000
points that has run through the labeling algorithm. Fig 3.3b is the same but with M=15970 points
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and zoomed in to see the points better.
(a) M=1000 (b) M=15970
Figure 3.3: Sphere discretization. 1 point has been drawn in black, its neighbors drawn in red, and
its secondary neighbors drawn in green. It has been checked for several different points and several
runs.
3.1.3 ESA
The distance between point pk and each of its neighbors can be calculated, and the energy
associated from the total deviations between each distance and the target distance can be determined
by ESA = coutSA
∑i=M
i=1
(∑j=Ni
j=1
(
d(pi, nj) − Li,j
)2), where coutSA is the penalty weight of the energy
associated with the surface area of the outer membrane layer, Ni is the number of neighbors the
ith point pi has, nj is the jth neighbor of point pi, Li,j is the target distance between the points,
and d(pi, nj) is the distance between point pi and its neighbor nj , which will be measured using
the Euclidean norm. In this formulation, each of the segments will be measured twice in the
summation, but this is of no consequence since this factor will be "absorbed" by the weight cSA.
(Computing the distance between connected points twice will increase the computing time, so for
actual implementation each ought to be computed just once.)
3.1.4 Ecurv
In order to determine the angle between adjacent faces, it needs to be known which points
belong to each face, which faces are adjacent to each other, then compute the angle between ad-
jacent triangles. For example, using Fig 3.2 we’d need to know that f1 is composed of pk, n1, n2;
f7 is composed of s1, n1, n2; etc.; and that f1 is adjacent to f7, f1 is also adjacent to f2, etc.
The angle between adjacent faces is determined by finding the vectors normal to each face then
calculating the angle between these normal vectors. Since we want as little bending as possible,
we want to penalize the difference between the angle found and the angle indicating the vectors
normal to the planes are parallel to each other. So, we have that the curvature penalty is given
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by Ecurv = ccurv
∑i=M
i=1
(∑j=2Ni−1
j=1
(∑j=2Ni
k=j+1(θj,k − θparallel)2
))
, where M is the total number of
points, ccurv is the penalty weight of the energy associated with the total curvature of the outer
membrane layer, Ni is the number of neighbors the ith point pi has, θj,k is the angle between adjacent
faces j and k (so θj,k isn’t computed if the faces aren’t adjacent to each other), and θparallel is the
the angle if the planes are parallel. Rather than finding the difference between the internal angle
and a normal angle, we can just find the external angle, and hence make the following change:
Ecurv = ccurv
∑i=M
i=1
(∑j=2Ni−1
j=1
(∑j=2Ni
k=j+1(θ
external
j,k )
2
))
(see Fig 3.4 for schematic). See the Appen-
dix on bending energy for a more rigorous treatment on the curvature and bending energy.
Figure 3.4: The angle between faces f1 and f7 along with the external angle at the joint between
them.
3.1.5 Evol
For this implementation, using MATLAB or C++, the volume isn’t explicitly controlled. Instead,
just as was done in Kapustina et al. 2016 [52], the surface of the cell will consist of an outer
membrane that is attached by randomly-chosen special pinning points to an inner cortical layer. The
inner cortex is a sphere of a fixed specified volume, so pinning the membrane to this layer loosely
controls the volume within the cell, but not at extremely reliably. This approach replaces Evol with
Epin, Ecross, Eintersect, where Epin is the penalty to ensure points on the membrane are pinned to
corresponding points on the inner cortex, Ecross is the penalty to ensure that membrane points do
not lie within the inner cortex, and Eintersect guarantees that the membrane does not intersect itself.
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Using the 2-layer formulation, we can guarantee an excess of surface by starting with a sphere-
shaped membrane and then pinning several of the points to a cortex that is a sphere of a smaller
size. This will decrease the internal volume while maintaining the surface area. However, using this
approach means that the final internal volume won’t be known prior to beginning the simulation. If
a particular volume is desired, then the object can be shrunk or expanded to the desired size, but
then the surface area won’t be known until after this process. Furthermore, finding the steady state
using this approach means that the cell is only at the final volume at the end of the simulation,
meaning that this approach may yield the steady state, but it can’t be used as a simulation of a
cell transitioning from a spread to a rounded state. Fig 3.5 shows a simulation using this 2-layer
formulation.
(a) Iteration 2700 of the 2-layer formulation. (b) Steady state of the 2-layer formulation.
Figure 3.5: The evolution to the steady state in the 2-layer formulation using MATLAB, with
iteration 2700 in Fig 3.5a and the final steady state in Fig 3.5b. Notice the special pinning points on
the outer layer moving towards the inner layer in Fig 3.5a.
3.2 IBAMR formulation
IBAMR may be used with .spring and .beam input files to minimize Etot = Evol +ESA +Ecurv.
If the Eulerian mesh size is chosen small enough, Evol will be near zero as a consequence of
incompressibility and no fluid being able to leak between "close" Lagrangian points. If springs
are attached between all neighbors with a relaxed spring length set as the initial distance between
the points, then ESA will be near zero as a consequence of spring forces maintaining the distance
between all neighboring points. Ecurv can be minimized by inserting a "beam" (a torsion spring that
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exerts a force when it is not at a specific angle) whose ends are each pk and each of its secondary
points sj , and whose target bending angle is a straight angle.
For simplicity, we begin with the initialized surface in the previous section (a discretized sphere
where each point has 5-7 neighbors (and consequently 5-7 secondary neighbors). However, to simulate
a cell in a "spread" state we center the sphere at (0,0,0), then "flatten" it by multiplying all of the z
coordinates by a factor, such as 1/8.
3.2.1 Evol
To conserve the internal volume, the Eulerian mesh needs to be chosen correctly. If done correctly,
then no fluid will be able to pass between Lagrangian points, which will make sure that roughly the
same amount of fluid will be contained within the cell throughout the simulation. As a general guide,
it just needs to be that dx > 2 ∗ ds (but the smaller dx is the more accurate, so dx ≈ 2 ∗ ds is best),
where dx is the spacing between Eulerian grid points and ds is the spacing between Lagrangian
points. In order to guarantee dx > 2 ∗ ds, we need to make sure that dx > 2 ∗max(ds), so the
grid spacing is larger than twice the distance between any of the neighboring points. dx is given by
dx = L/N , where N is the number of Eulerian grids and L is the length of the system, so N and L
need to be determined in order to define dx.
We don’t want the boundary to influence the cell, so we decided to make sure that the cell could
wander its full length in any direction and not hit the boundary. Since the sphere created by the
initialization code is a unit sphere, that means that we want to have 2 units of empty Eulerian grids
between the cell and the boundary in all directions. Hence, we let L = 6, and made sure that the
following relationship holds: N = L/dx < L/(2 ∗max(ds)). For the case M = 15970, we have that
N = L/dx < 6/(2 ∗max(ds)) = 3/(max(ds)) ≈ 3/0.0255 ≈ 118. Notice that, for a 3d simulation,
there are N ×N ×N grids. 1183 = 1, 643, 032, while (3/0.01)3 = 27, 000, 000, which would make a
huge difference in computing time, so it is important to carefully select the right number of Eulerian
grids.
3.2.2 ESA
For our initial discretized object, we have a bunch of triangle faces. The surface area of this
object is just the sum of all the areas of all triangles. If each of these faces maintains its size, then
the surface area of the entire object will be preserved, regardless of any distortions from changing
the angles between one face and a neighboring face. Hence, if the length of each side of each triangle
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is unchanged throughout the simulation, then the total surface area of the object is also unchanged
throughout the simulation. To preserve the length of each side of each triangle, we can just assume
each side is a spring with a resting length equal to the initial distance between those triangle vertices.
If each spring is at its exact resting length when the simulation finishes, then the surface area is
preserved exactly.
3.2.3 Ecurv
As discussed in the previous approach, the curvature can be minimized by minimizing the external
angles of adjacent faces. If a torsion spring (with a target angle of a straight angle) were attached to
point pk and one of its secondary points, then the spring will exert a force to minimize the external
angle between two adjacent faces. Hence, "beams" can be used to connect each point pk to each of its
secondary points. However, beams need to know the endpoints (in this situation pk and a secondary
point sj) of the beam, as well as an intermediary point for the joint of the beam. Hence, some point
mj needs to be found somewhere along the line that is the common edge between the two adjacent
triangles, since that edge is the joint about which the faces bend. Fig 3.6 shows an illustration of
point pk, along with all of its neighboring points, its secondary points, and the intermediary points.
Figure 3.6: Point pk (black), along with all of its neighboring points ni (red), its secondary points sj
(green), and its intermediary points ml (yellow).
If all sides of the triangles had the same length, then the point mj would be right in the middle
of the edge between the two adjacent faces, and if both faces were on the same plane, then mj would
be exactly between pk and sj . Notice, though, that it will likely be the case that not all of the sides
will have the same length, so the intermediary point will likely not be exactly between vertices along
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the edge between the adjacent faces. Fig 3.7a shows two faces, f1 and f7, which share a common
side in the line n1n2. Assume that f1 and f7 are on the same plane. Then the point m1, which is
exactly between n1 and n2, makes for a poor choice for a joint, because the angle ∠pkm1s1 is not a
straight angle. Hence, instead of the beam trying to minimize the external angle between f1 and f7,
the beam will be essentially changing the shapes of 4pkn1n2 and 4s1n1n2, which changes the area
of these triangles, as well as affects other adjacent faces.
(a) The choice of position for intermediary
point m1 is poor since straightening the
beam will change the shape of the faces
rather than just rotating them about the
edge n1, n2.
(b) The choice of position for intermediary
pointm1 is fine since straightening the beam
will rotate the faces about the edge n1, n2
and not change their shape.
Figure 3.7: Adjacent faces f1, f7 with a beam connecting opposite vertices pk, s1.
In order to choose the correct position of the intermediary point mj , the two adjacent faces need
to be projected onto the same plane, and then mj will lie at the intersection of the line pksj and
the line of the edge between the two adjacent faces. Fig 3.7b illustrates a good choice for where
to position m1, which is the intermediary point between pk and s1. Notice that in very extreme
cases, such as that shown in figure 3.8, the intermediary point may not lie on the edge between the
adjacent faces. Details on how to calculate the position of the intermediary point are in the Details
section of this chapter, as well as more discussion on the extreme case of the intermediary point
lying off of the edge between adjacent faces.
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Figure 3.8: Adjacent faces f1, f7 with a beam connecting opposite vertices pk, s1. This is an extreme
case where the intermediary point must not lie on the edge between the faces.
A consequence of adding the intermediary points is that the spring file must be changed. Instead
of having a single spring connecting two adjacent neighbors of point pk, the two neighbors (call them
n1 and n2) will each have a spring connecting to an intermediary point (call it m). Hence, instead
of a single spring connecting for segment n1n2 there will be two springs connecting the segments
n1m and n2m. Since we want the area of each triangle to be preserved, even in the two-segment
case we need n1n2 to be a straight line. We can try to accomplish this by making point m the joint
of a beam with ends n1 and n2. See the Details section for more details, and the Results section for
some results using this formulation.
3.3 Details
3.3.1 Finding the coordinates of the intermediary point
The following is a description for how to find the intermediary point that acts as the joint for
the beam to minimize the exterior angle between adjacent faces. For illustration of the procedure,
we will look at the adjacent planes given by 4pkn1n2 and 4s1n1n2. The intermediary point is at
the intersection of the line connecting points n1 and n2 and the line connecting p and s1 if the two
faces f1 and f7 are rotated about the common edge n1n2 until the two faces lie on the same plane.
The point is at the intersection of these two lines because the intermediary point is both the joint
of the beam with ends n1 and n2 and the beam with ends pk and s1, and both beams should be
straight when the two faces lie on the same plane. The description outlines how to determine the
location of the point by placing f1 and f7 on the same plane. It also outlines how to check for and
resolve the extremely rare cases that that the intermediary point does not lie on the segment n1n2,
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but rather on the extended line that contains those points (see Fig 3.9.)
(a) Case(1): Typical adjacent triangles pro-
jected onto the same plane, where the seg-
ment connecting pk and s1 goes between
points n1 and n2.
(b) Case(2): Unlikely event of two adja-
cent triangles projected onto the same plane,
where the segment connecting pk and s1 is
to the "left" of points n1 and n2.
(c) Case(3): Unlikely event of two adja-
cent triangles projected onto the same plane,
where the segment connecting pk and s1 is
to the "right" of points n1 and n2.
Figure 3.9: The 3 generalized cases for where the intermediary point is located.
Generalized form Fig 3.10 shows the labels of most of the sides and angles that are used in the
algorithm for determining the location of the intermediary point. Notice that quadrilateral pn1n2s is
convex, so we are in the regime given by Fig 3.9a, which is the case for nearly every pair of adjacent
triangles (there was a single exception in the run with 100 points originally discretizing the sphere,
and no exceptions in the runs with 1570 points and 15970 points). For the other cases, the same
labels will be used in order to represent those cases, and with the exception of the angles being
interior or exterior all of the labels will be the same, although the relative location of m will be
different (between n1, n2 or outside of them).
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Figure 3.10: Generalized triangle labels for sides and angles used in calculation of location of
intermediary point
Calculation of position for m The following is the algorithm for determining the (x, y, z) co-
ordinates for the intermediary point. The notation is given by Fig 3.10. It should be mentioned
that in the rare cases seen in Figs 3.9b and 3.9c, the intermediary points are in a sense isolated and
not actually on the surface of the sphere. Rather, they are attached via n1 or n2, and still act as
the joint of the beam with ends pk and s1, as well as acts as an endpoint of the beam that ensures
that n1, n2, and m lie on the same line. That being said, let’s look at the algorithm, which takes in
the coordinates of p, s, n1, and n2, and finds the coordinates of m. (Also, as a practical use of the
function, it notes whether quadrilateral pn1n2s is of the type found in Fig 3.9a, Fig 3.9b, or Fig 3.9c
in order to determine which of the points is the joint of the beam, as well as what the max distance
is between the points in order to help find the step size of the Eulerian grids, as was discussed in the
volume conservation section.)
p = (xp, yp, zp)
s = (xs, ys, zs)
n1 = (xn1, yn1, zn1)
n2 = (xn2, yn2, zn2)
pn1 =
√
(xp− xn1)2 + (yp− yn1)2 + (zp− zn1)2
pn2 =
√
(xp− xn2)2 + (yp− yn2)2 + (zp− zn2)2
sn1 =
√
(xs− xn1)2 + (ys− yn1)2 + (zs− zn1)2
sn2 =
√
(xs− xn2)2 + (ys− yn2)2 + (zs− zn2)2
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n1n2 =
√
(xn2− xn1)2 + (yn2− yn1)2 + (zn2− zn1)2
pn12 = pn22 + n1n22 − 2 ∗ pn2 ∗ n1n2 ∗ cos(θpn2n1)
⇒ θpn2n1 = cos−1
(pn22 + n1n22 − pn12
2 ∗ pn2 ∗ n1n22
)
pn22 = pn12 + n1n22 − 2 ∗ pn1 ∗ n1n2 ∗ cos(θpn1n2)
⇒ θpn1n2 = cos−1
(pn12 + n1n22 − pn22
2 ∗ pn1 ∗ n1n22
)
sn12 = sn22 + n1n22 − 2 ∗ sn2 ∗ n1n2 ∗ cos(θsn2n1)
⇒ θsn2n1 = cos−1
(sn22 + n1n22 − sn12
2 ∗ sn2 ∗ n1n22
)
sn22 = sn12 + n1n22 − 2 ∗ sn1 ∗ n1n2 ∗ cos(θsn1n2)
⇒ θsn1n2 = cos−1
(sn12 + n1n22 − sn22
2 ∗ sn1 ∗ n1n22
)
θpn1s = θpn1n2 + θsn1n2
θpn2s = θpn2n1 + θsn2n1
IF: θpn1s > pi
THEN: case "midpoint" actually "left" of n1 and n2 (see Fig 3.9b)
IF: θpn2s > pi
THEN: case "midpoint" actually "right" of n1 and n2 (see Fig 3.9c)
OTHERWISE:
case "midpoint" between n1 and n2 (see Fig 3.9a)
CASE (θpn1s > pi)
redefine: θpn1s = 2 ∗ pi − θoldpn1s
ps =
√
pn12 + sn12 − 2 ∗ pn1 ∗ sn1 ∗ cos(θpn1s)
θspn1 = asin(sn1/ps ∗ sin(θpn1s))
θpn1m = pi − θpn1n2
θpmn1 = pi − (θpn1m + θspn1)
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n1m = pn1 ∗ (sin(θspn1)/ sin(θpmn1))
n2m = n1n2 + n1m
t = n1m/n1n2
xm = xn1− t ∗ (xn2− xn1)
ym = yn1− t ∗ (yn2− yn1)
zm = zn1− t ∗ (zn2− zn1)
CASE (θpn2s > pi)
redefine: θpn2s = 2 ∗ pi − θoldpn2s
ps =
√
pn22 + sn22 − 2 ∗ pn2 ∗ sn2 ∗ cos(θpn2s)
θspn2 = asin(sn2/ps ∗ sin(θpn2s))
θpn2m = pi − θpn1n2
θpmn2 = pi − (θpn2m + θspn2)
n2m = pn2 ∗ (sin(θspn2)/ sin(θpmn2))
n1m = n1n2 + n2m
t = n2m/n1n2
xm = xn2 + t ∗ (xn2− xn1)
ym = yn2 + t ∗ (yn2− yn1)
zm = zn2 + t ∗ (zn2− zn1)
CASE (θpn1s, θpn2s ≤ pi)
ps =
√
pn12 + sn12 − 2 ∗ pn1 ∗ sn1 ∗ cos(θpn1s)
θspn1 = acos((ps2 + pn12 − sn12)/(2 ∗ ps ∗ pn1))
θpmn1 = pi − (θpn1n2 + θspn1)
n1m = pn1 ∗ (sin(θspn1)/ sin(θpmn1))
n2m = n1n2− n1m
t = n1m/n1n2
xm = xn1 + t ∗ (xn2− xn1)
ym = yn1 + t ∗ (yn2− yn1)
zm = zn1 + t ∗ (zn2− zn1)
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3.3.2 Designing ellipsoid for specified excess ratio
The initial configuration for the points pk is a sphere or radius 1 centered at the origin. The
spread cell can be represented as an ellipsoid. If we scale all of the z coordinates of the unit sphere
by a shrinking factor but leave the x and y coordinates in tact, we will get an ellipsoid. By doing
this, we will decrease the surface area and volume, but we will be shrinking the volume at a faster
rate than the surface area. Of interest is knowing how much to scale the z coordinates in order to
create an ellipsoid with a surface area that is ER (for "excess ratio") times larger than the surface
area of the sphere that has the same volume as the ellipsoid. That is, we want to find the minor
radius of the ellipsoid (with the other radii=1 unit) such that the following holds:
SAellipsoid = ER ∗ SAsphere
Vellipsoid = Vsphere
We can find the minor radius by the following:
Vsphere = 4/3pir
3
Vellipsoid = 4/3pia ∗ b ∗ c
SAsphere = 4pir
2
SAellipsoid ≈ 4pi
((ab)p + (bc)p + (ca)p
3
)1/p
where we let a = b = 1, and we’ll let p = 1.6075 from Knud Thomsen
Vellipsoid = Vsphere
⇒ 4/3piabc = 4/3pir3
⇒ r = c1/3
SAellipsoid = ER ∗ SAsphere
⇒ 4pi
((ab)p + (bc)p + (ca)p
3
)1/p
= ER ∗ 4pir2
⇒
((1)p + (c)p + (c)p
3
)1/p
= c2/3
⇒ 1 + 2cp = 3 ∗ ERp ∗ c2/3p
⇒ 1 + 2cp − 3 ∗ ERp ∗ c2/3p = 0
From here, we can just use Newton’s method to solve for c:
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f(cn) = 1 + 2c
p
n − 3 ∗ ERp ∗ c2/3pn
f ′(cn) = 2pcp−1 − 2pERpc2/3p−1
c0 = 1
cn+1 = cn − f(cn)
f ′(cn)
Since the original configuration is a sphere of unit radius (i.e., an ellipsoid with a = b = c = 1),
then we can just let c be the scaling factor; i.e., we can change the original coordinates (x, y, z) to
(x, y, c ∗ z) for all coordinates.
3.3.3 Determining the number of vertices, springs, and beams
The easiest way to determine the number of vertices, springs, and beams that construct our
cell is to ask the computer the length of the term holding all of the information about them (e.g.,
NumberBeams = length(BeamInfo)). But there is a way to calculate them explicitly.
Our initial discretized cell is a sphere with N points that are equally spaced apart. If these points
are truly equally spaced, then the points can be thought of as either the centers of faces of a regular
3d polyhedron or the vertices of a regular polyhedron. However, it is known that there are only 5
regular polyhedra (or Platonic solids), so to be truly equally spaced we need to restrict N to 4, 6, 8,
12, or 20 (or the number of faces to 4, 6, 7, 12, or 20 with faces possibly not triangular). We want to
have many more points than that. So, instead, we searched for code that will distribute the points to
be roughly equally spaced. The MATLAB code (by Anton Semechko) that we found that distributes
the points will take in N ∈ [100, 1000]∩Z and output distributed points and connect them to nearby
points to form a triangular mesh. For N > 1000, there is also code (by Anton Semechko) that will
subdivide each triangle into 4 triangles. Now, let’s look at how this code informs the number of
vertices, springs, and beams for our cell.
Overview of procedure for writing files The process for setting up the .vertex, .spring, and
.beam files is the following:
• Run Distribution Code with NumberPoints = N
• Run Subdivide Code
• Run Neighbor/Secondary Point Code
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• Run Insert Intermediary Points Code
• Run Determine/Write .vertex Code
• Run Determine/Write .spring Code
• Run Determine/Write .beam Code
After running the Distribution code, we will have a discretized sphere and triangulation. We
will have input N points, and after running it we will have N points, T = 2 ∗N − 4 triangles, and
E = 3 ∗N − 6 edges (segments connecting the points that make up the triangles).
To summarize, we have the following:
NumPoints = N0
NumTriangles = 2 ∗N0 − 4
NumEdges = 3 ∗N0 − 6
After running the Subdivide code, we will have a new discretized sphere and triangulation.
The subdivide code takes in the points and their connections (triangles and edges), along with
the desired number of divisions k, then divides each triangle into 4 triangles by placing a new
point that divides each edge into 2 edges, then connects the new points in each triangle together.
Hence, since in each subdivision each old triangle becomes 4 triangles, the number of new triangles
is given by Tnew = 4k ∗ Told. Given that T = 2 ∗ N − 4, we have that 2 ∗ Nnew − 4 = Tnew =
4k ∗ Told = 4k ∗ (2 ∗ Nold − 4), which means that 2 ∗ Nnew − 4 = 4k ∗ (2 ∗ Nold − 4), which can
simplify to Nnew = 4k ∗ (Nold − 2) + 2 = 4k ∗ Nold − (2 ∗ 4k − 2). Since E = 3 ∗ N − 6, then
Enew = 3 ∗Nnew − 6 = 3 ∗
(
4k ∗ (Nold − 2) + 2
)
− 6 = 3 ∗ 4k ∗ (Nold − 2).
To summarize, at this point we have the following:
NumPoints = 4k ∗ (N0 − 2) + 2
NumTriangles = 2 ∗ 4k ∗ (N0 − 2)
NumEdges = 3 ∗ 4k ∗ (N0 − 2)
The Neighbors/Secondary Point code only prepares all of the variables, so it does not change the
number of points, triangles, nor edges.
For the Insert Intermediary Points code, a new point is placed on every edge. This does not affect
the number of triangles nor edges, but it does change the number of points. The number of points
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increases by the number of edges, so Nnew = Nold+Eold =
(
4k ∗ (N0−2)+2
)
+
(
3∗4k ∗ (N0−2)
)
=
4k+1(N0 − 2) + 2.
To summarize, at this point we have the following:
NumPoints = 4k+1(N0 − 2) + 2)
NumTriangles = 2 ∗ 4k ∗ (N0 − 2)
NumEdges = 3 ∗ 4k ∗ (N0 − 2)
At this point in the process, we can now write the input files, which will reference the number of
points and edges.
.vertex file The format of the code is the following:
NumPoints
xCoordPt1 yCoordPt1 zCoordPt1
xCoordPt2 yCoordPt2 zCoordPt2
...
xCoordPtNumPoints yCoordPtNumPoints zCoordPtNumPoints
The number of points is given by NumPoints = 4k+1(N0 − 2) + 2, where N0 is the number
of points input into the original sphere construction code and k is the number of subdivisions
in the subdivision code. If a specific number of vertex points is desired to run the simulation,
then the number of points to input in the original sphere construction code can be given by
N0 =
N − 2
4k+1
+ 2. However, it should be noted that not every number can be expressed due to the
fact that N0 ∈ [100, 1000] ∩ Z and k ∈ N ∪ {0}.
.spring file The format of the code is the following:
NumSprings
IndexV ertex1Spring1 IndexV ertex2Spring1 SpringConstSpring1 RestLenSpring1
IndexV ertex1Spring2 IndexV ertex2Spring2 SpringConstSpring2 RestLenSpring2
...
IV 1SprNumSprings IV 2SprNumSprings SCSprNumSprings RLSpringNumSprings
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Each of the connections between the vertices is a spring connection. Notice that before running
the Insert Intermediary Points code the number of connections was the number of edges E. However,
after inserting the intermediary points, the number of triangle edges remained the same, but the
number of connections had doubled (since each edge gained a point which has a connection to
it on either side). Hence, the number of connections, and therefore the number of springs, is
NumSprings = 2 ∗ E.
The indices are found using several of the variables from the Neighbors/Secondary Point code.
However, we didn’t want to repeat any connections (e.g., Point1 connected to Point2 and Point2
connected to Point1), so we wrote more code to find all of the unique connections prior to adding the
intermediary points. Notice that since every triangle vertex connects to 2 intermediary points and
no triangle vertices, and each intermediary point connects to 2 triangle vertices and no intermediary
points, then every spring contains 1 intermediary point and 1 triangle vertex. Hence, IndexV ertex1
can be the triangle vertex and IndexV ertex2 can be the intermediary point, which makes organizing
the list without repeats a bit easier.
The resting length of each spring is the distance between an intermediary point and one of its
connecting triangle vertex points. Determining the position of the intermediary points is described
in another section. The position of the intermediary points is determined in part by calculating the
distances between the intermediary point and each of its connecting points.
The spring constant between each of the springs is set to be the same for all springs. It is
desirable to have the surface area maintained, which is done by ensuring that all of the springs are
at their resting lengths, so the spring constant should be somewhat large. The precise value can
only be determined by trial and error.
.beam file The format of the code is the following:
NumBeams
IndexV ertex1Beam1 IndexV ertex2Beam1 IndexV ertex3Beam1 BeamConstBeam1
IndexV ertex1Beam2 IndexV ertex2Beam2 IndexV ertex3Beam2 BeamConstBeam2
...
IV 1BeamNumBeams IV 2BeamNumBeams IV 3BeamNumBeams BCBeamNumBeams
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The purpose of the intermediary points is to create joints for beams that connect a point to
each of its secondary points, which will then reduce the external angles between adjacent faces,
and hence reduce the curvature of the entire system. Since each intermediary point is the joint
point for 1 of these "curvature" beams (and there are no "curvature" beams that do not have an
intermediary beam as the joint), then the number NCurvBeams of "curvature" beams is equal to
the number of intermediary beams. As shown earlier, the number of intermediary points is equal
to the number E of edges of the triangles, so NCurvBeams = 3 ∗ 4k ∗ (N0 − 2), where N0 is the
number of points input into the original sphere discretizing code, and k is the number of subdivisions
in the subdivision code.
The insertion of the intermediary points ought to not change the shape of any of the triangles.
That means each edge must continue to be a straight line with an unchanged length. Large spring
constants should help maintain the length of each edge. In order to make sure that the edge remains
a straight line, a beam must be inserted with the intermediary point as the joint and the ends of the
edge as the ends of the beam. Similar to the other beams, because all of the intermediary points are
the joints of all of the "edge" beams, and all of the "edge" beams have an intermediary point as
the joint, then the number NEdgeBeams of "edge" beams is equal to the number of intermediary
points, so NEdgeBeams = 3∗4k ∗ (N0−2), where N0 is the number of points input into the original
sphere discretizing code, and k is the number of subdivisions in the subdivision code.
The total number NumBeams of beams is the sum of the 2 types of beams, so NumBeams =
NCurvBeams+NEdgeBeams = 6 ∗ 4k ∗ (N0 − 2).
Notice that for both sets of beams, the intermediary point is the joint. That means that
IndexV ertex2 always refers to an intermediary point. For the "curvature" beams, IndexV ertex1
can always refer to the point pk and IndexV ertex3 to the secondary point, which makes organizing
and not repeating easier. For the "edge" beams, IndexV ertex1 and IndexV ertex2 will be defined
by the intermediary point position algorithm.
Since maintaining the edges is important for preserving surface area, the beam constant (similar
to a spring constant) should be relatively high (and the same for each of the "edge" beams). All of
the "curvature" beams should have the same value as one another, but this value should be less than
the "edge" beams since we don’t want the curvature minimization to compromise the straightness of
the edges. As was the case with the spring constants, the precise values of the beam constants can
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only be discovered through trial and error.
Plots made from input files In order to check whether the vertices, springs, and beams were
created correctly, and that the files were written correctly, plots were made from reading the files.
Recall that, in the vertex file, each vertex has a reference number to identify that vertex, then the
x, y, and z coordinates of that vertex. A spring connects two vertices, so, in the spring file, each
spring has two numbers which refer to the identity of the two vertices the springs are connected
to. Using MATLAB, we’ve plotted all of the vertices from the list of vertices written to the vertex
file. Then, on the same plot, we went through the spring list, drawing a line from the first vertex of
the spring to the second vertex of the spring. Fig 3.11 shows these plots. We wanted to distinguish
between the springs, so we made the color of the line on one side of the intermediary point blue, and
the color on the other side of the intermediary point red. From these plots, it appears that we’ve
created the vertices and springs correctly, and written the files correctly.
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(a) 100 triangle vertices comprising
the full cell.
(b) 100 triangle vertices comprising
the full cell. Only the points with a
z coordinate greater than 0 plotted.
(c) 100 triangle vertices comprising
the full cell. Zoomed in to see the
details better.
(d) 1570 triangle vertices compris-
ing the full cell.
(e) 1570 triangle vertices compris-
ing the full cell. Only the points
with a z coordinate greater than 0
plotted.
(f) 1570 triangle vertices comprising
the full cell. Zoomed in to see the
details better.
(g) 15970 triangle vertices compris-
ing the full cell.
(h) 15970 triangle vertices compris-
ing the full cell. Only the points
with a z coordinate greater than 0
plotted.
(i) 15970 triangle vertices compris-
ing the full cell. Zoomed in to see
the details better.
Figure 3.11: Plots for validating vertex and spring files.
A beam connects two vertices to a single vertex, where the latter point is the joint of the beam.
In the beam file, each beam has a number which refers to the identity of the vertex acting as the
first end of the beam, then another number which refers to the identity of the vertex acting as the
joint of the beam, followed by a number which refers to the identity of the vertex acting as the other
end of the beam. In MATLAB, we’ve plotted all of the vertices from the list of vertices written to
the vertex file. Then, on the same plot, we went through the list of beams, drawing a line from the
joint to the first end, then from the joint to the other end. Fig 3.12 shows these plots. We wanted to
distinguish between the vertices of the triangles and the intermediary points in order to see the ends
and joints of the beams, so we colored all of the triangle vertices black and the joints red. We also
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wanted to distinguish between the types of beams, so we made the color of the n1 −m− n2 beams
black and all of the p−m− s beams either red, blue, green, yellow, magenta, or cyan. We wanted
to make sure that the two halves of the p−m− s beam were the same color (the first half from the
joint to the first end and the second half from the joint to the second end), so we coded them to be
so and cycled through the 6 colors from one beam to the next. From these plots it appears that
we’ve created the vertices and beams correctly, and written the files correctly.
(a) 100 triangle vertices comprising
the full cell.
(b) 100 triangle vertices comprising
the full cell. Only the points with a
z coordinate greater than 0 plotted.
(c) 100 triangle vertices comprising
the full cell. Zoomed in to see the
details better.
(d) 1570 triangle vertices compris-
ing the full cell.
(e) 1570 triangle vertices compris-
ing the full cell. Only the points
with a z coordinate greater than 0
plotted.
(f) 1570 triangle vertices comprising
the full cell. Zoomed in to see the
details better.
(g) 15970 triangle vertices compris-
ing the full cell.
(h) 15970 triangle vertices compris-
ing the full cell. Only the points
with a z coordinate greater than 0
plotted.
(i) 15970 triangle vertices compris-
ing the full cell. Zoomed in to see
the details better.
Figure 3.12: Plots for validating vertex and beam files.
3.4 Results
We submitted several jobs to the cluster. However, we still haven’t found the right values for the
spring and beam constants to get good runs. The cluster times out after a week, which should be
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reasonable to complete a job, but we are not getting anything close to completed runs. The .vertex,
.spring, and .beam files seem to be set up correctly to create the desired geometry and evolve the
cell, but we are still not successful at producing a single good run. Here are some of the results:
3.4.1 100 points
The images in Fig 3.13 are all with 100 points (before adding the intermediary points–394 total
points at runtime). They all start from the same initial configuration (Fig 3.13a), and each snapshot
is taken from the same angle (so there is some rotation as the cell evolves). In these we have the
radius in the x- and y-direction set to 1 unit, while that of the z-direction is 1/4, so there is an excess
ratio of roughly 2.75. In all runs we have L=6, rho=1000, mu=70, max_levels=1, ref_ratio=1,
N=20, and smallest_patch_size level_0=20,20,20.
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(a) Initial configuration of the
points for all runs.
(b) Run 1 final configuration.
Spring constant: 1.00E+07, p−
m− s beam constant: 1.00E+05,
n1 − m − n2 beam constant:
1.00E+07
(c) Run 2 final configuration.
Spring constant: 1.00E+07, p−
m− s beam constant: 1.00E+06,
n1 − m − n2 beam constant:
1.00E+07
(d) Run 3 final configuration.
Spring constant: 1.00E+08, p−
m− s beam constant: 1.00E+06,
n1 − m − n2 beam constant:
1.00E+08
(e) Run 4 final configuration.
Spring constant: 1.00E+08, p−
m− s beam constant: 1.00E+05,
n1 − m − n2 beam constant:
1.00E+08
(f) Run 5 final configuration.
Spring constant: 1.00E+07, p−
m− s beam constant: 1.00E+05,
n1 − m − n2 beam constant:
1.00E+08
Figure 3.13: Runs with 100 regular points and 294 intermediary points.
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3.4.2 1570 points
The images in Fig 3.14 are all with 1570 points (before adding the intermediary points–6274
total points at runtime). They all start from the same initial configuration (Fig 3.14a), and each
snapshot is taken from the same angle (so there is some rotation as the cell evolves). In these we
have the radius in the x- and y-direction set to 1 unit, while that of the z-direction is 1/4, so there
is an excess ratio of roughly 2.75. In all runs we have L=6, rho=1000, mu=70, max_levels=1,
ref_ratio=1, N=40, and smallest_patch_size level_0=40,40,40.
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(a) Initial configuration of the
points for all runs.
(b) Run 1 final configuration.
Spring constant: 1.00E+07, p−
m− s beam constant: 1.00E+05,
n1 − m − n2 beam constant:
1.00E+07
(c) Run 2 final configuration.
Spring constant: 1.00E+07, p−
m− s beam constant: 1.00E+06,
n1 − m − n2 beam constant:
1.00E+07
(d) Run 3 configuration when un-
expectedly aborted. Spring con-
stant: 1.00E+08, p−m−s beam
constant: 1.00E+06, n1−m−n2
beam constant: 1.00E+08
(e) Run 4 configuration when un-
expectedly aborted. Spring con-
stant: 1.00E+08, p−m−s beam
constant: 1.00E+05, n1−m−n2
beam constant: 1.00E+08
(f) Run 5 configuration when un-
expectedly aborted. Spring con-
stant: 1.00E+07, p−m−s beam
constant: 1.00E+05, n1−m−n2
beam constant: 1.00E+08
Figure 3.14: Runs with 1570 regular points and 4704 intermediary points.
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Fig 3.15 is also with 1570 points (before adding the intermediary points–6274 total points at
runtime). For this run we have the radius in the x- and y-direction set to 1 unit, while that
of the z-direction is 1/16, so there is an excess ratio of roughly 6.5. In all runs we have L=6,
rho=1000, mu=70, max_levels=1, ref_ratio=1, N=40, and smallest_patch_size level_0=40,40,40.
The following parameter values were used for the springs: spring constant: 1.00E+07, p−m− s
beam constant: 1.00E+05, n1 −m− n2 beam constant: 1.00E+08. For each of these the left image
is t=0 and the right is t=18, and each left-right pair is taken from the same angle.
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(a) Initial configuration of the
points as viewed with the x axis
coming out of the page.
(b) A later configuration of the
points as viewed with the x axis
coming out of the page.
(c) Initial configuration of the
points as viewed from an angle
not perpendicular to any of the
axes.
(d) A later configuration of the
points as viewed from an angle
not perpendicular to any of the
axes.
(e) Initial configuration of the
points as viewed from the top.
(f) A later configuration of the
points as viewed from the top.
Figure 3.15: Run with 1570 regular points and 4704 intermediary points from different angles.
3.4.3 15970 points
Fig 3.16 is with 15970 points (before adding the intermediary points–63874 total points at
runtime). For this run we have the radius in the x- and y-direction set to 1 unit, while that of the
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z-direction is 1/16, so there is an excess ratio of roughly 6.5. In all runs we have L=6, rho=1000,
mu=70, max_levels=1, ref_ratio=1, N=120, and smallest_patch_size level_0=120,120,120. The
following parameter values were used for the springs: spring constant: 1.00E+07, p−m− s beam
constant: 1.00E+05, n1−m−n2 beam constant: 1.00E+08. The run initialized and started running
but aborted before saving any of the later time points.
(a) Initial configuration of the points as
viewed with the x axis coming out of the
page.
(b) Initial configuration of the points as
viewed from an angle not perpendicular to
any of the axes.
Figure 3.16: Initialization of run with 15970 regular points and 47904 intermediary points from
different angles. The run aborts before showing any other results.
3.5 Further investigations
From here, more simulations can be run using different parameter values. However, it is not
clear that, even if parameter values are chosen that allow the points to evolve to a steady state, the
steady state could adequately capture the structures of the rounded cells observed and modeled
in Kapustina et al. 2016 [52]. In the 2d models, it was clear that the minimum energy state of
each BLiPs was a bulb shape. However, in a 3d regime it is impossible to form a concave object
using a mesh that preserves the distance between vertices unless that shape is known ahead of time.
This is clear when considering that since the neck of the bulb has a smaller circumference than the
head of the bulb, then if the distance between vertices is roughly uniform, then there must be fewer
connected vertices for one cross section of the neck of the bulb than one cross section of the head
of the bulb. If the cell starts from a smooth shape with no BLiPs to a rounded shape with BLiPs,
then the BLiPs must be formed as the object evolves, meaning that the bulb must be formed from
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a relatively flat surface. Notice that in the flattened state the circle making up the cross section
of the head of the bulb must be inside the circle making up the cross section of the neck of the
bulb in order for the bulb protrude outward. This would imply that the neck would have a larger
circumference and contain more vertices than the head of the bulb, in conflict with what we expect.
So, either the distance between the vertices must be allowed to vary in order to make the points
comprising the neck get closer together, or the connections between the vertices must be allowed to
broken so that new connections may be formed and new shapes can be made. The former should not
be allowed, since varying the distance between the points results in varying the surface area of the
object, and preserving the surface area is a requirement for the model. The latter cannot occur since
there is no convenient way to dynamically determine the new connections in order to remake the
.spring and .beam files. Notice that the conflict of neck and bulb relative circumferences between
flattened and BLiP states exists even if the circumference of the neck isn’t smaller than the bulb;
that is, any significant protrusion will require that the neck’s circumference be much larger than the
bulb’s if it is to evolve from a flat state if the distance between the vertices is to remain constant
and there are no broken vertex connections. However, some interesting mountain-like shapes can be
made with the 3d model described in this chapter, especially if the "curvature" beam constants are
non-uniform, which could lead to some insight on the dynamics of a rounding cell, even if the fine
details of BLiPs aren’t captured. Since fluid forces are calculated using IBAMR, this model may
serve as a coarse graining of the cell rounding phenomenon, whereby the details of the surface aren’t
captured, but the overall dynamics of the fluid inside and outside of the cell can be examined.
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CHAPTER 4
Using Computational Modeling To Optimize the Design of Antibodies That
Trap Viruses in Mucus2
Antibodies (Abs) produced by our immune system are found in abundant quantities in both
blood and mucosal secretions and serve as key molecules that help regulate numerous complex
defense mechanisms against foreign pathogens. [53–55] For example, Abs can directly block contact
between viruses and target cells, a process known as neutralization. [56,57] Abs can also facilitate
other protective functions, such as ingestion and destruction of the pathogens (opsonization) or
infected cells (antibody-dependent cellular cytotoxicity, or ADCC) by specialized immune cells,
as well as activation of a cascade of enzymes that lead to direct lysis of the pathogen membrane
(complement). [58–60] These various protective mechanisms most certainly contribute to the robust
protection observed with topically delivered Abs against mucosally transmitted infections in a
multitude of animal studies. [61–64]
2This chapter previously appeared as an article in ACS Infectious Diseases. The original citation is as follows:
Timothy Wessler, Alex Chen, Scott A. McKinley, Richard Cone, M. Gregory Forest, and Samuel K. Lai. "Using
Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus," ACS Infect. Dis., 2 no.
1 (2016): 82-92
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Figure 4.1: Schematic of our model that captures the dynamics of HIV from seminal fluid diffusing
across a cervicovaginal mucus (CVM) layer containing HIV-binding IgG to reach the underlying
vaginal epithelium. To reduce infection, IgG must bind to HIV in sufficient quantities to neutralize
or to trap the virions in mucus before HIV virions successfully penetrate CVM. Our model captures
the tandem effects of IgG-antigen binding kinetics (kon, koff ) as well as IgG-mucin interactions
(mon, moff ).
In the female reproductive tract, immunoglobulin G (IgG) is the predominant Ab secreted into
cervicovaginal mucus (CVM) coating the vaginal epithelium, [65–67] yet its role in protection against
vaginal infections is not yet well understood. CVM is composed primarily of a heterogeneous mesh
network of mucin fibers with low viscosity fluid-filled pores, most of which are larger than the
majority of viruses. [68] Indeed, HIV virions are capable of diffusing nearly unimpeded through
the mucus gel. [69–71] Noting the abundance of Abs produced and secreted by the immune system
into mucus secretions, we hypothesized that virus-specific IgG may work in tandem with the mucin
mesh to prevent infections. We recently showed that IgG can indeed trap viruses in CVM, thereby
facilitating an additional and highly potent mechanism of immune protection. [67] Interestingly, the
diffusivity of IgG in mucus is only slowed ∼10-20% compared to in buffer; [72, 73] hence, individual
IgG molecules must make only weak and transient bonds with mucins and thus were previously
thought incapable of effectively trapping viruses in mucus gels. Nevertheless, as IgG accumulates
on the virus surface, the array of virion-bound IgG can collectively form multiple weak Ab-mucin
bonds between the virion and CVM, thereby generating sufficient avidity to slow or even immobilize
individual virions in mucus akin to multiple weak links formed by a Velcro patch. Trapping viruses in
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mucus not only reduces the flux of virus reaching target cells in the vaginal epithelium, but trapped
viruses are also quickly eliminated along with natural mucus clearance mechanisms, as evident by
protection against vaginal herpes transmission using a non-neutralizing monoclonal IgG. [67]
Many viruses, including HIV, can rapidly diffuse through mucus gels under physiological con-
ditions, limiting the window of opportunity for Abs to accumulate on the virus surface before the
virus reaches and infects the underlying vaginal epithelium. [74] The extent to which IgG can hinder
the diffusion of viruses in mucus, and consequently the potency of protection based on IgG-mediated
trapping of viruses, is thus critically dependent on whether virus-specific IgG, topically delivered
or elicited by vaccine or prior infection, can accumulate rapidly enough on a virion and impart
sufficient binding avidity between the virion and mucus to trap the virus before it can reach the
underlying cells. We are interested in developing potent "muco-trapping" IgG (i.e., that enables
effective trapping with fewer virion-bound IgG) not only because this would (i) reduce the dose of
IgG needed for passive immunization of the vagina but also because this would (ii) likely improve
protection against viruses, such as HIV, that have only a small number of antigens on their surface.
Our aim quickly posed a conundrum: although fewer virus-bound IgGs would be needed to trap
a virus if each bound IgG binds more tightly to mucins, high IgG affinity to mucins would reduce or
even prevent the diffusive mobility of IgG in the mucus gel. Because the Smoluchowski encounter rate
between two diffusive species is proportional to the sum of their diffusivities, mucin-associated IgG
would therefore have markedly reduced encounters with virions and, by definition, exhibit lower rates
of binding to viral antigens. The IgG-mucin and IgG-antigen affinities and actual binding/unbinding
rates that maximize viral trapping and protection will depend on specific characteristics of the target
virus, such as its diffusivity in mucus and surface antigen density.
Because an empirical, experimental determination of these numerous parameters and their
relative contributions to trapping and protection remains exceedingly challenging, we turned to
mathematical modeling to better understand the subtle interplay between the various kinetic and
diffusive processes among IgG, virions, and CVM during vaginal transmission of sexually transmitted
viruses. Specifically, we consider CVM containing a specific concentration of antigen-specific IgGs
that possess tunable binding and unbinding kinetics to mucins in CVM subjected to introduction
of virus-laden semen (Figure 4.1). With a mathematical model, starting from the moment of viral
deposition in the female reproductive tract, we can model the subsequent codiffusion of virions and
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IgG as well as the binding and unbinding kinetics among IgG molecules, viruses, and mucins and
freely explore the vast parameter space in the context of physiologically relevant spatial dimensions
and time scales. As a proof-of-concept, we focused on HIV, given the great need for alternative
strategies to prevent vaginal HIV transmission; indeed, passive immunization has recently garnered
attention as a promising approach for HIV prophylaxis. [75,76] In turn, the model allows us to explore
whether, and the extent to which, tuning IgG-mucin affinity can facilitate improved protection
against vaginal HIV infection. In doing so, we report that the model suggests a "sweet spot" in the
characteristics of IgG that maximize trapping and minimize infectious flux of HIV to the vaginal
epithelium.
4.1 RESULTS
Incorporating Mucin-Binding Kinetics into Previous Models for HIV Penetration
of Ab-Laden CVM. We have previously modeled the diffusion of HIV through CVM by combining
a stochastic/deterministic hybrid model for the one- dimensional Brownian movement of individual
HIV virions together with a continuum model that describes the average local concentration of
broadly neutralizing monoclonal IgG in CVM. [77] That model allowed us to show that a multitude
of weak bonds between virion-bound IgG and mucins alone, defined by the ratios of IgG diffusion in
mucus versus buffer (α) in the range of 0.8-0.9, is sufficient to immobilize the vast majority of HIV
near the semen/CVM interface. Nevertheless, to further explore the IgG trapping potency across
the full range of IgG-mucin affinity, it was necessary to incorporate additional complexity into the
model. First, when modeling IgG that binds more tightly to mucins, we made the assumption that
the probability of a successful bond between an IgG molecule and the corresponding viral antigen
is directly proportional to the overall collision frequencies between the two bodies, which can be
described by the classical Smoluchowski principle. [78] Because an IgG bound to mucins will possess
a far reduced range of motion relative to that of a free, unbound IgG molecule, the bound IgG
should possess a reduced kon rate, denoted k′on, proportional to the reduction in collision frequency
with viral antigen, which in turn can be approximated by the ratios of the diffusivity of IgG versus
mucins in CVM. Although the diffusivity of individual mucins in CVM remains unknown, we have
previously shown that CVM is composed of heavily bundled mucins that likely reflect an exceedingly
limited range of motion for individual mucins. [68] We thus made a very conservative estimate that
an IgG bound to mucin will possess a 30-fold reduced kon rate compared to individual free IgG (i.e.,
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k′on = kon/30), which roughly equates to assuming the range of motion of mucins to match that for
individual HIV virions. Although obviously an over conservative assumption, further reduction in
kon does not meaningfully affect estimates generated by our model (Figure 4.9).
Figure 4.2: Distribution of time HIV virions spend freely diffusing or associated with mucins in CVM
containing 1 µg/mL NIH45-46 with different affinity to mucins, ranging from no affinity at α = 1
to very strong affinity at α = 0.001. To minimize bias toward virions with no surface-bound IgG
undergoing free diffusion, Abs are allowed to accumulate on HIV for 30 min first prior to measuring
the time of free diffusion or association with mucins for the subsequent 90 min.
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A second important detail we incorporated into our model is the kinetics of IgG binding to and
unbinding from mucins, which we termed mon and moff , respectively. Experimentally, mon and
moff appear to be extremely transient and difficult to measure individually8 (see also the Supporting
Information). Instead, IgG-mucin affinity is inherently reflected by the diffusion coefficients of IgG
in CVM versus in buffer, which we denote α. α reflects the fraction of bound versus unbound IgG at
any moment in time and is equivalent to the ratio moff(moff+[M ]mon) at steady state. Assuming IgG
binding to its antigen does not increase its affinity to mucins, the rates with which individual IgG
can bind to mucins must be far faster than the rate of virion-associated IgG binding to mucins. We
thus introduced a correction factor of ∼30 for the mucin-association kinetics for virion-bound IgG,
which is equivalent to the difference in diffusivities of HIV versus IgG in CVM. This correction was
necessary to ensure we do not overestimate the trapping potency of viruses.
As a first step toward understanding how IgG-mucin affinity can affect trapping potency, we
modeled the probability and duration of HIV-IgG complexes associating with mucins in CVM
containing 1 µg/mL NIH45-46 with varying IgG-mucin affinity. Naturally, HIV with surface IgG
possessing no affinity to mucins, defined by α = 1, never binds to mucins, and the HIV-IgG complex
undergoes free diffusion for the entire duration (Figure 4.2A). When IgG-mucin affinity is slightly
increased such that individual IgGs associate with mucins ∼5 and 10% of the time (i.e., α = 0.95
and 0.9, respectively), the fraction of time an HIV-IgG complex spends freely diffusing in mucus
begins to decrease, with a corresponding increase in the fraction of time spent associated with mucins
(Figure 4.2B,C). Interestingly, the fraction of time the HIV-IgG complex associates with mucins
appears to peak between α = 0.1 and 0.25 (Figure 4.2D-F). This is attributed to the facts that (i)
increased IgG-mucin affinity markedly reduces the fraction of NIH45-46 that can freely diffuse and
readily bind to HIV, including IgG that diffuses from CVM into the semen layer and binds to HIV
virions before they enter the CVM layer (Figure 4.7); and (ii) mucin-associated IgG captures HIV
with far lower efficiency (i.e., reduced kon’ vs kon). These two factors together increase the number
of HIV virions with no bound IgG. With further increases of mucin affinity to α = 0.01, the amount
of HIV free of bound IgG dominates relative to HIV-IgG complexes, and most HIV again undergoes
Brownian motion in CVM (Figure 4.2G).
Influence of IgG-Mucin Affinity on Maximizing Trapping Potency and Vaginal Pro-
tection. We next quantified how the probability of HIV-mucin association affects the fraction of
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HIV that can penetrate CVM and reach the underlying vaginal epithelium and the corresponding
reduction in infectivity based on the decrease in HIV-Env free of bound IgG on those virions.9 In
good agreement with the estimate of the fraction of time spent associated with mucins, the maximum
reduction in HIV flux reaching the vaginal epithelium peaks at IgG-mucin affinities corresponding to
α = 0.25 (Figure 4.3A). At 5 and 10 µg/mL NIH45-46 initially present in CVM and an IgG-mucin
affinity equivalent to α = 0.25, only ∼3 and ∼0.3% of the HIV viral load in semen, respectively, are
predicted to reach the vaginal epithelium over the first 2 h post-ejaculation, equating to 10-100-fold
reduced flux compared to the estimated ∼30% of HIV load over the same duration in the absence
of IgG-mucin affinity (Figure 4.3A). Under this scenario, each HIV virion on average possesses
∼2 bound IgGs (Figure 4.3B), and the overall infectivity is reduced by 86-94% (i.e., ∼7-16-fold)
compared to IgG without affinity to mucins (Figure 4.3C,D). Note that the reduction in infectivity
is less than the reduction in the flux of HIV viruses because NIH45-46 without affinity to mucins
can still neutralize the virus.
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Figure 4.3: Predicted trapping potency and protection by 5 and 10 µg/ mL NIH45-46 with varying
affinity to mucins as characterized by α: (A) predicted fraction of HIV load initially in semen that
can diffuse across CVM containing NIH45-46 over the first 2 h post-deposition; (B) average number
of NIH45-46 bound to HIV arriving at the vaginal epithelium (values <1 represent HIV virions that
arrive at the vaginal epithelium without any bound NIH45-46); (C, D) extent of NIH45-46-mediated
protection, as quantified by infectivity relative to (C) no NIH45-46 present in CVM or (D) the same
amount of NIH45-46 present but without any affinity to mucins.
When IgG-mucin affinity is further increased (i.e., lower α), the fraction of HIV reaching the
vaginal epithelium begins to increase. Furthermore, there are also substantially fewer IgGs bound to
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HIV-Env on virions that reach the vaginal epithelium. Indeed, when α drops below 0.1, on average
<1 IgG molecule is bound to each virion over the entire population of HIV virions, which implies
that there must be HIV virions without any bound IgG (Figure 4.3B). As a result, the infectivity
of HIV may actually be greater for hypothetical NIH45-46 that can bind tightly to mucins than if
NIH45-46 possessed no mucin affinity at all (Figure 4.3C,D).
To begin to understand how to engineer more potent HIV-trapping IgG, we evaluated the relative
impact of the rate of IgG binding to the virus surface compared to IgG-mucin affinity. The rate
of IgG binding to HIV is the product of both the local IgG concentration and kon, the binding
kinetic constant: a doubling of IgG kon has the same impact on IgG binding to HIV as doubling the
IgG concentration. The reduction of HIV flux arriving at the vaginal epithelium and the reduction
in mean number of NIH45-46-free Env proteins on HIV that reached the vaginal epithelium were
sensitive to both IgG- antigen binding rate and IgG-mucin affinity (Figure 4.4). When IgG-mucin
affinity was increased, the amount of initial NIH45- 46 in CVM needed to reduce the flux of viruses
arriving at the vaginal epithelium by 50% decreased from 5 to 50 µg/mL for α = 0.8-0.9 (this
IgG-mucin affinity is within the range of what was previously measured for IgG in CVM) to <1
µg/mL when α = 0.25 (Figure 4.4A). Similarly, the amount of NIH45-46 proteins on HIV by 80%
decreased from 26 µg/mL for α = 0.8 to 3 µg/mL for α = 0.25 (Figure 4.4D). Overall, the amount
of NIH45-46 needed to reduce infectivity by 90% decreased from 7 µg/mL when α = 1 to 2 µg/mL
when α = 0.25 (Figure 4.4C).
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Figure 4.4: Phase diagrams mapping the predicted trapping potency and protection as a function
of NIH45-46 concentration in CVM and IgG affinity to mucins as characterized by α: (A) fraction
of HIV load initially in semen that can diffuse across CVM containing NIH45-46 over the first
2 h postdeposition; (B) average number of Ab-free Env trimers on HIV arriving at the vaginal
epithelium; (C, D) extent of NIH45-46-mediated protection, as quantified by infectivity relative to
(C) no NIH45-46 present in CVM or (D) the same amount of NIH45-46 present but without any
affinity to mucins.
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Figure 4.5: Phase diagrams mapping the predicted trapping potency and protection as a function
of NIH45-46 unbinding kinetics from HIV virions (koff ) as well as accumulation kinetics on HIV
virions, which is influenced by both the local NIH45-46 concentrations and the binding rate (kon):
(A) fraction of HIV load initially in semen that can diffuse across CVM containing NIH45-46 over the
first 2 h post-deposition; (B) average number of Ab-free Env trimers on HIV arriving at the vaginal
epithelium; (C, D) extent of NIH45-46-mediated protection, as quantified by infectivity relative to
(C) no NIH45-46 present in CVM or (D) the same amount of NIH45-46 present but without any
affinity to mucins.
Influence of IgG-Antigen Binding Affinity on Maximizing Trapping Potency and
Vaginal Protection. A longstanding assumption for neutralizing IgG against HIV and other viruses
is that higher binding affinity between IgG and viral antigen facilitates more potent protection.
However, it is important to note that high-affinity IgGs are typically identified and selected on
the basis of neutralization assays in the absence of mucus coatings and with some incubation time
between virus and IgG prior to exposure of the virus to target cells. Thus, we sought to quantitatively
evaluate whether a high antigen-IgG affinity that typically maximizes neutralization potency in vitro
would also be maximally protective against mucosal HIV transmission in our model.
Interestingly, we found that the antigen-unbinding rate koff generally possessed only a very
minor effect on increasing the fraction of HIV load that is trapped in mucus or facilitating more
effective protection, especially when the IgG concentration or the kon rate is low (Figure 4.5A). For
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example, at 1 µg/ mL of IgG with kon of 1.5× 104M−1 s−1 (kon[Ab] = 10−4 s−1), improvements
of koff from 10−3 s−1 to 10−4 s−1 reduced the HIV flux arriving the vaginal epithelium by only
1.6%, and a further improvement from 10−4 s−1 to 10−5 s−1 essentially resulted in no appreciable
difference in reduction of flux (Figure 4.5A). This is similarly reflected by the minimal change in
the infectivity of the viruses relative to IgG with no mucin affinity from 100% with koff = 10−3
s−1 to 96% with koff = 10−4 s−1 to finally 92% with koff = 10−5 s−1 (Figure 4.5C,D). The lack
of impact by koff is directly attributed to the exceedingly limited number of IgG molecules that
can accumulate on the surface of HIV either when IgG is present at low to modest concentrations
or when IgG possesses inadequate binding kinetics (Figure 4.5B); slower unbinding kinetics simply
cannot enhance HIV trapping in mucus or neutralization when few or no IgGs are bound to HIV in
the first place.
In contrast to koff , the IgG-antigen binding rate kon plays a far more critical role in effective
mucosal protection. Because the rate of IgG accumulation on the virion surface is the product of
the IgG concentration and kon, increasing IgG kon by definition would have the same magnitude of
impact as increasing IgG concentration. In other words, a 10-fold faster kon would reduce the fraction
of HIV reaching the vaginal epithelium and overall infectivity to the same extent as increasing the
total HIV-binding IgG in CVM by 10-fold (Figure 4.5A), because both would result in the same
increase in the number of IgG bound to HIV before the virions can reach the vaginal epithelium. Our
current finding on the relative importance of kon versus koff is consistent with an earlier investigation
that simply evaluated the kinetics of neutralization, which did not take into account IgG-mucin
interactions. [77] Incorporating IgG-mucin affinity appears to amplify the difference, likely because
rapidly binding IgG can protect by either trapping or neutralization, and viruses slowed by IgG-
mucin interactions will also be more completely neutralized prior to reaching target cells underlying
the vaginal epithelium.
4.2 DISCUSSION
A hallmark of HIV is its exceptionally high mutation rate, which enables the virus to readily
escape antibodies generated by the immune system and prevents the host from mounting a protective
immune response. Comprehensive studies of elite controllers–the rare individuals who can maintain
undetectable viral load without antiretroviral therapy–led to the discovery and cloning of monoclonal
antibodies that can broadly neutralize the vast majority of HIV strains. These broadly neutralizing
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antibodies (bnAbs) were thought to provide a template for the development of an HIV vaccine.
Unfortunately, HIV vaccines, including those that can block vaginal transmission of HIV, remain
elusive to date, for at least two reasons. First, bnAbs are typically highly somatically mutated, and
vaccines may not be able to elicit the extent of somatic hypermutation needed in most individuals to
generate the desirable bnAbs. Second, many HIV vaccine candidates are based on DNA or subunit
proteins rather than attenuated virus; the durability of antibody response from subunit vaccines is
generally shorter than that of vaccines based on attenuated virus, and the level of antibody titers
induced in the vagina may be inadequate to block vaginal HIV transmission.
To overcome these challenges, a recently emerged strategy is to passively immunize the vagina
via sustained delivery of bnAbs. [76,79] By dosing the bnAbs directly into the vagina, this strategy
not only bypasses the limitations of somatic hypermutation but also ensures protective levels of
bnAbs are present in the vagina to block HIV transmission. Despite these important advantages, a
critical shortcoming for passive immunization is the relatively high cost of maintaining protective
levels of antibody in the body compared to vaccination. Much effort has been spent on reducing
the costs of antibody production, such as the production of antibodies in plants, [80, 81] as well
as cheaper and more efficient methods of purifying antibodies. [82,83] Here, we introduce a novel
and completely distinct approach–based on tuning IgG- mucin interactions–that could markedly
reduce the dose of bnAbs needed to block vaginal HIV transmission. The majority of bnAbs against
HIV appear to possess kon in the range of 104 M s−1, which we previously estimated may require
concentrations in excess of 5-10 µg/mL to facilitate effective protection. Although we predict
enhanced vaginal protection can be accomplished with both increasing kon and optimizing IgG-mucin
affinity, bnAbs generally bind to a very unique epitope on HIV-Env that makes it unlikely that
kon can be substantially improved without compromising binding affinity (i.e., resulting in higher
koff ). In contrast, simply by tuning the interactions between IgG-Fc and mucins, we can potentially
reduce the required dose of bnAb for effective protection by 3.5-fold or more without jeopardizing
the broad antigen coverage of bnAb. Optimizing IgG-Fc interactions with mucins thus offers a
promising strategy to markedly reduce the costs for effective passive immunization of the vagina.
The convergence of these various approaches may synergistically drive down costs and make passive
immune protection against HIV cost-effective even in resource-poor settings.
Surprisingly, our model suggests that high-affinity IgG- mucin interactions are unlikely to enhance
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protection. Instead, the ideal IgG-mucin affinity that maximizes protection in our model (α ∼
0.25) is comparable to the mucin affinity previously measured for IgM molecules. [72, 73] It is
also worth noting that IgM, due to its pentameric structure, has 10 Fab arms compared to 2 Fab
arms for each IgG and hence can bind to its antigenic target and accumulate on the surface of
virions with exceptional speed even if each Fab possesses relatively poor affinity compared to a
fully affinity-matured IgG. Thus, an IgM molecule appears to simultaneously satisfy both of the
design requirements we have identified in this study–rapid kon and modest mucin affinity. Indeed, we
recently found that IgM that binds HIV-sized nanoparticles exhibited greater muco-trapping potency
than corresponding IgG (Henry et al., submitted for publication). IgM is the first antibody isotype
produced by our immune system and appears early in the course of an infection. Virus-specific IgM
also usually reappears upon re-infection. Although speculative, our study raises the hypothesis that
an evolved effector function of IgM may be to quickly begin purging a new pathogen from mucosal
surfaces that likely represent the initial site of infection early in the course of infection, and thereby
minimize the viral titers that can enter the systemic circulation.
As discussed above, it is unlikely that we can markedly improve the kon for bnAbs without
potentially compromising their broad antigenic coverage. An alternative method to enhance the
overall rate of IgG accumulating on the viral surface at mucosal secretions is to include IgG targeting
other viral epitopes, including potentially non-neutralizing epitopes, because trapping virions in
mucus requires only binding and not necessarily neutralizing IgG. It is important to note that the
immune system typically generates a polyclonal Ab response against diverse epitopes, rather than
solely a neutralizing Ab response against a single viral epitope. Indeed, many of the naturally
produced IgG against HIV found in HIV patients associate with either the lipid membrane of HIV
virions, or other parts of the gp120 site on the Env spike not directly involved in HIV infection of
immune cells. [84] Likewise, virtually all of the IgGs detected in the moderately successful RV144
trial were non-neutralizing. [85] Such a polyclonal response would likely result in a substantially
faster rate of Ab accumulation than with an individual monoclonal IgG. Thus, codelivery of multiple
IgGs to enhance passive immune protection of the vagina, or inclusion of multiple immunogens
(including non-neutralizing epitopes) in vaccine formulations, would both harness the same strategy
our immune system has evolved to fend off foreign pathogens.
Although often under-appreciated, CVM represents the first line of defense against sexually
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transmitted infections in the female reproductive tract. In addition to minimizing trauma to the
vaginal epithelium upon coital stirring, the presence of the CVM layer also prevents virions in semen
from immediately contacting the vaginal epithelium upon ejaculation and directly reduces the virion
flux and total viral load in semen that can reach target cells over time. Reinforcing the CVM barrier
against sexually transmitted viral infections using virus-specific Abs that trap viruses in mucus is
likely an important mechanism of the vaginal mucosal defense, but one that continues to be largely
under-appreciated and under-explored. We expect that the combination of quantitative, predictive
models with experimental validation will enable development of improved passive immunization as
well as vaccination methods that harness the mucus barrier to reinforce mucosal defense against HIV
and other sexually transmitted infections.
4.3 MATERIALS AND METHODS
Model Parameters for Vaginal Transmission of Cell-free HIV. In the female reproductive
tract, mucus flows into the vagina from the cervical os, spreads over the vaginal epithelium, and
is eventually cleared through the introitus. In this process, the thickness of the CVM layer likely
varies within the vagina, with the thickest layer likely to be at the cervical os and vagina fornices,
the thinnest near the introitus, and possibly substantial variations throughout. In the absence of
experimental measurements of the thickness of the mucus layer coating the human vagina, we made
the assumption that CVM approximately evenly covers the entire vaginal epithelial surface, due
to spreading by repeated coital motion. We estimated the CVM layer thickness by dividing the
volume of mucus (∼750 µL; range typically between 500 µL and 2 mL) with the approximate surface
area of the vaginal lumen (145 cm2; [86] Table 4.1), which results in a thickness of roughly L =
50 µm. Our estimate of approximate mucus volume is based on the volume that may be collected
by repeated use of a menstrual collection device, the Instead Softcup, which we have utilized in
prior studies. [67–70,87] Although the Softcup is intended to be placed over the cervical os during
menses, in our studies, donors typically insert the Softcup for only 5-10 s. Due to the limited
duration of insertion, the mucus we collect reflects predominantly mucus overlaying the vaginal
surface that was gathered on the Softcup during the insertion/extraction process, rather than mucus
that flowed out of the cervical os and pooled onto the cup over many hours. This procedure allows us
to obtain substantial volumes of mucus that contains the same microbial communities and densities
as sampling by vaginal swabs. [70]
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parameter symbol value refs
HIV-1
diffusivity in CVM Dv 1.27 µm2/sa [69]
diffusivity in semen assume same as in CVM
viral load in semen 8.4× 105 copies/ejaculateb [88, 89]
no. of Env trimer spikes N∗ 14± 7 (SD) [90]
IgG
diffusivity in CVM DAb 40 µm2/s [72,73]
diffusivity in semen assume same as in CVM
IgG concentration in CVM variable
IgG-Env affinity kon, koff variable
IgG-mucin affinity mon[M],moff variable
ratio of DAb vs diffusivity in
buffer
α variable
vagina
surface area of lumen SAvagina 145 cm2c [86, 91]
volume of luminal CVM VCVM ∼750 µmd [92, 93]
thickness of CVM layer L 50 µmd
volume of semen Vsemen ∼3 mL [89]
thickness of semen d 200 µmd
Table 4.1: Parameters and Values Incorporated into the Model
aThe geometrically averaged Deff for HIV was previously measured to be 0.25 µm2/s, but with a
substantial fraction of viruses exhibiting more rapid mobility. For the current analysis, we used 1.27
µm2/s, which represents the top 25th percentile of virus mobility; this is in reasonable agreement
with a more recent study of HIV diffusion in genital secretions. [71] bEstimated on the basis of a
median semen volume of 3.0 mL [89] and 2.8× 105 HIV-1 RNA copies/mL, which represents the
upper limit of HIV-1 RNA copies/mL in seminal plasma from ref 21. This is in reasonable agreement
with another report by Chakraboty et al., which estimated 5×105 HIV-1 RNA copies/ejaculate, with
a maximum of about 2× 107 HIV-1 RNA copies/ejaculate. [94] cThe mean surface area of the vagina
in the native state was previously estimated to be ∼90 cm2 by injection of vinyl polysiloxane casts
vaginally. Alternatively, the surface area of vaginal lumen may also be inferred by the surface area of
the erect penis (average ∼200 cm2) assuming complete insertion into the vagina. We took the average
from the two approaches. dCVM (L) and semen (d) thicknesses are estimated by VCVM/SAvagina
and Vsemen/SAvagina, respectively.
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Similar to previous studies, [74, 77, 95, 96] we modeled the diffusion of HIV (DHIV ∼ 1.27
µm2/s [77]) from a virion-rich (8.4x105 virions, the average viremia in semen of acutely infected
males [74,88]) semen layer (volume ∼ 3.0 mL [89]) uniformly deposited on top of a cervicovaginal
mucus layer (CVM) that evenly covers the entire vaginal epithelium. This results in thicknesses
of d=200 µm and L=50 µm for the semen and CVM layers, respectively. Broadly neutralizing Ab
(DAb ∼ 40 µm2/s [77]) accumulate on HIV virions at rates depending on Ab-antigen affinity, the
number of available antigen sites on the virus surface, and the local Ab concentration. For a model
monoclonal broadly neutralizing Ab against HIV, we focused on NIH45-46, which binds to the CD4
binding site of gp120 and whose binding affinities were previously described. [97] The number of Env
spikes N∗ on individual HIV virions is variable, and was estimated to follow a negative binomial
distribution with N∗ = 14± 7 (range 4 – 35) based on cryo-electron microscopy of HIV virions. [90]
Ab Binding to HIV Env Spikes. We assume each Env spike can bind up to three Ab
without significant steric hindrance; thus, individual Ab at concentration u(z, t) can bind and unbind
independently with rates kon and koff , and overall binding/unbinding rates depend on the number
of unoccupied binding sites 3N∗ − n, where n is the number of bound Ab. However, since the
diffusivity for a mucin-bound Ab ub(z, t) is reduced compared to free individual Ab, the Smoluchowski
encounter rate implies that the binding rate for a mucin-bound Ab (k′on) to its antigen should be
reduced proportionally to the difference in diffusivities of the Ab (DAb) and the virus (Dv); hence,
k′on = Dv/(DAb +Dv)kon ≈ 1/30kon. The Ab-virion binding rate equations can be summarized as
(Ab) + (Abn)Z(t)
(3N∗ − n)
(
kfonuf (Z(t), t) + k
b
onub (Z(t), t)
)
GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGBF GG
(n+ 1)koff
(Ab)n+1Z(t) (4.1)
where (Ab) is an unbound Ab, (Ab)nZ(t) denotes a virion at Z(t) with n bound Ab, and super-
script/subscript f and b denote free and bound terms, respectively. Individual Ab also bind and
unbind to mucins at rates mon[M ] and moff , where [M ] is the effective concentration of Ab binding
sites in the mucin network. In addition, virion-bound Ab may associate with mucins, effectively
immobilizing the entire Ab-virion complex for the duration of the interaction.
HIV Diffusion through CVM. We developed two different methods to simulate HIV pene-
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tration across the vaginal mucus layer. In the first method, a stochastic particle simulation was
used for virion diffusion, virion-Ab binding, and Ab-mucin interactions. Since the number of Ab is
much larger than the number of virions, we utilized a diffusion partial differential equation (PDE)
for the Ab concentration. Virion diffusion for a particle Z is given by the stochastic differential
equation (SDE) dZ =
√
2DdW , where W is Brownian motion and D =

DHIV , free
0, bound
, where
"free" indicates that all virion-bound Ab are free from mucin, and "bound" indicates that at least
one virion-bound Ab is associated with mucin. We assume Brownian diffusion of virions based on
our previous findings that HIV and other viruses and nanoparticles can diffuse nearly unobstructed
in CVM. [67, 69, 70, 87] Importantly, although we are measuring the rate of virus arriving the
epithelium, an essentially 1D process, the actual simulated random walks are in 3D. Ab binding
and unbinding to virus were simulated with a Poisson random variable with rates given by eq 4.2.
Lastly, Ab-mucin interactions were simulated with Poisson random variables and rates dependent
on the total number of virion-bound Abs and those Abs currently interacting with mucins. Due to
the great computational expense involved in simulating Ab-mucin interactions, particularly when
mon[M ] > moff , we computed lookup tables giving the distributions for the time that a virion
spends freely diffusing and the time that a virion spends interacting with mucins (see the Supporting
Information and Figure 4.6). The (random) time that a virion spends freely diffusing is given by the
last time that none of the surface-bound Abs associate with mucin until the next time that at least
one of its associated Abs binds to mucin. Similarly, the time that a virion spends interacting with
mucins is given by the last time that at least one of the virion-bound Abs associates with mucin
until the next time that none of the surface-bound Abs associate with mucin. We then sampled from
these lookup tables whenever a virion’s state changes (freely diffusing or bound to mucin, binding or
unbinding an Ab, crossing the semen/CVM interface). These methods were used to generate data
presented in Figure 4.2.
The second simulation method consists of a reaction-diffusion PDE to capture the average
behavior of the virus population. The virus population is represented by a vector ~V (z, t), where
the component Vn(z, t) represents the concentration of virus with n bound Abs. We previously
introduced a parameter α = moffmoff+[M ]mon to represent the fraction of time that Abs in CVM spend
freely diffusing. [77] Because Ab-mucin interactions likely occur at fast time scales,
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uf (z, t) =

αu(z, t), 0 < z ≤ 50
u(z, t), 50 < z ≤ 250
and ub(z, t) = u(z, t)− uf (z, t).
In the limit mon,moff → ∞ (keeping moff(moff+[M ]mon) fixed), the stochastic model can thus be ap-
proximated by the reaction-diffusion system
∂~V
∂t
= D
∂2~V
∂z2
+ ~f(~V , u)− ~g(~V , u),
∂u
∂t
= DAb0
∂2u
∂z2
,
where the diffusion tensor D, is a diagonal tensor with entries Dv0 , β1Dv0 , . . . , β3N∗Dv0 along the
diagonal (the diffusion factors βi are determined below) for 0 < z ≤ 50 and diagonal entries are allDv0
for 50 < z ≤ 250; DAb =

αDAb0, 0 < z ≤ 50
DAb0, 50 < z ≤ 250
; and the reaction terms ~f(~V , u) and ~g(~V , u) have
entries fn = (3N∗−n+1)
[
kfonuf (z, t) + k
b
onub(z, t)
]
Vn−1(z, t)χn>0+(n+1)koffVn+1(z, t)χn<3N∗ and
gn = (3N∗ − n)
[
kfonuf (z, t) + k
b
onub(z, t)
]
Vn(z, t) + nkoffVn(z, t) for n = 0, 1, . . . , 3N∗, respectively,
with χ denoting the indicator function.
Simultaneous Diffusion of HIV and Ab. We use a forward-time central-space scheme to
model diffusion for both the virus and Ab populations in 3D, with reflecting boundary conditions at
the semen/lumen interface, reflecting conditions for Ab and absorbing conditions for virus at the
CVM/cell interface, and Fick’s law for the discontinuous diffusion coefficients at the semen/CVM
interface. We assume that the number of Abs binding to virions is negligible compared to the overall
Ab population, so there are no local depletion effects.
If each virion-bound IgG binds and unbinds to the mucin mesh independently, then the virion
spends approximately a fraction αn of time with all its bound Abs simultaneously free from mucin.
This yields a time-averaged diffusivity for the virion of Dvn = αnDv0 in CVM. One adjustment
is made, however, to account for the lower diffusivity of a virion-Ab complex compared with
an individual Ab. Similar to the adjustments on kon, we define mfirst = (1/30), so that initial
Ab-mucin encounters occur at rate mfirstmon[M ]. For subsequent interactions of virion-bound
Abs with mucin, the rate may increase because the Ab-virus complex is already located in close
proximity to a mucin molecule or may decrease due to the reduced diffusivity of the Ab-virus
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complex associated with mucins relative to a nonassociated Ab-virus complex. Due to the lack
of empirical data in the literature, we assumed other Abs bound to the same virion with at least
one Ab already associating with mucins will associate with mucins with the same mucin-binding
kinetics as a free Ab molecule. To calculate the diffusion factors β1, β2, . . . , β3N∗ , we first neglect
the factor mfirst and consider the total time freei that a virion with i bound Ab spends freely
diffusing and the total time boundi that it spends bound to mucins up to a time T . Because the
Abs are assumed to bind and unbind to mucin independently, limT→∞
freei
freei + boundi
= αi, and
thus βi =
freei/m
first
freei/mfirst + boundi
=
αi
αi +mfirst(1− αi) .
The stochastic simulations and the reaction-diffusion simulations show excellent agreement,
particularly at rapid mon[M ] and moff . Indeed, for mon[M ] = 101s−1, the difference between
stochastic simulations and the reaction-diffusion simulations is on average ∼8.5% and decreases to an
average of ∼3.5% for mon[M ] = 102s−1 (Figure 4.8; see the Supporting Information for theoretical
estimates of mon[M ] and moff ). Hence, we used the deterministic simulations except where noted.
These methods were used to generate data presented in Figures 4.3A,B, 4.4A,B, and 4.5A,B.
Env Neutralization by Binding Abs. In addition to measuring reduction in the flux of viruses
arriving at the epithelium, we also incorporated virus infectivity and extent of Ab neutralization in
our analysis. Determining the number of Abs required to neutralize a given HIV remains an active
area of research, due to the difficulty in simultaneously distinguishing the number of Abs necessary
to neutralize a particular Env spike and the minimum number of Ab-free Env spikes necessary for
HIV to successfully infect. [98] It was previously proposed that the binding of a single Ab molecule
to an Env spike appears to be sufficient to inactivate the infectivity associated with that spike. [99]
The minimum number of Ab-free Env spikes and, consequently, the number of Env spikes that must
be inactivated to neutralize a virion, remain more controversial. Estimates for minimum infectivity
range from a single Ab-free Env spike [99] to many. [100,101] For our current model, we assume that
each additional Ab binding to a previously unoccupied Env incrementally reduces the likelihood
of infection, and we measure the overall reduction in infectivity by the reduction in number of
unoccupied Env arriving at the vaginal epithelium over the first 2 h post-ejaculation. These methods
were used to generate data presented in Figures 4.3C,D, 4.4C,D, and 4.5C,D.
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4.4 SUPPLEMENTARY MATERIAL
Probability distribution of times for virus freely diffusing vs. interacting with mucins
We derive probability distributions for the time that virions spend interacting with mucins and for
the time that the virions spend freely diffusing. We model these interactions by assuming a rate of
Ab binding to mucin, mon[M ], where [M ] is the concentration of mucin proteins. For brevity, we
assume a uniform mucin concentration and abbreviate the forward reaction rate as mon, with units
of s−1. Similarly, Ab unbind from the mucin network at a rate moff (s−1).
With attachments and detachments following a Poisson process, the probability density function
(pdf) for the waiting time of a free Ab to associate with the mucin network is
hfree(t) = mone
−moff t. (4.2)
Similarly, the waiting time for an Ab fixed to the mucin network to dissociate is
hinteract(t) = moffe
−moff t. (4.3)
We assume that Ab already bound to virus also interact with mucins with the same binding/unbinding
rates mon and moff , with the exception of the first binding, which has rate mfirstmon, where
mfirst = 130 . We assume that virions are freely diffusing if and only if all of its bound Ab are free
from the mucin network. Thus, it is of interest to calculate the waiting time distributions hfree,n(t)
for the time a virion with n Ab remains freely diffusing and the distribution hinteract,n(t) of time it
is fixed to mucins.
The term mfirst simply modifies the freely diffusing distribution, without affecting the virion-mucin
interaction distribution. The distribution for the time a virion with n Ab is freely diffusing is the
distribution of the minimum of n exponential variables with rate mfirstmon. It is a standard result
that this is again an exponential distribution but with rate mfirstmon [102]:
P (min(z1, ..., zn) < t) = 1−P (z1 > t, z2 > t, ..., zn > t) = 1−P (z1 > t)n = 1−e−nmfirstmont, (4.4)
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so that the freely diffusing density function is given by
hfree,n(t) = nm
firstmone
−nmfirstmont. (4.5)
For the density function of the time interacting with mucin, we represent the number of Ab associated
with mucin over time as a stochastic process {Xt} with X0 = 1, with jump times {Tk}k≥1 (when an
Ab-mucin event takes place), and calculate the stopping time τ such that Xτ = 0. For notational
convenience, we also define the process {Yk}k≥1 by the relation Y1 = X0 and Yk = XTk . Thus, {Yk}
is a discrete Markov chain representing state changes in Ab-mucin interactions.
The transition probabilities from each state depend only on the number of Ab r currently associated
with mucin. That is, suppose Xt = r, and let zi denote the waiting time for the ith Ab associated
with mucin to dissociate, and let wj denote the waiting time for the jth Ab not currently associated
with mucin to associate. Then the probability of the next event being a new Ab association is:
Pr(Xt = r + 1) = P (min(z1, ..., zn−r) < min(w1, ..., wn−r)).
Since zi are all independent and identically distributed, min(z1, ..., zn−r) has density function
(n− r)mone−(n−r)mont. Similarly, min(w1, ..., wn−r) has density function rmoffe−rmoff t.
Then
P (min(z1, ..., zn−r) < min(w1, ..., wr)) =
∫∞
0
∫ w
0 (n− r)mone−(n−r)monzrmoffe−rmoffwdzdw
=
(n− r)mon
(n− r)mon + rmoff (4.6)
We can also derive the waiting time distribution for the next Ab-mucin interaction, given that the
next event is dissociation:
P (min(z1, ..., zn−r) < t|min(z1, ..., zn−r) < min(w1, ..., wr))
=
P (min(z1, ..., zn−r) < t,min(z1, ..., zn−r) < min(w1, ..., wr))
P (min(z1, ..., zn−r) < min(w1, ..., wr))
(4.7)
The numerator is
∫∞
0
∫ t
0 (n−r)mone−(n−r)monzrmoffe−rmoffwdzdw−
∫ t
0
∫ t
w(n−r)mone−(n−r)monzrmoffe−rmoffwdzdw
=
(n− r)mon
(n− r)mon + rmoff
[
1− e−[(n−r)mon+rmoff ]t
]
. (4.8)
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So
P (min(z1, ..., zn−r) < t|min(z1, ..., zn−r) < min(w1, ..., zr)) = 1− e−[(n−r)mon+rmoff ]t (4.9)
Similarly, we can show that the waiting time distribution given that the next event association is
the same; that is, the distribution of Tk+1 − Tk, given Xt = r is:
P (min(z1, ..., zn−r) < t) = 1− e−[(n−r)mon+rmoff ]t. (4.10)
Now we derive the pdf for the total time that a virion interacts with mucin. To do this, it suffices to
take a weighted sum of the waiting time distributions over all paths {Yk} of the Ab-mucin interaction
state. The total probability P ({Yk}) of a given path is the product of the probabilities PYk(Yk+1) of
taking the corresponding path at each point:
P ({Yk}) =
∏
k≥1
PYk(Yk+1), (4.11)
where
PYk(Yk+1) =

(n− Yk)mon
(n− Yk)mon + Ykmoff if Yk+1 = Yk + 1
Ykmoff
(n− Yk)mon + Ykmoff if Yk+1 = Yk − 1
0 otherwise
And the total waiting time for a path h({Yk}) is given by a convolution of the waiting times hYk+1|Yk
along the path:
hYk+1|Yk =
∗∏
k≥1
hYk+1|Yk(t), (4.12)
where hYk+1|Yk = [(n− Yk)mon + Ykmoff ]e−[(n−Yk)mon+Ykmoff ]t, and
∏∗
k≥1 hYk+1|Yk(t) represents the
convolution hY1|Y0 ∗ hY2|Y1 ∗ ... ∗ hYk+1|Yk(t).
Then the waiting time distribution for Ab-mucin interaction is
hinteract,n(t) =
∑
{Yk}
P ({Yk})h({Yk}), (4.13)
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Equation 4.13 can further be simplified since it is the convolution of exponential variables, with
exactly n different rates. Since the convolution of exponential variables with the same rate parameter
is a gamma distribution, the waiting time for a given path can be written simply as the convolution
of n gamma density functions.
For example, when n = 2, the formula reduces to
∑∞
k=0
(
mon
mon +moff
)k+1
h∗k1→2 ∗ h∗k2→1 ∗ h∗k1→0(t)
=
∞∑
k=0
(
mon
mon +moff
)k+1
Γ(k + 1,mon +moff ) ∗ Γ(k, 2moff ). (4.14)
Numerical examples of the waiting time distributions
We conclude with a few examples of the freely diffusing and interaction distributions for common
numbers of Ab.
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Figure 4.6: Distribution of time virus spends (A,B) freely diffusing and (C,D) interacting with mucin
for virions with (A,C) 2 associated Ab and (B,D) 10 associated Ab.
Theoretical estimate of IgG-mucin bond rates & times
From the Smoluchowski equation, the diffusional flux to a flat sink of radius "a" at steady state is
given by Fsteady state = 4DaCo. Since the radius of reactive sites for many diffusion-limited enzymes
is found to be ∼1 Angstrom i.e. 10-4 mm, assuming a = 10−4 mm, an average IgG concentration of
∼500 µg/mL in CVM [67] and diffusivity of ∼40 µ m2/s, the flux of IgG to the site would be on
the order of 30 IgG/s. We assume binding sites on mucins are not saturated, based on the previous
finding that addition of exogenous IgG to CVM can quickly immobilize HSV [67], that the trapping
potency of exogenous IgG is indistinguishable to endogenous HSV-binding IgG [67], and that the
total amount of IgG in CVM appears substantially less than the total binding sites available (see
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below). If the binding sites on mucins are not saturated, by definition the bond times between
IgG and mucins at steady state, which is equal to 1/moff , must be less than 1/ (30 s−1) = 0.03
s. This estimate is consistent with observations that IgG-mucin interactions appear to be weak
and exceedingly transient during Fluorescence Recovery After Photobleaching (FRAP) experiments,
where complete recovery is observed within seconds [73].
Alternatively, we consider the possibility that IgG binds selectively to different parts of mucins,
either directly to an entire mucin molecule (or 1 binding site per mucin), naked protein domains on
mucins, or to select glycans on the mucins (10% of all glycan chains). Mucins possess a MW of ∼0.5
MDa, are ∼80% by weight sugar, and possess ∼4 naked protein domains (NPDs) per mucin. At
a mucin concentration of 2% w/v (typically ∼1-5% w/v in various mucus secretions [103]), this is
equivalent to 40 µM of mucins in CVM, 160 µM of NPD, or ∼1 mM of glycan binding sites. At ∼500
µg/mL total IgG in CVM (∼3.3 µM), and assuming up to 20% of IgG associates with mucins at any
moment in time (the ratio of diffusivity in mucus to that in water, Dm/Dw, typically ranges between
0.8-1 [73]), this would imply that at steady state, up to 1 in 60 binding sites are occupied if there is
only 1 binding site per mucin, 1 in ∼300 binding sites are occupied if IgG binds to NPD on mucins,
and 1 in ∼2000 binding sites are occupied if IgG binds to 10% of the glycan chains on mucins. For
equilibrium binding, the fraction of sites with a ligand bound is given by 1/(1+ KD/[IgG]). Hence,
the KD for IgG-mucin interactions ranges from ∼200 µM if there is only 1 binding site per mucin to
∼800 µM if IgG binds to NPD to ∼5 mM if IgG binds to 10% of the glycan chains. Arrhenius had
derived a very simple relationship between the time a bound particle remains bound, Tb, and the
binding energy ∆ε, by assuming that the bound particle has average kinetic energy by equipartition
of energy. Hence 1/2 mv2 along the escape axis equals 1/2 kT. If the particle is constrained within
the bond to bounce back and forth a distance ∆x, then it will collide with the barrier (of magnitude
∆ε) and escape with a frequency of v/2∆x. The odds it will have enough energy to escape per
collision is given by e−(1/2)kT/∆ε. Thus, Tb ∼ ∆x(m/kT )1/2e∆ε/kT . The corresponding bond times
for KD in the 200 µM to 5 mM range would be in the 10−6 to 10−4 s range.
From both approaches, the estimated bond times between IgG and mucins are exceedingly short (i.e.
IgG readily unbinds, thus high moff at rates likely substantially exceeding 1 s−1). This supports
our assumption that the binding rates are exceptionally fast, and justifies our use of partial differ-
ential equations in our model. Unfortunately, such rapid binding and unbinding rates also pose a
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very difficult challenge to make such measurements experimentally, which remains unresolved to date.
Figure 4.7: IgG concentration profiles in genital secretions overlaying the vaginal epithelium over
time for IgG with distinct affinity to mucins (represented by α).
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Figure 4.8: Comparison of mon and moff dynamics to the deterministic reaction-diffusion system.
(A) Predicted fraction of HIV load initially in semen that can diffuse across CVM containing
NIH45-46 over the first two hours post-deposition, at various values of mon[M], with moff adjusted
so that moff/(mon + moff ) = 0.3. The solid black line indicates the predicted HIV load for the
PDE system at α = 0.3. (B) Predicted HIV load diffusing across CVM for various values of
α = moff/(mon[M ] +moff ), with results for the equivalent PDE system at the rightmost point.
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Figure 4.9: Comparison of how differences in (A,C) mfirst and (B,D) k′on can affect (A,B) the
predicted fraction of HIV load initially in semen that can diffuse across CVM containing NIH45-46
over the first two hours post-deposition as well as (C,D) the average number of Ab-free Env trimer
on HIV arriving the vaginal epithelium for Ab with different mucin-affinity (i.e. α). Dashed line
represents the value chosen in the model to minimize over-estimating the protective efficacy of
Ab-mediated trapping in mucus.
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CHAPTER 5
H2O transport and drainage
5.1 Introduction
The model by Wessler et al. [104] in the previous chapter laid the foundation for simulations to
showcase the potency of a strategy of using the antibodies (Ab) found in cervical vaginal mucus
(CVM) to protect against HIV in semen. The aim of the research in this chapter is to build on
the work from that chapter by incorporating some physiological features and explore the extent at
which those features affect the body’s ability to protect against the spread of male to female HIV. In
particular, we are looking at two new components: the effects of osmosis of water from the semen to
the CVM and liquefaction and consequential draining of semen out of the vagina.
5.2 Brief description of the system
Our system is a cylindrical shell with the following parameters (using values from our previous
work unless otherwise cited):
lenV=distance from cervix to introitus=6.27cm [105]
SA=surface area of lumen=145cm2
LCVM=thickness mucus=50um = 50e− 4cm
Lsem=thickness semen (at start)=200um = 200e−4cm
That means that we have a (lenV )× (SA/lenV/pi)× (LCVM +Lsem) rectangular prism "rolled"
into a cylindrical shape. There is symmetry along the circular dimension, but (as the model evolves)
not along the lenV dimension. So, we can essentially simulate many stacked "rings" where each ring
is a 1d simulation that comprises one portion of the lenV dimension (see the Fig 5.1).
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(a) Rectangular system with labels for qual-
itative relative positions of features
(b) A close and unscaled view of a single
ring
(c) A single cross-section "rolled" into a sin-
gle ring, still not to scale
(d) A view of several "stacks" of 1d simula-
tions, each simulation representing a single
"ring"
Figure 5.1: Some images to help visualize the system
5.3 Brief description of transport
CVM has a molarity of 380 mOsm/L while semen has a molarity of 340mOsm/L. Thus, H2O
will transport from the semen into the CVM until the molarities match. The CVM doesn’t change
its osmolarity, but rather the extra H2O is assumed to be immediately absorbed into the cell layer.
As the H2O moves, it creates a fluid flow, which carries with it virions and antibodies. Here are
some parameter values we’re using:
OsmCVM=osmolarity of CVM (at start of simulation)=380mOsm/L = 380zeptoOsm/um3
Osmsem=osmolarity of semen (at start of simulation)340mOsm/L = 340zeptoOsm/um3
tT rans0=time at which transport process begins=0s
tTransDur=duration of transportation process=15min = 15 ∗ 60s
tTransF=tT rans0 + tT ransDur
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The total amount if H2O that will be transported can be given by
(
1 − Osmsemen
OsmCVM
)
Lsem ≈(
1− 340mOsm/L
380mOsm/L
)
200µm ≈ 21µm. As the amount of H2O in the semen decreases, the molarity
of the semen will increase. Since the amount of bulk remains constant, and we’re assuming
symmetry, we have Osmsem(t) ∗ Lsem(t) = Osmsem(0) ∗ Lsem(0), so the molarity at any given
moment can be given by Osmsem(t) = Osmsem(0) ∗ Lsem(0)/Lsem(t). This H2O transport begins
immediately and is complete within 15min, so Osmsem(0) = 340mOsm/L, Lsem(0) = 200µm and
Osmsem(15min) = 380mOsm/L, Lsem(15min) ≈ 179µm.
We will assume both layers are sufficiently porous so that the velocity of the H2O transport is
equal to the velocity of the fluid. For determining the velocity of the fluid, we will assume that it’s
proportional to the difference between the osmolarities of the layers; that is, v = Const∗(OsmCVM−
Osmsem). Also, we will assume that the change in molarity of the semen is proportional to the
difference in molarities; that is,
dMsem
dt
= Const ∗ (MCVM −Msem). From this latter equation, we
get the exact solution, Msem(t) = MCVM + (Msem(0)−MCVM )e−Const∗t. So, if we want it to be
the case that 379.5 mOsm/L < Msem(15) < 380.5 mOsm/L (but it won’t ever exceed 380mOsm/L,
so it’s really just 379.5 mOsm/L < Msem(15)), then we want Const >
ln(1/80)
−15 ∗ 60 ≈ 0.0048689. This
value for Const guarantees that if we dynamically change the osmolarity of the seminal layer at
each iteration proportional to the difference between osmolarities at that moment then after 15min
the seminal layer will be the same as the osmolarity of the CVM (rounding the nearest mOsm/L).
But this is the case for no loss of bulk, which isn’t the case with drainage and an absorbing cell
layer. So, we can instead increase Const slightly to ensure that even if the discussed effects slow the
equalization then we will still balance the osmolarities within the prescribed timeframe. Slightly
adjusting the rate will not affect the final osmolarity of the semen, but will change how quickly it
moves to the osmolarity. Since the time 15min is approximate anyhow (as are the values of the
osmolarities of the CVM and semen), this slight adjustment is not significant. In fact, we varied the
rates significantly and found that they played very little role as long as the fluid osmolarities are
able to balance within the timeframe.
Putting these together we have the following:
vtrans(t) = Const ∗ (OsmCVM −Osmsem(t))
where Osmsem(t) = Osmsem(0)Lsem(0)/Lsem(t)
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where Lsem(t) = Lsem(t− dt)− v(t− dt) ∗ dt
and we plug this into the following equation to handle the transport advection portion of the Ab
(and the equations for the virions are similar):
∂u
∂t
= D
∂2u
∂x
+ v
∂u
∂x
,
where D =

DAb x ∈ semen
αDAb x ∈ CVM
, v =

vtrans x ∈ semen
αvtrans x ∈ CVM
Since there is mass transfer and hence a changing volume as H2O transports from the semen to the
CVM, Lsem is changing dynamically. We start with Nsem compartments each dxsem =
Lsem(0)
Nsem
units
wide. H2O leaves the seminal layer, so the seminal layer compresses. We compress the entire layer
uniformly, by changing the length of each compartment to be dxnewsem =
Lnewsem
Nsem
units wide, effectively
bringing the contents of each compartment closer to the CVM/semen interface. (A numerical note:
to satisfy the stability requirement while still using the largest time step possible, dt < 1/2dx2
is resized as dx resizes.) Notice that absent any drainage and absorption, the concentration of
Ab and virions in the seminal layer increases as the seminal layer shrinks. The amount of Ab in
each compartment is equal to the concentration times the volume, so Ab(x) = u(x)dx. Hence, to
have mass conservation, the concentration must be changed after each compartment resizing by
u(x) =
dxold
dxnew
u(x). Fig 5.2 illustrates the shrinking of the seminal layer and consequential increasing
of concentration, where Fig 5.2a shows a uniform concentration before the shrinking and Fig 5.2b
shows a uniform concentration after the shrinking.
(a) Concentration of Ab and edges of com-
partments before shrinking
(b) Concentration of Ab and edges of com-
partments after shrinking
Figure 5.2: illustration of shrinking of seminal layer–notice concentration increases as volume
decreases
114
5.4 Brief description of drainage
After a few minutes of delay, there is liquefaction in the seminal layer, which drains from the
cervix to the introitus. The semen should thin at the cervix and thicken at the introitus and exit in
drips, but instead, for simplicity, we will model the flow of fluid in a conveyor-belt fashion. It will
begin thinning at the cervix, and that thinning will travel toward the introitus (see the Fig 5.3).
Here are some parameter values we’re using:
tDrain0=time at which drainage process begins=5min = 5 ∗ 60s
tDrainDur=duration of drainage process=5− 10min = 5 ∗ 60s− 10 ∗ 60s
tDrainF=tDrain0 + tDrainDur
PercentDrained=percent of semen that is drained=50%− 95%
LostSemDrain=amount of semen drained=PercentDrained ∗ Lsem Lsem=thickness semen (at
start)=200um = 200e− 4cm
LCVM=thickness mucus=50um = 50e− 4cm
lenV=length from cervix to introitus=6.27cm = 62700um
115
(a) Before draining–0th
time step
(b) After 1st draining time
step
(c) After 2nd draining time
step
(d) After 3rd draining time
step
(e) After 4th draining time
step
(f) After 5th draining time
step
(g) After 6th draining time
step
(h) After 7th draining time
step
(i) After 8th draining time
step
(j) After 9th draining time
step
(k) After 10th draining time
step
(l) After 11th draining time
step
(m) After 12th draining
time step
(n) After 13th draining time
step
(o) After 14th draining time
step
(p) After 15th draining time
step
(q) After 16th draining time
step
Figure 5.3: These are not to scale. Blue is semen layer, cyan is CVM layer. The left boundary of
each picture is the cervix, and the right is the introitus. The space between the bars is to illustrate
that the results come from several independent simulations. The height of each bar is (initially)
250um, and the effective width is 1um, so there would be 62700 bars (the average distance from
cervix to introitus is 62700um) for a full simulation.
116
It is not the case that all of the "rings" start draining at the same time: since the thinning
starts at the cervix, the rings near the cervix see the reduction in Lsem before the rings near the
introitus. Determining the start and finish time for the draining process for each ring is necessary to
orchestrate the draining process for the whole system. Here we will describe how to determine the
start and finish time for the ith ring.
There are NRings = ceil(lenV ∗dx) rings, and each ring loses NLost = floor(LostSemDrain ∗
dx) units of semen. The draining must happen such that at t = tDrain0 no draining has occurred; at
t = tDrain0+dtDrain the first ring has lost one unit of semen; at t = tDrain0+2∗dtDrain the first
ring has lost 2 units of semen and the second ring has lost one unit semen; at tDrain0 + 3 ∗ dtDrain
the first ring has lost three units of semen, the second ring has lost two units of semen, and
the third ring has lost one unit of semen; etc. The first ring drains all NLost of its units of
semen when t = NLost ∗ dtDrain, and the ith ring has drained its first unit of semen when
t = tDrain0 + i ∗ dtDrain. It follows, then, that the ith ring has drained all NLost units of semen
when t = tDrain0 + (i− 1) ∗ dtDrain+NLost ∗ dtDrain. Since all of the semen that drains must
be completed at t = tDrainF , we have tDrainF = tDrain0 + (NRings− 1 +NLost) ∗ dtDrain
and dtDrain =
tDrainF − tDrain0
NRings+NLost− 1 . For notation purposes we will begin the draining process
for the ith ring at tDrain0Ringi = tDrain0 + (i − 1) ∗ dtDrain, but it will not lose its first
unit until t = tDrain0 + i ∗ dtDrain, but we will say that it finishes its draining process at
tDrainFRingi = tDrain0 + (1− 1 +NLost) ∗ dtDrain. So, as the algorithm runs, the number of
units lost at time t will be
NLostRingi(t) =

0 if t < tDrain0Ringi
NLost− floor
(
t− tDrain0Ringi
dtDrain
)
if tDrain0Ringi ≤ t ≤ tDrainFRingi
NLost if t > tDrainFRingi
From this we can input to each 1d simulation which ring is being simulated, and the draining
process will occur during the correct time window. The number of semen units lost at each point in
time is all that is necessary to do the draining, because from that we know where the semen/lumen
interface is, which will be our boundary for the PDEs (and the concentration of virions and Ab
in the lumen is set to zero in the region of a recently-drained unit of semen). Note also that the
number of units of drained semen is also required to calculate the osmolarity of semen.
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5.5 Summary of parameters for the transport and drainage models
lenV=distance from cervix to introitus=6.27cm (Barnhart et al. [105])
SA=surface area of lumen=145cm2
LCVM=thickness mucus (at start)=50um = 50e− 4cm
Lsem=thickness semen (at start)=200um = 200e− 4cm
OsmCVM=osmolarity of CVM (at start of simulation)=380mOsm/L = 380zeptoOsm/um3
Osmsem=osmolarity of semen (at start of simulation)340mOsm/L = 340zeptoOsm/um3
tT rans0=time at which transport process begins=0s
tTransDur=duration of transportation process=15min = 15 ∗ 60s
tTransF=tT rans0 + tT ransDur
LostSemTrans =
(
1− Osmsem(0)
OsmCVM (0)
)
Lsem(0)
5.6 More discussion on the moving boundary
As H2O is transported away from the semen, the volume of the semen decreases and the
concentration of the bulk increases. That means that the semen/air interface after the transport
is completed will be closer to the cell/CVM interface than it was before the transport, and all of
the bulk will be compressed as it moves towards the CVM/semen interface. The distance that the
boundary has moved during an interval τ is equal the product of the velocity and the time interval,
d = v ∗ τ Hence, the length of the seminal layer is Lnewsem = Loldsem − v ∗ τ .
For the numerical simulation, we break up the semen into Nsem compartments, each dxsem =
Lsem
Nsem
units long. Since everything is made more compact, and everything is moved closer to the
CVM/semen interface, the compression and shifting can be accounted for by calculating dxnewsem =
Lnewsem
Nsem
. For numerical stability, τ < 1/2∗dx2, so τ must also be redefined each time dxsem is changed.
For illustrative purposes, Fig 5.4 shows the shrinking of the compartments in the seminal layer.
At t = 0min the compartments in the CVM and semen are the same size, while at t = 14min the
size of each compartment in the semen is 1/2 what it was at the start.
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(a) t=0min (b) t=2min (c) t=4min
(d) t=6min (e) t=8min (f) t=10min
(g) t=12min (h) t=14min
Figure 5.4: Blue=CVM, Red=semen. Plot of spacings between compartments. At t = 0min both
CVM and semen have equal spacings. At t = 14min spacing between compartments in semen is half
of what it was at t = 0min, while the compartments for CVM remain unchanged.
Let’s continue looking at the illustrative case that the seminal layer loses 1/2 of its volume. This
time, let’s let the y-axis represent the amount of Ab at the location given by the x-axis; let’s say
that the amount of Ab everywhere starts at 1. If the sizes of the compartments don’t change, then
there are consequences. The first approach to this is to just eliminate the furthest compartment at
the appropriate time. Fig 5.5 shows this scenario.
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(a) Starting profile, concentration is uniform
everywhere.
(b) Final profile, concentration is uniform
everywhere that is nonzero.
Figure 5.5: Plots of results of eliminating outermost layer of semen (blue=CVM, red=semen).
Notice that the total amount of Ab reduces from 25 units to 15 units. This is because eliminating
compartments eliminates everything that is in it.
An alternative to this method is to place all of the "stuff" that is in the compartment that is
about to be eliminated into the compartment immediately next to it. In doing this the total amount
of "stuff" is conserved. Fig 5.6 shows this approach.
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(a) Starting profile, concentration is uniform
everywhere.
(b) Upon elimination of last compartment
the compartment before it "absorbs" ev-
erything that was in the last compartment.
This creates a jump in amount of Ab.
(c) Final profile, concentration is uniform
everywhere but with a larger amount of Ab
at each position than at start.
Figure 5.6: Plot of results of eliminating outermost compartment of semen but placing all of the
"stuff" from the outermost compartment into the compartment next to it (blue=CVM, red=semen).
Notice that diffusion will even out the amounts of Ab so it will again have a uniform profile everywhere.
Also notice that the total amount of Ab stays at 25 units the whole time.
Another alternative is to shrink the semen layer as described above, but after doing so resize the
compartments so that they are the same size as they were at the start. Fig 5.7 shows this approach,
and is the approach that we use. The resizing helps us go back to the larger spatial, and consequently
temporal, step sizes.
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(a) Starting profile, is uniform everywhere. (b) Final profile after shrinking each com-
partment to half of the size. This increases
the concentration so the total Ab is con-
served.
(c) We now rescale the compartments to
the original size, so we split up all of the
Ab from the 20 small compartments into 10
regular-sized compartments.
Figure 5.7: Plot of results of shrinking each compartment then resizing the compartments once
completed (blue=CVM, red=semen). Notice that the total amount of Ab stays at 25 units the whole
time.
5.7 More discussion of transport velocity
H2O is transported by osmotic pressure from the semen to the CVM, and makes its way to the
cell layer. We will assume the velocity is the same at all spatial locations in both layers, meaning
that the H2O leaving the semen enters the CVM, but will immediately flow at an equal rate from
the CVM to the cell layer. By doing this, the osmolarity will not change in the CVM. We will also
assume that the velocity of the objects in the fluid will be the same as the velocity of the transported
H2O. We must come up with a strategy for determining the velocity of the fluid.
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5.7.1 Constant velocity
The most obvious way to determine the rate of flow is to have the H2O move at a constant rate
during the whole 15min. Since the boundary moves ≈ 21µm in 15min, we can just assign a rate of
v =
21µm
15min
=
21µm
15 ∗ 60sec , and have that advection and contracting boundary turn on immediately,
then shut off immediately after t = 15min. This will give us the exact values of Lsem and Osmsem
at the exact time that we want it to (if we use the exact amount that the boundary moves). This
strategy seems to have less fidelity with what is actually going on.
5.7.2 Difference in molarities
The rate that H2O flows from the seminal layer into the CVM ought to be related to the difference
between the two molarities, so that the flow is the strongest when the difference is the greatest.
That is, v = Const ∗ (OsmCVM −Osmsem). This is an ODE: dMsem
dt
= Const ∗ (MCVM −Msem).
Notice that the exact solution of this Msem = MCVM + (M0sem −MCVM )e−Const∗t, and from this
we see that Msem = MCVM when t =∞. But, since Msem −MCVM = (M0sem −MCVM )e−Const∗t,
the difference between Msem and MCVM shrinks exponentially, so we can choose Const so that
Msem will get sufficiently close to MCVM within the time that we desire. For example, if we want
MCVM −Msem < 1/2mOsm/L in 15min, then we want (MCVM −M0sem)e−Const∗(15∗60) < 1/2 ⇒
(380− 340)e−15∗60∗Const < 1/2⇒ e−15∗60∗Const < 1/80⇒ −15 ∗ 60 ∗ Const < ln(1/80)⇒ Const <
ln(1/80)
−15 ∗ 60 ≈ 0.0048689.
In doing this approach in practice, we calculate the molarity in the semen by Osmsem(t) =
Osmsem(t = 0)∗Lsem(t = 0)/Lsem(t), and from this calculate the velocity v(t) = Const∗(OsmCVM−
Osmsem(t)), and at the next iteration calculate Lsem(t) = Lsem(t− τ)− v(t) ∗ τ .
5.7.3 Darcy’s law
Darcy’s law is the following:
q =
−κ
µ
∇p, v = q
φ
Since semen and CVM are porous, we can let φ = 1, so the velocity v =
−κ
µ
∇p. From this we see
that v = Const ∗ (MolarityCVM −Molaritysemen. This is exactly the result that is described in
the previous approach by looking at differences in molarities.
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5.8 Discussion on different scales
There are kind of 4 time steps that are taking place here: the virion diffusion time step, the Ab
diffusion time step, the transport advection time step, and the drainage time step. The diffusion
time steps are determined by the stability of the diffusion algorithm, while the transport and
drainage time steps are determined by figuring out the average rate boundaries move in order to
move the proper distances in the proper amount of time. The time steps have the relationship
dtdrain < dtAb << dtvir << dttrans. We run the model using the virion diffusion time step, running
extra iterations to accommodate the stability requirement for the Ab diffusion. For the transport and
drainage, we make lists for the times that the boundary is supposed to be moved due to transport
and drainage, then we move the boundary the number of times that it would be moved in the interval
[t, t+ dtvir) (by looking at the times given in the lists). Since dtdrain << dtvir, multiple "steps" in
that staircase will be actually occur in the same time step, so the staircase doesn’t actually look
the way it is presented in the above figure; rather, several "stacks" in a row will have the same
semen thickness, and in the next time step the thickness of them will decrease by several units. This
becomes obvious upon realizing that the "wave" must travel 62700um in roughly 5min, which is way
faster than anything else in the system.
5.9 Discussion on inter-stack diffusion
We can only run each "slice" (or "stack") independently if there is no significant diffusion taking
place between adjacent stacks. The drainage takes place somewhere around t = 5min − 15min,
which is before the Ab have fully diffused into the semen. Hence, since the drainage starts in the
top stack (at the cervix) 5 min or so earlier than it does for the bottom stack, then the top stack
will not have as much Ab reaching the region that will be drained than the bottom stack will have,
so the amount of Ab in the top stack at the end of the simulation will be slightly greater than
that of the bottom stack. This suggests that there should be some inter-stack diffusion that could
take place, so we tried to see how much inter-stack diffusion there would be. This can be looked at
analytically because the relationship between length and time is known for diffusive processes, but
we will instead just show the results from simulations for plotting purposes.
First, we ran the top stack (call it stack1) for 2hrs, then we ran the bottom stack (call it
stack62701) for 2hrs. We then compared the concentrations of Ab of stack1 with the concentrations
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of Ab in stack62701. Fig 5.8 is a plot of
Ab1 −Ab62701
Ab1
for each distance from the cell layer (x-axis is
distance from cell layer, y-axis is basically % difference in Ab concentration).
Figure 5.8: Percent difference of Ab concentration between top and bottom stacks
So, it appears that there is about a 7.6% difference in Ab concentration between the 1d slice
nearest the cervix and that nearest the introitus. However, this 7.6% difference is over 62700um
(and hence 62700 different stacks), so the difference between each adjacent stack is very small. Still,
though, it is worth looking at whether or not diffusion could play a significant role if Ab are allowed
to diffuse between stacks. What we did to investigate this was set up a system Xum long, where
on the left we have a concentration of Ab1 (the concentration of Ab in semen in stack1) and on
the right we have a concentration of Ab62700 (the concentration of Ab in semen in stack62700), and
we linearly-spread the concentrations at all points in-between (i.e., we gradually decreased the
concentration from Ab1 to Ab62700). Then we let an Ab diffusion simulation run from t = 15min
(when the boundary quits moving) to t = 2hrs to see the effects of diffusion if the Ab in the semen
were at steady state in each stack at t = 15min (which they aren’t) and were allowed to diffuse at
that time (what we imagine as a conservative test). We tested it for a few different X values (if the
distance between the cervix and introitus were Xum long). Fig 5.9 show pictures after the 2hr run.
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(a) Lvag=1000um (b) Lvag=2500um
(c) Lvag=5000um (d) Lvag=25000um
(e) Lvag=62700um
Figure 5.9: The x-axis is the distance from the cervix towards the introitus; the y-axis is the Ab
concentration in the semen at that spatial point (after diffusing for 1hr45min). Notice that with a
length of 1000um the Ab come close to steady state, while with a length of 25000 there is virtually
no change is concentration from the start of the simulation.
From this, it seems that there is of course some diffusion, but that the difference in concentration
between adjacent stacks in the whole system (Lvag = 62700um) is so small that diffusion between
stacks plays a very minor role. Hence, inter-stack diffusion is not a reason to not use the 1d model.
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5.10 More details on PDE model
5.10.1 Unmoving boundary, extremely fast flow
Here, we put in advection with a velocity v = 0.5Dvir just to exaggerate the effects in order to
observe the effects of the H2O transport flow. The flow exists from t=0 to t=15min. Fig 5.10 shows
this scenario
(a) t=896sec–flow is present. (b) t=936sec–flow is not present
(c) t=1052sec–flow is not present (d) t=1208sec–flow is not present
(e) t=2026sec–flow is not present
Figure 5.10: Snapshots of Ab concentrations as time progresses for case with extreme advection
and no moving boundary. x=0 is cell/CVM interface, x=50 is CVM/semen interface, x=250 is
semen/lumen interface. This is with α = 0.25.
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In Fig 5.10a you can see the full effect of the flow in the case with the extremely high advection
rate: there is a force pushing everything pretty high against the "wall" of the cell layer. This is
actually the steady state with this flow and a reflecting boundary (the profile looked unchanged for
a while). At 900sec the flow shut off, so the force pushing the Ab against the cell layer was removed
and diffusion gradually evens out the free Ab concentration in Figs 5.10b - 5.10d, eventually reaching
the steady state seen in Fig 5.10e.
Fig 5.11 shows the concentration of virions (with 10 Env) taken at a few different times.
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(a) t=389sec–flow is present (b) t=896sec–flow is present
(c) t=1559sec–flow is not present (d) t=2533sec–flow is present
(e) t=3040sec–flow is present
Figure 5.11: Snapshots of virion concentrations as time progresses for case with extreme advection
and no moving boundary. x=0 is cell/CVM interface, x=50 is CVM/semen interface, x=250 is
semen/lumen interface. This is the concentration of all virions in the system with 10 Env.
Notice that if there is no Ab-mucin affinity and a reflective boundary then the virion profile
would look like the mucin-free Ab profile (monotonically decreasing as you move away from the cell
layer). In Fig 5.11a we see this increase in concentration as we move from the lumen/semen interface
further into the semen layer, but because there is an affinity between Ab and mucins that is passed
on to the virions in the mucus layer (so it is easier for virions to enter the mucus layer than leave it),
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we also see an increase in concentration as we move from the CVM/semen interface further into the
semen layer, so it has the "bowing" look in profile in the seminal layer. Also, because there is an
absorbing boundary at the cell layer, the concentration right at that interface will be very small, so
it will actually look like it is monotonically decreasing as we move away from the cell layer instead of
increasing. In Fig 5.11b, the flow is still turned on, and this "bowing" is more pronounced, and we
also start to see the high concentration at the CVM/semen interface that we’re familiar with. For
Figs 5.11c - 5.11e we see when the flow is turned off the concentration is monotonically increasing
as we move away from the cell layer towards the CVM/semen interface, as well as monotonically
increasing as we move from the CVM/semen interface towards the semen/lumen interface, and we
see the concentration in mucus right at the CVM/semen interface gets larger and larger. We know
that the Ab quickly diffusing and attaching to the virions in the semen before the virions reach the
CVM is at least partly responsible for creating such an effective shield right at the CVM/semen
interface. When there is such a strong flow the Ab cannot diffuse into the semen as well, so there
might be an inhibition in protection at that point, but we haven’t done any analysis to see if that is
the case.
5.10.2 Poor strategy for boundary movement
For the following simulation we used a constant velocity v = 1.33um/min, but also moved the
reflecting semen/air interface boundary from z = 250um to z = 230um while the time goes from
t = 0min to t = 15min (to account for the H2O mass transfer from the semen to the cell layer). So,
the reflective boundary is at z = 250um until t = 15 ∗ (250− 249)/20min is eclipsed, at which point
we move it to z = 249um, and it stays there until t = 15 ∗ (250− 248)/20min is eclipsed, and so
forth until we move it to z = 230um when t = 15 ∗ (250− 230)/20min is eclipsed. Notice that by
moving the reflective boundary we will (correctly) no longer allow Ab and virions into the region
newly-located beyond the boundary, but a decision needs to be made about what to do with Ab and
virions that exist in this region that will fall beyond the boundary once the boundary is moved, as
was discussed earlier. In the next section (drainage), the decision is easy, since the moving boundary
represents removal of semen and everything in it, so what we do with these stranded Ab and virions
is effectively throw them out. But for the transport, H2O is moved, which pulls everything else
together a bit more tightly, but nothing is removed. Fig 5.12 shows a strategy of moving everything
from the position that is about to be removed into the position that will become the new boundary.
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E.g., when we moving the boundary from z = 250um to z = 249um, we take all Ab and virions that
are at z = 250um and put them in z = 249um (i.e., u(t, 249) = u(t, 249) + u(t, 250)). Notice that
basically what we’re doing is doubling the concentration at the new boundary each time we move it.
Obviously, this is not a great strategy (see Fig 5.12c).
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(a) t=233sec–flow is present and boundary
still moving
(b) t=428sec–flow is present and boundary
still moving
(c) t=467sec–flow is present and boundary
still moving
(d) t=740sec–flow is present and boundary
still moving
(e) t=3585sec–flow is not present and bound-
ary no longer moving
Figure 5.12: Snapshots of Ab concentrations as time progresses for case with realistic advection
and a moving boundary due to H2O transport. x=0 is cell/CVM interface, x=50 is CVM/semen
interface, x=250 is semen/lumen interface. This is with α = 0.25.
In Figs 5.12a - 5.12d there is advection and the boundary is moving from z = 250um to
z = 230um. Notice in Fig 5.12b that the concentration at the boundary is about twice that at the
position right next to it. This is because all of the Ab that were about to become stranded were
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moved into the new boundary, basically doubling the concentration at the new boundary. This
excess concentration quickly diffuses away, but until then there’s a conceptual problem with this
method. In Fig 5.12e the flow is turned off and the Ab are at steady state, so this is the profile of
the Ab for the majority of the simulation, with the boundary at z = 230um.
Below are snapshots of virions with 4 Env from the same simulation.
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(a) t=78sec–flow is present and boundary
still moving
(b) t=428sec–flow is present and boundary
still moving
(c) t=857sec–flow is present and boundary
still moving
(d) t=2611sec–flow is not present and bound-
ary no longer moving
(e) t=3585sec–flow is not present and bound-
ary no longer moving
Figure 5.13: Snapshots of virion concentrations as time progresses for case with realistic advection
and a moving boundary due to H2O transport. x=0 is cell/CVM interface, x=50 is CVM/semen
interface, x=250 is semen/lumen interface. This is the concentration of all virions in the system
with 4 Env.
In Figs 5.13a - 5.13c the H2O transport due to osmolarity differences is active, while in Figs 5.13d
- 5.13e it is not. Since the diffusion rate is slower for virions than Ab, the effects of the concentration-
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doubling when the boundary is moved is longer-lasting for virions than for Ab (notice the relatively
high concentration of virions on the boundary of Fig 5.13b while there is no such behavior in
Fig 5.13b for the Ab even though they occur at the same time so have had the same amount of time
to resolve this issue). This is somewhat what it would be like if the fluid velocity is faster than the
velocity of the objects in it, since in that case the boundary would be pulling everything with it, and
there probably will be a higher concentration of slow-moving objects at the boundary. However,
using this strategy the doubling is unavoidable and seems extreme, so we don’t use it. Instead, we
use the "compression" strategy already discussed.
5.10.3 Results for drainage
Before orchestrating the full set of 1d simulations, we will look at just the draining scheme for
only a single 1d simulation.
Description for single simulation For this single simulation we moved the reflecting boundary
from z = 250 to z = 250−X% ∗ 200 (so lost X% of bulk) as t went from t = 5min to t = 10min in
equal intervals. When moving the boundary, we would eliminate everything that will be beyond the
boundary. E.g., the boundary will be at z = 250um until t =
((
5/(X%∗200))∗ (250−249)+5)min,
at which point we move the boundary to z = 249um and set the concentration of Ab and virions at
z = 250um to 0. So, we have a GRADUAL depletion of the seminal layer, losing X% of bulk over
the full 5min.
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(a) t=311sec (b) t=350sec (c) t=389sec
(d) t=428sec (e) t=467sec (f) t=506sec
(g) t=545sec (h) t=584sec (i) t=623sec
(j) t=1676sec (k) t=3585sec
Figure 5.14: Snapshots of Ab concentrations as time progresses with no advection but with a moving
boundary due to drainage. x=0 is cell/CVM interface, x=50 is CVM/semen interface, x=250 is
semen/lumen interface. This is with α = 0.25.
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(a) t=311sec (b) t=350sec (c) t=389sec
(d) t=428sec (e) t=467sec (f) t=506sec
(g) t=545sec (h) t=584sec (i) t=623sec
(j) t=1676sec (k) t=3585sec
Figure 5.15: Snapshots of virion concentrations as time progresses with no advection but with a
moving boundary due to drainage. x=0 is cell/CVM interface, x=50 is CVM/semen interface, x=250
is semen/lumen interface. This is the concentration of all virions in the system with 4 Env.
For both sets of figures we took snapshots at the same time (roughly every 39 sec while the
semen is draining, and then at a couple other times afterward). For Figs 5.14a - 5.14h and Figs 5.15a
- 5.15h the boundary is moving, while for Figs 5.14i - 5.14k (i)-(k) and Figs 5.15i - 5.15k it is not.
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5.10.4 Results from both transport and drainage
To allow for both transport and drainage, we just run both algorithms at the same time (with
the transport occurring from t = 0min to t = 15min, but in the middle of this we also have drainage
from t = 5min to t = 10min).
Fig 5.16 show some results from running both at the same time.
(a) t=389sec (b) t=779sec (c) t=3507sec
Figure 5.16: Snapshots of Ab concentrations as time progresses for case with realistic advection and
a moving boundary due to both H2O transport and drainage. x=0 is cell/CVM interface, x=50 is
CVM/semen interface, x=250 is semen/lumen interface. This is with α = 0.25.
The boundary is moving in Fig 5.16a and Fig 5.16b. The Ab concentration is at steady state in
Fig 5.16c.
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(a) t=39sec (b) t=117sec (c) t=194sec (d) t=272sec (e) t=350sec
(f) t=428sec (g) t=506sec (h) t=584sec (i) t=662sec (j) t=740sec
(k) t=818sec (l) t=896sec (m) t=974sec (n) t=1052sec (o) t=1130sec
(p) t=1208sec (q) t=1286sec (r) t=1364sec (s) t=1442sec (t) t=1520sec
(u) t=1598sec (v) t=1676sec (w) t=1754sec (x) t=1832sec (y) t=1909sec
(z) t=1987sec
Figure 5.17: Snapshots of virion concentrations as time progresses for case with realistic advection
and a moving boundary due to both H2O transport and drainage. x=0 is cell/CVM interface, x=50
is CVM/semen interface, x=250 is semen/lumen interface. This is the concentration of all virions in
the system with 10 Env.
These snapshots are taken about every 78sec from t = 39sec to t = 1987sec. In Figs 5.17a - 5.17l
there is transport, and in Figs 5.17e - 5.17h there is drainage. In Fig 5.17b and Fig 5.17l you can see
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the slight uptick in concentration at the boundary due to the contraction of the semen layer and
consequential dragging of the virions at that edge since the poor strategy of transport boundary
movement is being used. The drainage wave is over the course of 10 min, which is fast, as can be
seen by looking at Figs 5.17e - 5.17l.
Description for full simulation For the full simulation, we need to consider the fact that the
drainage is from the cervix to the introitus, where at t = 5min there is all of the semen at every
stack, while as t = 15min elapses all of the semen that will be drained has drained everywhere.
For illustration purposes, let’s say that there are 1000 stacks, and the semen layer will go from
200um thick to 100um thick in those 10min. So, at t = 5min all stacks have a semen thickness
of 200um, and as t = 15min elapses all stacks have a semen thickness of 100um. We want the
first change in semen thickness to be the topmost stack going from 200um to 199um, which will
happen right after t = 5min, and we want the last change in thickness to be the bottommost
stack going from 101um to 100um right after t = 15min. In between those time points we have a
traveling wave of this staircase-looking profile of semen layer thicknesses. Since there are 100um of
thickness changes to occur, the staircase will be 100 stairs long. Since the wave starts at the top of
the staircase on the topmost stack and finishes at the bottom of the staircase on the bottommost
stack, the wave has 1000+100 units to travel, and 10min to do it in. Hence, every 10/1100 min
the wave moves 1 unit. So, at t = 5min the semen for all of the stacks is 200um thick, while
at t = (5 + 1 ∗ 10/1100)min the semen for the top stack is 199um thick while for the rest of the
stacks it’s still 200um thick; at t = (5 + 2 ∗ 10/1100)min the semen for the top stack is 198um
thick, and the semen for the next-to-top stack is 199um thick, while it is 200um thick everywhere
else; at t = (5 + 1099 ∗ 10/1100)min the semen for the bottom stack is 101um thick while it is
100um thick everywhere else; and, finally, at t = (5 + 1100 ∗ 10/1100)min the semen is 100um
thick at all stacks. In a more generalized form, we have that the drainage starts at tStart and
ends at tEnd, with a starting thickness LsemStart = 200 and an ending thickness of LsemEnd,
and a total number of stacks of Nstacks, which gives me that the nth stack loses its first bit of
semen at t =
(
tStart + n ∗ (tEnd − tStart)/(LsemStart − LsemEnd + Nstacks)). The number
of stairs in the staircase is LsemStart− LsemEnd, so the nth stack loses its last bit of semen at
t =
(
tStart+(n+LsemStart−LsemEnd)∗(tEnd− tStart)/(LsemStart−LsemEnd+Nstacks)).
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More simply, though, once the nth stack has starting losing semen, it will continue losing it one
stair’s-worth every (tEnd− tStart)/(LsemStart− LsemEnd) time units.
To run the full simulation on the cluster, we will submit Nstacks jobs, each job having its
own input n = 1, 2, 3, ..., Nstacks. This way, we will have a new start time for the nth stack,
tn =
(
tStart+ n ∗ (tEnd− tStart)/(LsemStart−LsemEnd+Nstacks)), and we can let the layer
shrink in equal time intervals until its thickness is LsemEnd. We will then have data for Nstacks
simulations, and by combining all of these we will have an idea of the flux, etc. for the whole 2d
(3d) system. From Barnhart et al. [105] we have that the length of the system is 62700um from
cervix to introitus, which would mean 62700 stacks for a full simulation, which is a lot, but not
completely unmanageable (we have each run down to <4min without the advection and other changes
incorporated, but can run several runs simultaneously). Instead, though, we did some exploration in
order to determine how many stacks we really need to run.
Investigating number of stacks needed Rather than run with all 62700 stacks, a sample of
them will be run, and the results will be interpolated. Fig 5.18 illustrates the changes in profile
of a few stacks as time progresses. The x-axis of each plot represents the distance from the cell
layer in um. (Technically, it is the indices for each of the 250 spatial locations, which is different
from the distance because the spatial locations of the semen contract as H2O transports out of the
seminal layer, but these figures don’t make the adjusts to portray the true distance from the cell
layer.) The y-axis represents the number of virions at this spatial location. Moving left to right
along a single row of plots are plots for stack 1, 10001, 30001, 45001, 50001, and 60001, where the
stack number also signifies the number of um from the cervix. Moving top to bottom along a single
column of plots are for t=300sec, 348sec, 443sec, 515sec, 539sec, and 587sec. Recall first that the
H2O transport begins at t=0 and pulls virions towards the cell layer, which is responsible for the
lower virion numbers near the semen/lumen interface. Also, recall that draining starts at stack 1 at
t=5min. Hence, all of the stacks are identical on the top row before any draining has occurred. At
t=5min, the 2nd row, only the first stack has drained and the rest of the stacks are identical. At
t=6min, the 3rd row, the first 2 stacks have drained, while the others haven’t, so the right 4 stacks
are identical. The first 2 stacks are similar, but are not identical, as a slight dip has developed on
the right of the curve of stack 1 due to the "pulling" effects of the H2O transport, but hasn’t yet
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developed on stack 10001 since the spatial locations visibly affected by the H2O transport were the
ones just drained. By the bottom row, all but stack 60001 have undergone draining. Notice that
there isn’t much difference in profiles between stacks 30001, 45001, and 50001, while on the 3rd row
there are some differences between the two stacks that have drained. The reason for this is that the
velocity of transport is greater at earlier times than at later times because the velocity depends on
the osmotic pressure, which decreases as time goes on because the differences in osmolarities between
the CVM and semen decreases as H2O is transported from the semen to the CVM. This means that
"dip" being formed becomes less and less prominent the later and later the formation occurs.
Figure 5.18: Percent difference of Ab concentration between top and bottom stacks
From Fig 5.18 we can see that snapshots of the stacks are not identical. We look at how much
these differences translate to differences in our measured outcomes, such as flux of virions and
infectivities (which are described in the paper in previous chapter, Wessler et al. [104]). Fig 5.19
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shows the difference in fluxes uses for a few different stacks for different α values. Notice that there
is very little difference in flux for the different stack positions.
Figure 5.19: Flux for a few different stack positions for different α values. The different colors in
curves represent different stack numbers.
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(a) Flux for each stack position when no Ab
are present.
(b) Flux for each stack position when no Ab
are present.
(c) # of Ab-free trimers that reach cell layer
when no Ab are present.
(d) # of Ab-free trimers that reach cell layer
when Ab have no affinity with mucins.
Figure 5.20: Plots of measured outcomes for different stack positions.
Fig 5.20 shows that different stacks leads to different measured outcomes, although not necessarily
significantly. However, different parameter combinations may lead to more significant differences,
so the differences shouldn’t be ignored. Also, it is clear from the shapes of the curves that taking
only the middle stack, taking just the first and last and averaging those, and even taking first, last,
and middle stacks and averaging or interpolating those will not be sufficient for approximating the
behavior of the full system without simulating all 62700 stacks. So, we decided to use 6 different
stacks and do a spline interpolation to get the full system approximation.
Before showing results for the full system, some discussion on the worst-protected stack (when no
Ab are present) should be had. The stack that allows the most virions to reach the cell layer (when
there’s no trapping), and consequently allows the most Ab-free trimers to reach the cell layer, is near
stack 45000, not stack 62700 as perhaps would be expected. If stack 62700 is the last stack to be
drained, then it is the stack that gives the most time for virions to diffuse into the CVM before being
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drained, and hence is expected to be the stack that drains the fewest number of virions. However,
keep in mind that H2O transport begins before any of the stacks have drained, but has terminated
before the final stack has been drained. While H2O transport is occurring, virions are being pulled
towards the cell layer, causing the "dip" in virion numbers near the semen/lumen interface, as can be
seen in Fig 5.18. So, while H2O transport is occurring, there are fewer virions 250um from the cells
than 200um from the cells. So, when comparing the number of virions drained while H2O transport,
which is pulling the virions toward the cell layer and away from the lumen/semen interface, with the
number of virions drained after H2O transport has finished and the virions have had time to diffuse
back into the region near the lumen/semen interface. Fig 5.21 shows how many virions are drained
for each stack. It is the case that the stack with the fewest number of virions drained isn’t stack
62700; rather, it is the stack that drains just as H2O transport finishes, near stack 45000.
Figure 5.21: Percent difference of Ab concentration between top and bottom stacks
5.11 Results from PDE model
First, let’s look at the extant that H2O transport and semen drainage affects protection. Logically,
any amount of H2O transport should hurt protection, since it aids the virions in reaching the cell
layer as well as reaching before many Ab can attach (see Fig 5.22), and the greater the difference in
osmolarities between the seminal and CVM layers the more the virions are helped. Also, logically,
any amount of drainage should help protection, since any drainage should remove some virions,
which means that there are fewer virions with a chance to penetrate the CVM to the cell layer.
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However, it is not obvious which of these two plays the more dominant role.
Figure 5.22: The number of virions with n Ab attached as time advances, where n is given on the x
axis. As time goes on, more virions have Ab attached, but also the more Ab that become attached
on each virion. This highlights the vulnerability to virions early in the simulation because it takes
several Ab attached to effectively trap a virion.
Fig 5.23 looks at the influence of drainage on the flux of virions to the cell layer, without the
presence of H2O transport. The x-axis of each plot is the percent of the seminal layer that is drained.
0% means that there is no drainage whatsoever, while 100% means that afterward the model has
only 1 layer: the CVM. The y-axis is the percent of the viral load that penetrates to the cell layer
after the 2hr simulation. The left column of plots is for simulations using [Ab]=1ug/mL; the middle
column of plots is for simulations using [Ab]=5ug/mL; and the right column is for simulations using
[Ab]=10ug/mL. The top row of plots is for simulations using α=0.8; the row of plots immediately
below the top is for simulations using α=0.5; the row of plots immediately above the bottom is for
simulations using α=0.3; and the bottom row of plots is for simulations using α=0.02. Each colored
curve in each plot represents a different start time for the draining to occur, whereby the blue curve
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is for simulations with the draining beginning at t = 0; the orange curve is for simulations with the
draining beginning at t = 1min; the yellow curve is for simulations with the draining beginning
at t = 5min; and the purple curve is for simulations with the draining beginning at t = 10min.
Unsurprisingly, protection gets better the earlier the draining takes place, and the more semen is
removed. Also, as is expected, the higher the Ab concentration the better the protection. After the
research of Wessler et al. [104] and in a paper currently in review by this research group led by Jay
Newby, it should also be unsurprising that the best protection is not by the lowest α value, but by
some intermediate value, which in our exploration is somewhere around α = 3. It should be noted
that the effects of drainage depend on start times and percent loss when the Ab concentration is
lower compared to when it is higher, where Ab protection is extremely great no matter what.
Figure 5.23: Flux of virions to the cell layer for different drainage start times and different percent
of seminal layer being drained.
Figs 5.24 and 5.25 look at the influence of H2O transport on the flux of virions to the cell layer
147
without the presence of drainage. In each plot in Fig 5.24, the x-axis represents the osmolarity of
the seminal layer, where we looked at 320 mOsm/L, 340 mOsm/L, and 360 mOsm/L (where CVM
is 380 mOsm/L). The y-axis, again, represents the percent of the viral load that penetrates to the
cell layer. The green bars are for Ab concentrations of 10ug/mL, the red are 5ug/mL, and the blue
1ug/mL. Left set of bars are for α=0.02, the right set of bars are for α=0.8, and the two middle sets
are for α=0.3 and α=0.5. Unsurprisingly, the greater the difference in osmolarity (so the smaller
the osmolarity of the semen), the greater the osmotic pressure, and hence the worse the protection.
As expected, the higher the concentration of Ab the better the protection. Also, as expected from
Wessler et al. [104], the optimum α value is not at α=0, but instead at some intermediate value.
Fig 5.25 looks at more osmolarities rather than just the three in Fig 5.24. In Figs 5.25, the
x-axis is the difference in osmolarities between the CVM and semen, where the osmolarity of the
CVM is still 380mOsm/L. When x=0, then the osmolarity of semen is 380mOsm/L, so there is no
H2O transport whatsoever; when x=60, then the osmolarity of semen is 320mOsm/L. Qualitatively,
Fig 5.25 shares the same information as Fig 5.24, but does so for a fuller set of data. Overall, it
appears that the effects of H2O transport are greater than those semen drainage. However, even
without the added aid of drainage as a tool for protection, and the worst conditions for H2O transport,
it seems like Ab can be engineered with certain properties in order to be a viable form of protection.
The next section set of plots try to measure the ability of Ab of certain types to protect.
148
Figure 5.24: Percent difference of Ab concentration between top and bottom stacks
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Figure 5.25: Percent difference of Ab concentration between top and bottom stacks
Fig 5.26 are phase diagram plots to measure the level of protection by Ab for different combinations
of Ab concentration and α values for various different measures of protection, as described in Wessler
et al. [104]. The simulations to produce these plots include both H2O transport and drainage. Each
color represents a certain level of protection, so there are various combinations of [Ab] and α to get
that level of protection. For example, in Fig 5.26a we see that in order to have 25% flux, either
[Ab]=10ug/mL for Ab with α = 0.85, or can reduce the Ab concentration to 1/10 the value by
choosing Ab with α = 0.25. In Fig 5.26c the colors signify improvements in protection by Ab that
can trap virions compared to those that cannot, where the lower the color values are the more the
improvement, and 100 means exactly the same amount of protection. Notice that for extremely small
α values the protection is worse, so protecting with neutralization (see the previous chapter, Wessler
et al. [104] for description) and no trapping would be favorable to neutralization and trapping for
these extreme α values. In the previous paper [104], we saw poor protection compared to the base
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case of [Ab]=0 for very high α values, which we don’t see in this. This is because, as we can see in
Fig 5.26d, only for high α values do we not have very few Ab attached, so only for high α do we
have any sort of protection by neutralization, which makes up for the high flux we see for high α in
Fig 5.26a.
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(a) Flux for different α and [Ab] combinations.
(b) Relative Infectivity (with a base case of no
Ab) for different α and [Ab] combinations.
(c) Relative Infectivity (with a base case of Ab
have no affinity with mucins) for different α and
[Ab] combinations.
(d) Ave number of Ab attached to a penetrating
virion for different α and [Ab] combinations.
(e) Ave number of Ab-free trimers on a penetrating
virion for different α and [Ab] combinations.
Figure 5.26: Parameter sweep phase diagram plots for Ab concentration and α values
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5.11.1 Calculation of values in Fig 5.26
Flux Percentage (Fig 5.26a)
Flux(α, [Ab]) = 100%
# total virions penetrated (trial (α, [Ab]))
# total virions
Average number of Ab attached to a virion that penetrates (Fig 5.26d)
AveAbAttached(α, [Ab]) =
# total Ab brought to cell layer (trial (α, [Ab]))
# total virions penetrated (trial (α, [Ab]))
=
∑N∗=maxspikes
N∗=minspikes
(∑n=3N∗
n=0 (n)× (# virions penetrated with n Ab attached)
)
# total virions penetrated
Average number of Ab-free trimers is given by the following (Fig 5.26e)
AveAbFreeTrimers =
# total unoccupied trimers (trial (α, [Ab]))
# total virions penetrated (trial (α, [Ab]))
=
∑N∗=maxspikes
N∗=minspikes
(∑n=3N∗
n=0 (N∗ − (P (k|N∗, n)))(# virions penetrated with N∗, n)
)
# total virions penetrated
,
where P (k|N∗, n)) =

0, if 0 ≤ n < k∑n−k−mod(n−k,2)
2
a=0 f(a, n,N∗, k)/
(
3N∗
n
)
, if k ≤ n ≤ 2k∑n−k−mod(n−k,2)
a=n−2k f(a, n,N∗, k)/
(
3N∗
n
)
, if 2k ≤ n ≤ 3k
0, if 0 ≤ n ≥ 3k
,
and f(a, n,N∗, k) = 3k−a
(
N∗
a
)(
N∗−a
n−k−2a
)(
N∗+a+k−n
a+2k−n
)
Relative Infectivity (compared to base case [Ab]=0) (Fig 5.26b)
RIAb0 = 100%
# total unoccupied trimers (trial (α, [Ab]))
# total unoccupied trimers (trial (α, [Ab] = 0))
where the number of unoccupied
trimers, as above, is given by the following:∑N∗=maxspikes
N∗=minspikes
(∑n=3N∗
n=0 (N∗ − (P (k|N∗, n)))(# virions penetrated with N∗, n)
)
and it is important to get the number of virions penetrated with N∗ trimers and n Ab attached for
each trial. Since the α value for an Ab doesn’t matter if there are no Ab present, the denominator
(the base case) is the same for every trial, so only needs to be calculated once.
Relative Infectivity (compared to base case α=1) (Fig 5.26c)
RIAlpha1 = 100%
# total unoccupied trimers (trial (α, [Ab]))
# total unoccupied trimers (trial (α = 1, [Ab]))
where the number of unoccupied trimers, as above, is given by the following:∑N∗=maxspikes
N∗=minspikes
(∑n=3N∗
n=0 (N∗ − (P (k|N∗, n)))(# virions penetrated with N∗, n)
)
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and it is important to get the number of virions penetrated with N∗ trimers and n Ab attached for
each trial. Unlike for the [Ab]=0 base case, the denominator is not the same for every trial. Instead,
it is different for each distinct [Ab] value in the trial (but not for each distinct α value, so it is not
the case that every (α, [Ab]) trial run needs its own unique base case in order to be calculated).
5.11.2 Protection compared to no H2O transport and/or no drainage
Determining whether or not these effects are significant, or to which extent they affect the level
of protection, depends on the metric used. An obvious way to measure the increased vulnerability is
to divide the trial case by the base case. For example, the Flux V ulnerability Factor could be the
flux of virions when there is transport and drainage divided by the flux of virions when there is no
transport nor drainage. Figs 5.28 and 5.27 show the results of representing the extent of change
in protection in terms of how many times more virions penetrate as a result of adding transport
and/or drainage (where the difference between the two is that each subfigure in Fig 5.27 has its own
color scale, which is better for appreciating the subtle differences in Vulnerability Factors within
each subfigure, while all of the subfigures in Fig 5.28 have the same color scale, which is better for
appreciating the differences in scales between the subfigures). It is unsurprising that drainage helps
protection slightly and transport hurts protection more significantly, but it may not be obvious
that the greatest decrease in amount of protection occurs where the protection is best without
transport–the highest Ab concentration and near the optimum α value.
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(a) Plot of "Vulnerability Factor" com-
paring drainage to no drainage; i.e.,
#virions penetrating with drainage
#virions penetrating without drainage
.
(b) Plot of "Vulnerability Factor" com-
paring transport to no transport;
i.e.,
#virions penetrating with transport
#virions penetrating without transport
.
(c) Plot of "Vulnerability Factor" com-
paring both drainage and transport
to neither drainage nor transport; i.e.,
#virions penetrating with drainage and transport
#virions penetrating without drainage and without transport
.
Figure 5.27: Plots "Vulnerability Factor" (in terms of how many times more virions that penetrate),
with the color scales ranging from hottest to coldest in each subfigure, rather than hottest to coldest
for the whole group.
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(a) Plot of "Vulnerability Factor" com-
paring drainage to no drainage; i.e.,
#virions penetrating with drainage
#virions penetrating without drainage
.
(b) Plot of "Vulnerability Factor" com-
paring transport to no transport;
i.e.,
#virions penetrating with transport
#virions penetrating without transport
.
(c) Plot of "Vulnerability Factor" com-
paring both drainage and transport
to neither drainage nor transport; i.e.,
#virions penetrating with drainage and transport
#virions penetrating without drainage and without transport
.
Figure 5.28: Plots of "Vulnerability Factor" (in terms of how many times more virions that penetrate),
with the color scale the same for all plots (ranging from 0.8 to 3.0).
Another metric is to determine the Ab concentration required to get the same level of protection.
That is, we want to answer the following question: if the flux for a given Ab concentration and α
value is F when there is no transport, what is the concentration of Ab required to still have a flux
F? It is more natural to ask what the concentration required is to get a certain level of protection
(like was done to report values in Wessler et al. [104]), but for comparative purposes (not clinical
purposes), framing it this way is of interest. Code was written to produce plots that report these
values. For these plots, the x-axis is the Ab concentration in the base case, and the y-axis is the Ab
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concentration required to achieve the same level of protection (whichever measure of protection is
desired). To accomplish this, shell script is written to copy/write/submit different jobs for each Ab
concentration. Each job does a run to get the base case level of protection without transport and
without drainage, then determines the Ab concentration with transport and/or drainage required to
get the same (or within some tolerance of exactly the same) level of protection. Since it is the case
that increasing the Ab concentration always increases the level of protection, that means that we
were able to use the Left/Right algorithm (described in the Appendix) that was developed to solve
similar problems, such as, like was mentioned, to determine the Ab concentration required to get
some round value for relative infectivity. Also, it was used to find the optimum α value for each Ab
concentration, which is shown in Fig 5.29. This highlights an interesting result, that the optimum α
value depends on what the Ab concentration is. Of course, for a fixed α value, the more Ab the
better. However, if there is a specific Ab concentration that will be introduced, further optimization
can be done in terms of protecting by making sure that the Ab have a specific affinity with the
mucins.
Figure 5.29: Optimum α value for each Ab concentration. For each Ab concentration, there is a
single α value that offers the most protection.
5.11.3 Notes on PDE model implementation
In order to do several different stacks for many different parameters, UNC’s computer clusters
were used. Because we knew there would be many jobs to run, we did an investigation into whether
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an implicit or explicit algorithm should be used to solve the PDEs. Because of the compression
approach to move the boundary during the H2O transport phase, which results in a dynamically
changing spatial step, an implicit method is not viable during this phase. This is because a changing
spatial step would require inverting a matrix every time step, which would require a very large
time step to overcome the effort involved for the inversions. However, since the Ab and virions
are coupled through the binding and unbinding kinetics, the time steps for both can get only so
large to maintain stability in the binding and unbinding events. However, the stability time step
requirement for the Ab is more stringent than that for the virions because the Ab diffuse much faster
than the virions, which was previously handled by running the Ab at a different time scale than
the virions, so an implicit method could be used to increase the time step to allow both agents to
run at the same time scale during the times that there is no H2O transport. For just the Ab we
have performed runs using explicit algorithms throughout, precalculating the inverse matrix for the
implicit method and loading it, and also inverting the matrix during the runtime, and there is not
a significant advantage for any of the approaches, especially because the Ab simulation takes up
only a small fraction of the overall runtime. Because N∗=4–35 and number of binding sites for each
virion is 0–3N∗, we have
∑N∗=35
N∗=4 (3×N∗ + 1) matrices of size 250× 250 to invert, because that is
how many different virion agents we model. UNC’s clusters seem to be very slow at loading data, so
the gains from precalculating and loading aren’t appreciable. After performing tests for speed, it
was our determination that using an implicit method for the virions is not worth it.
5.12 Stochastic approach
It may be surprising that draining a significant portion of the semen doesn’t improve protection
a significant amount in most situations. Furthermore, it may be surprising that the amount of
semen that is drained doesn’t seem to matter at all in many situations, and the difference between
0% drained and 50% drained is negligible in nearly all situations. We had reason to believe from
earlier investigations that the reasons behind these observations were that the virions that start very
far away are those that aren’t expected to penetrate anyhow, so draining them won’t change the
results, and that much of the vulnerability is in the first few minutes, so draining after these first
few minutes adds protection after the most vulnerable period has already concluded. To verify these
theories, we created a new stochastic model in order to determine which virions would be drained
and whether or not they would penetrate if they aren’t drained. Some of this analysis can be done
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without developing a stochastic model, but a stochastic model is a natural solution.
5.12.1 Introduction to stochastic approach
Rather than do the stochastic approach in Wessler et al. [104], whereby random wait times
between binding and unbinding events are drawn to determine for a virion periods of random walking
and immobilization, we are doing a stochastic process whereby the virion is always doing a random
walk but with an effective diffusivity. This approach is a hybrid of the PDE approach and the
stochastic approach in Wessler et al. [104] since the effective diffusivity is that used in PDE approach
with the same rationale for its use: if there are n Ab attached to the virion, and each Ab has a
likelihood α of not interacting with mucins, and the attachments and detachments are assumed to
occur instantaneously, then the likelihood that none of the n Ab are interacting with the mucins is
αn, and consequently, between time t and t+ dt the virion will have been freely diffusing the fraction
αn of the time, hence the effective diffusivity Deffvir = α
nDnativevir . To be more precise, the effective
diffusivity will also include the factor mfirston as was done in Wessler et al. [104].
5.12.2 Procedure for stochastic approach
UNC’s clusters are used to run the stochastic code. Each simulation runs several (100s) of
virions, but shell script is written to make several (100s) of copies of the code for each simulation
and run each of those using a different random seed to start each individual simulation. Since there
are problems with the random number generator on the cluster, before copying all of the code the
random seed is reset and a list of numbers from {1, 2, ..., 232 − 1} that has as many elements as there
are copies of code. Then, each copy of the code, which is identified by its individual copy number
N , takes the N th element from that list, and that value is used as the seed value for resetting the
random number generator. This way each simulation is as random as possible, but there is also a
record that allows for replicability. To be clear, there are N copies of the code, and let’s say that
each version runs k virions, meaning that in all there are N ∗ k virions being simulated.
For each of the N copies, before any virions are run, the Ab are run. The Ab are run using
a continuum approach, as was done in Wessler et al. [104]. However, this time we include H2O
transport, so there is advection as well as a moving boundary. If a crude run is being performed, then
the Ab will move at a faster time scale than the virions, so the Ab concentrations and the boundary
location will be saved at the time points that the virion will move. If an accurate run is being
performed, then the virion will move at a faster time scale than the Ab, so the Ab concentrations
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and boundary location will be saved at every iteration. It should be noted that for convenience, and
because the Ab evolution is not the primary drain on time, there is not an adaptive time stepping
for the Ab in this version, but instead the smallest spatial step is pre-calculated and the largest
time step that allows for stability at that spatial step is used, where the advection and diffusion is
calculated using an explicit method.
After the Ab has run, the individual virion runs begin. The number of trimers for each
individual virion is drawn from the negative binomial distribution, as was described in Wessler et
al. [104]. The starting (x, z) location for the virion is chosen randomly so that it is equally likely
to begin at any location in the semen, where the z location is the distance from the cell layer
and the x location can be thought of as the distance from the cervix, although for simplicity the
x domain will only be about as large as Lsem + LCVM and have periodic boundaries. At each
iteration, the virion will move according to Brownian motion given its current effective diffusivity,
where the effective diffusivity is depends on whether it’s in the semen or CVM, and if it’s in the
CVM then it depends on how many Ab are attached to it. After moving, the number of Ab
attached will be updated by using the reaction equation given in Wessler et al. [104]. Whether
an attachment or detachment occurs is determined by a random number r ∈ [0, 1] and the values
of ProbAdd = (NSites − n) ∗ (kon ∗ AbFreeCurrent + konB ∗ AbBoundCurrent) ∗ dtV ir and
ProbLose = n ∗ koff ∗ dtV ir, where kon, koff are the attachment and detachment rates (where
konB is the adjusted binding rate described in Wessler et al. [104]), NSites = 3N∗, n is the number
of Ab bound, AbFreeCurrent and AbBoundCurrent are the Ab concentrations at that spatial and
temporal spot, and dtV ir is the time step for the virions. If r < ProbAdd, then an Ab is attached; if
ProbAdd ≤ r < ProbAdd+ProbLose, then an Ab is detached; if ProbAdd+ProbLose ≤ r, then no
attachments or detachments take place in this iteration. After this attachment and detachment even,
the effective diffusivity is updated for the next iteration. It should be noted that AbCurrent is the Ab
concentration at that block in time and space. That is, the Ab concentration is constant in time from
time = t to time = t+ dtAb, so if dtV ir < dtAb, then the Ab concentration will remain constant for
dtAb/dtV ir iterations. Similarly, the Ab concentration is constant for position = z+ dz, where dz is
the spatial step for the Ab PDE algorithm. Recall, though, that the spatial step size changes in the
seminal layer due to compression from H2O transport. That means that the Ab concentrations are
constant in each interval for the intervals (0, dz], (dz, 2dz], ..., (LCVM − dz, LCVM ], (LCVM , LCVM +
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dzSem], (LCVM + dzSem,LCVM + 2dzSem], ..., (Boundary − dzSem,Boundary], where dzSem
is the changing spatial step size of the seminal layer, and Boundary is the moving boundary
(= NSegsSemen ∗ dzSem). The concentrations are constant in the x direction. Thus, the Ab
concentration is that which corresponds to the z-interval that the virion lies in. When the virion
randomly walks into a new interval, it will have a new corresponding Ab concentration around it. If
the virion randomly walks beyond the Boundary, it is placed on the boundary, meaning that an
unmoving object would be pulled in by a contracting seminal layer.
Each individual virion keeps iterating through this process until either time ≥ Tf or z ≤ 0,
meaning that either the virion has reached the end of the simulation time or the virion has reached
the cell layer. If the virion reaches the cell layer, the time at which it reaches is recorded. Regardless
of whether or not the virion reaches the cell layer, the final z and x locations are recorded, as well as
the number of Ab attached. As mentioned before, the purpose of doing the stochastic approach is to
get profiles for which virions reach the cell layer. In particular, we want to know where the virion
starts and where it is at the time that the draining process begins. That means that we also save
that data, whereby for the latter we make a flag to make a single recording for the first iteration at
or after time = tDrainStart. For other statistics we also need to know N∗, so we also record it for
each virion. Once all of the N ∗ k virions have finished, code is run to compile, process, and plot
the results. It should be noted that for the case that in the case Osmsem = OsmCVM the results of
this model agree with those in Wessler et al. [104], and for all cases they agree with the PDE model
described above.
5.12.3 Results of stochastic approach
In order to see how many virions that would have made it to the cell layer if they weren’t drained,
we will look at where the virions are when the draining begins, make note of the virions that would
be drained at that point, and then continue the simulation to see what happens. This is only one of
the measures we want from the simulation, so we won’t continue running the simulation for only
those that would have been drained, but instead run it for all virions.
For the following results, we are using [Ab]=5ug/mL, α=0.5, Osmsem=340mOsm/L, OsmCVM
=380mOsm/L, and the rest of the parameters the same as used by Wessler et al. [104].
Fig 5.30a shows where each of the virions were when the simulation began, and Fig 5.30b shows
where they ended up when the simulation ended. Fig 5.30 combines Figs 5.30a and Fig 5.30b into a
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single plot. Notice that no virions start within 50um from the cell layer, because that is the mucus
layer. Also, notice that no virions finish beyond roughly 230um from the cell layer despite the fact
that many virions started there, because during the simulation osmosis transports H2O to the CVM
(and from there to the cell layer), which results in a thinning of the seminal layer. In Fig 5.30b
there is a noticeable virion-sparse region in the semen near the semen-CVM interface right next to
a virion-rich region in the CVM right next to the semen-CVM interface. This is because virions
with many Ab attached are mobile in the semen but quite immobile in the CVM. As a result, a
virion of that type that crosses from the semen to the CVM becomes immobilized so struggles to go
deeper into the CVM nor cross back to the semen, so is stuck right at the interface. As a result,
the only way to populate the region in the semen next to the CVM is from the region in the semen
further from the semen-CVM interface, and the relative difficulty to occupy that region results in
the relative vacancy in that region. Similarly, there is a noticeable relatively sparse region in the
CVM next to the CVM-cell interface next to a dense region right at the cell layer. The reason for
this is similar to what is happening at the semen-CVM interface, except rather than virions being
quite immobile upon reaching the CVM, they are absolutely frozen upon reaching the cell layer.
(a) Position of all virions at the beginning of the
simulation
(b) Position of all virions at the end of the simu-
lation
Figure 5.30: Position of all virions at beginning (orange) and end (purple) of the simulation
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Figure 5.31: Position of all virions at beginning (orange) and end (purple) of the simulation
Comparing the positions at the start of draining (Fig 5.32a) with those at the start (Fig 5.30a),
we notice that there are a couple of differences. The first is that already there are no virions further
than 230um from the cell layer, even though the H2O transport process is still underway. However,
because the osmotic pressure is strongest when the difference in osmolarities is the greatest, most of
the H2O transport occurs at the beginning of the regime, so most of the contraction of the seminal
layer has occurred by the time the draining begins. The other noticeable difference is that the
CVM is pretty well occupied, except for the somewhat sparse region next to the cell layer, and the
somewhat dense cell layer itself. This means that by the time the draining has begun there are
already virions that have crossed to the cell layer. The lack of a very dense region in the CVM next
to the semen-CVM interface suggests that not many Ab have had a chance to attach to the virions
and trap them. These virions deep in the CVM haven’t crossed to the cell layer, yet, but are in a
good position to do so.
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(a) Position of all virions when draining would
begin
(b) Position of all virions at the end of the simu-
lation
Figure 5.32: Position of all virions when draining would begin (orange) and at the end of the
simulation (purple)
Figure 5.33: Position of all virions when draining would begin (orange) and at the end of the
simulation (purple)
164
From Figs 5.31 and 5.33 it is impossible to see if there is any relationship between how far a
virion is early in the simulation and where it ends up, to see if there is any relationship at all. An
obvious way to see any relationship between how far a virion is early in the simulation and where
it ends up is to plot the ending position as a function of the early position. Fig 5.34 does that.
Figs 5.34a and 5.34b show that there is definitely a relationship: the dense regions show that the
further a virion is from the cell layer early the further it will end up, and the closer a virion is early
the closer it will be late; the sparse regions show that if a virion begins far then it is very hard for it
to penetrate far into the CVM, and that if it begins very close then it is unlikely to end up in the
semen. This is especially stark for Fig 5.34b. There are very few virions in the semen that were in
the mucus or near the semen-CVM interface when draining began. It seems that if a virion starts in
the mucus or near the semen-CVM interface when draining began then it will almost certainly stay
in the mucus or will cross to the cell layer.
(a) The distance from the epithelium at the end
for each starting distance
(b) The distance from the epithelium at the end
for each starting distance
Figure 5.34: Relationship between starting and ending positions
Qualitatively, Fig 5.34 shows that there is a relationship between where a virion is early on and
where it ends up. However, it doesn’t show quantitatively where each the penetrating virions was
early on. In Fig 5.35, each of the virions that penetrated is traced back to where it was early on,
and a histogram is made for early positions. On the x axis of Fig 5.35a is the distance a penetrating
virion was from the epithelium at the start of the simulation. Notice that the lowest value is 50um,
because no virions can start in the CVM. The y axis are the number of virions that crossed from
that starting range. On the x axis of Fig 5.35b is the distance a penetrating virion was from the
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epithelium at the start of the simulation. Virions that penetrated before the draining began were
given a distance of 0um from the epithelium. The y axis are the number of virions that crossed from
that starting range. Notice that for Fig 5.35a the number of occurrences monotonically decreases
as the distance from the epithelium increases, which isn’t very surprising. However, in Fig 5.35b,
we see that a large portion of penetrating virions crossed before the draining began, and there is
monotonically deceasing number of occurrences as the distance from the epithelium increases from
the semen-CVM interface to the semen-lumen interface, but there is an increase in occurrences as
the distance from the epithelium increases through the CVM.
Fig 5.35b is the figure to explain why draining doesn’t alter the penetration rates. Notice that is
50% of the semen is drained, then only the occurrences from roughly 150-250um would be removed,
which make up almost none of the total penetrating virions. If instead 75% of the semen is drained,
then only the occurrences from roughly 100-250um would be removed, which still makes up a small
percent of the penetrating virions. From Fig 5.35a we see that it isn’t just the case that it’s the
virions that are close by the beginning of draining are the ones that cross, there are very few virions
that start in the outer 50% that end up penetrating, showing that starting distance plays a large
factor in determining whether or not a virion is able to penetrate.
(a) The distance from the epithelium at the end
for each starting distance
(b) The distance from the epithelium at the end
for each starting distance
Figure 5.35: Relationship between starting and ending positions
Related to starting distance and likelihood of penetrating is how long it takes for a virion to
penetrate. It could be that by the time draining begins a large fraction of the virions that will cross
already have. Obviously the closer that a virion starts the less time it should take to penetrate.
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Each point in Fig 5.36 represents a virion that has penetrated, where it’s x coordinate representing
the distance from the epithelium that it started, and the y coordinate how long it took to penetrate.
The only clear pattern to see in this plot is that virions that started very close to the epithelium
penetrated very quickly, and otherwise there is no relationship at all to be drawn between distance
from epithelium and time to penetration. However, looking at Fig 5.37 we see that there a vast
majority of the virions that penetrate do cross very early, so the little bit of a pattern we see in
Fig 5.36 is a significant one, and the lack of a pattern everywhere else also seems to be significant
in the sense that if the virion doesn’t cross early then it may still cross as a there is a small yet
constant flux of virions into the cell layer as time goes on.
Figure 5.36: The distance from the epithelium at the end for each starting distance
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Figure 5.37: The distance from the epithelium at the end for each starting distance
The last thing to look at is to see if there is any bias towards a particular N∗ for increasing
chances of a virion to penetrate. Fig 5.38 tries to do that: Fig 5.38a shows the distribution of N∗ for
the entire population of virions, while Fig 5.38b shows the distribution of N∗ for the population of
virions that penetrated to the epithelium. It appears that the smaller N∗ virions are over-represented
in the population of virions that penetrate and perhaps the larger N∗ virions are under-represented,
but this general trend is expected: the more binding sites available the easier it is to attach Ab,
and the more Ab that could possibly attach, so the fewer we expect to cross. What we really want
to investigate is what the best strategy is for virions, since the more binding sites makes a virion
more vulnerable to be trapped (as we see from Fig 5.38), but the more binding sites the more able a
penetrated virion is to attach to and infect a host cell. So, this investigation can end at just looking
at over- and under-representation.
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(a) Distribution of N∗ for every virion in the entire
study
(b) Distribution of N∗ for every virion that pene-
trated to the cell layer
Figure 5.38: Comparing distribution of N∗ for population of virions with distribution of N∗ for
penetrating virions.
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CHAPTER 6
anti-PEG antibodies and PEGylated drugs
6.1 Introduction
In order to perform its intended function, a minimum concentration of drug must be present in
the blood or the targeted organ. If the concentration falls below this minimum concentration, then
it can’t function adequately, and another dose must be administered. If the blood concentration is
too high, then the drug may be toxic. Since drug administration may be inconvenient, maximization
of the length of time for the "therapeutic window" (the range of concentrations where you see drug
efficacy, but not toxicity) is paramount. An increasingly popular strategy to increase the therapeutic
window is to covalently attach polyethylene glycol (PEG) polymer chains to a drug molecule in order
to mask it from the immune system, a process known as PEGylation. The mechanism of masking
the drug from immune system is by physically preventing the adsorption of plasma proteins with
the underlying drug by having the PEG act as a hydrophilic shield. However, the use of PEG is
also becoming increasingly popular in everyday products, such as cosmetics, food preservatives, and
drug excepients. As a consequence, PEG-exposed individuals have developed anti-PEG antibodies in
order to expedite the foreign object’s removal. It is now the case that >30% of the population now
has anti-PEG antibodies in their blood. The presence of anti-PEG antibodies greatly accelerates the
elimination of PEGylated drugs, which shortens the therapeutic window and requiring more frequent
dosing. The aim of this research is to increase the therapeutic window of PEGylated drugs (referred
to as Drug) for patients who have anti-PEG antibodies (referred to Ab in this section) in their blood.
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6.2 Model parameters
Name Value Units Description
V olBlood 5000 mL volume of blood (human)
FracP lasma 0.55 −− volume fraction of blood that
is plasma
V olPlasma FracP lasma ∗ V olBlood mL volume of plasma
V olISF 500 mL volume of interstitial fluid that
can exchange Ab with blood
BWMouse 0.025 kg weight of a mouse
BWHuman 70 kg weight of a human
Table 6.1: Human/Mouse Parameters
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Name Value Units Description
CAb varies (default=1) ug/mL initial concentration of free Ab
WtAb 146 kDa weight of each Ab
TotAb
V olPlasma ∗ (1e1) ∗ CAb
WtAb ∗ (1.660540 ∗ 6.022140857) nmol number of free Ab in plasma
kon 6.20E+04
1
M ∗ s binding rate of Ab to PEG and
drug
koff 6.19E-04
1
s
unbinding rate of Ab from
PEG and drug
HLAbfree 21 day amount of time it takes for 1/2
of free Ab to be eliminated
RateHLAb
−log(1/2)
HLAbfree
1
day
elimination rate of free Ab
RateExchangeISFBlood 0.4
1
day
rate at which Ab move be-
tween ISF and blood
MaxProdConc 100 ug/mL Ab concentration during a pe-
riod of maximum Ab produc-
tion
TotMaxAb
V olPlasma ∗ (1e1) ∗ CAb
WtAb ∗ (1.660540 ∗ 6.022140857) nmol number of free Ab in plasma
during a phase of maximum
Ab production
TMaxProdStartAb 2 day time at which the Ab produc-
tion moves from the regular
rate to the maximum rate
TMaxProdLengthAb 3 day length of time under a phase
of maximum free Ab concen-
tration
RateProdRegAb TotAb ∗HLAbfree
nmol
day
rate of Ab production during
regular production phase
RateProdMaxAb Tot
Max
Ab ∗HLAbfree
nmol
day
rate of Ab production during
maximum production phase
Table 6.2: Antibody Parameters172
Name Value Units Description
DrugDose 8 mg total Drug administered
WtDrug 540 kDa weight of each Drug
NSitesDrug varies (default=100) −− number of locations that an Ab
can bind to each Drug
AbAttachedMaxDrug 4 −− maximum number of Ab that
may be attached to each Drug
NSitesPerAbDrug NSitesDrug/AbAttach
Max
Drug −− number of unoccupied poten-
tial binding sites each Ab re-
moves upon binding to a Drug
HLMultiplierDrug
[
1
10 ;
1
7.5 ;
1
5 ;
1
2.5 ; 1; 1.25; 1.5; 1.75; 2
]
– Multiplier for trial run for Half
Life values for Ab-free Drug
HL0 Ab,defaultDrug 12.5 day elimination time for 1/2 of Ab-
free Drug (default value)
HL0 AbDrug HL
Multiplier
Drug ∗HL0 Ab,defaultDrug day elimination time for 1/2 of Ab-
free Drug (default value)
HL1 AbDrug HLFreeAb day elimination time for 1/2 of
Drug with exactly 1 Ab at-
tached
HLAb−CoveredDrug,Mouse 45 min elimination time for 1/2 of Ab-
covered Drug complexes (in
mice)
HLAb−CoveredDrug HL
Ab Covered
Drug,Mouse
(
BWHuman
BWMouse
)1/4
min time it takes for 1/2 of Ab-
covered Drug complexes (in hu-
mans)
NumAbcoveredDrug 2 −− number of Ab on a Drug
that gives that Drug complex
the behavior of an Ab-covered
Drug complex
RateHLObj
−log(1/2)
HLObj
1
s
rate of decay of Obj in the
blood
Table 6.3: Drug Parameters
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Name Value Units Description
PEGAbFactor varies (default=100) −− molecular ratio of PEG 50kDa
molecules to starting free Ab
PEGDose PEGAbFactor
50
WtPEG
AbTot nmol total free PEG administered
WtPEG ordered list={16,20,50} kDa weight of each PEG simulated
NSitesPEG ordered list={16,50,125} −− number of locations that an
Ab can bind to each PEG sim-
ulated
AbAttachedMaxPEG ordered list={2,3,4} −− maximum number of Ab that
may be attached to each PEG
simulated
NSitesPerAbPEG NSitesPEG/AbAttach
Max
PEG −− number of unoccupied poten-
tial binding sites each Ab re-
moves upon binding to a PEG
HL0 AbPEG,Mouse ordered list={17.6,169,987} day elimination time for 1/2 of free
PEG (in mice)
HL0 AbPEG HL
0 Ab
PEG,Mouse
(
BWHuman
BWMouse
)1/4
day time it takes for 1/2 of free
PEG to be eliminated (in hu-
man)
HL1 AbPEG HLFreeAb day elimination time for 1/2 of
PEG with exactly 1 Ab at-
tached
HLAb−CoveredPEG,Mouse 45 min elimination time for 1/2 of Ab-
covered PEG complexes (in
mice)
HLAb−CoveredPEG HL
Ab Covered
PEG,Mouse
(
BWHuman
BWMouse
)1/4
min elimination time for 1/2 of Ab-
covered PEG complexes (in hu-
mans)
NumAbcoveredPEG 2 −− number of Ab on a Drug
that gives that Drug complex
the behavior of an Ab-covered
Drug complex
RateHLObj
−log(1/2)
HLObj
1
s
rate of decay of Obj in the
blood
Table 6.4: PEG Parameters
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Name Value Units Description
FracTotDose1stInfusPEG 3/4 −− fraction of the total dose of
PEG that will be given in the
first course
PEGTot1stInfus FracTotDose1stInfusPEG ∗
PEGDose
nmol total PEG administered in the
first infusion
PEGTot2ndInfus PEGDose −
PEGTot1stInfus
nmol total PEG administered in the
second infusion
T 1stInfus0 0 hr time first course of PEG starts
being introduced
LenT 1stInfus 1 hr length of time to administer
first infusion
T 2ndInfus0 T
1stInfus
0 + LenT
1stInfus hr time second course of PEG and
Drug starts being introduced
LenT 2ndInfus 2 hr length of time to administer
second infusion
TimeInfusionEnds T 2ndInfus0 + LenT
2ndInfus hr time at which infusion treat-
ments are finished
Tf 28 day total simulation time
dt 1e-1 sec numerical time step used
Table 6.5: Infusion/Time Parameters
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Name Units Description
AbTotBlood(t) nmol total number of Ab in the blood
AbTotISF (t) nmol total number of Ab in ISF
AbBound(t) nmol total number of Ab in blood bound
to PEG or Drug
AbFree(t) nmol total number of Ab in blood not
bound to PEG nor Drug
AbBoundFracBlood(t) −− fraction of Ab in blood that are
bound to PEG or Drug
AbFreeFracBlood(t) −− fraction of Ab in blood that are not
bound to PEG nor Drug
PEG(t) nmol total number of PEG molecules in
blood with n Ab attached
PEGTotSystem(t) nmol total number of PEG molecules in
blood
PEGAbFree(t) nmol total number of PEG molecules in
blood that don’t have any Ab at-
tached
Drug(t) nmol total number of PEGylated proteins
in blood with n Ab attached
DrugTotSystem(t) nmol total number of PEGylated proteins
in blood
DrugAbFree(t) nmol total number of PEGylated proteins
in blood that don’t have any Ab at-
tached
Table 6.6: Recorded Terms 1
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Name Units Description
ObjLostKidneyTotal(t) nmol total number of Object (Ab, PEG,
Drug) eliminated by kidneys between
time=0 and time=t
ObjLostLiverSpleenTotal(t) nmol total number of Object (Ab, PEG,
Drug) eliminated by spleen and liver
between time=0 and time=t
ObjLostKidneyTotalFracSystem(t) −− fraction of Object (Ab, PEG, Drug)
in the system eliminated by kidneys
between time=0 and time=t
ObjLostLiverSpleenTotalFracSystem(t) −− fraction of Object (Ab, PEG, Drug)
in the system eliminated by liver and
spleen between time=0 and time=t
ObjLostKidneyTotalFracTotalObj(t) −− fraction of all of Object (Ab, PEG,
Drug) eliminated by kidneys between
time=0 and time=t
ObjLostLiverSpleenTotalFracTotalObj(t) −− fraction of all of Object (Ab, PEG,
Drug) eliminated by liver and spleen
between time=0 and time=t
AUCDrug(t) nmol ∗ sec area under the curve for the drug ex-
posure between time=0 and time=t
Table 6.7: Recorded Terms 2
6.3 Simulation outline
6.3.1 Define input parameters
These values are given above.
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6.3.2 Convert parameters to useful values
• change input values of Ab [ug/mL] and Drug [mg] into nmol
• convert kon
[
1
M ∗ s
]
to
[
1
nmol ∗ s
]
• from HLObject [s] get RateHLObject [1/s], which is necessary for computing the amount
of Object eliminated each iteration
6.3.3 Set up other terms used in simulation
These are values such as AbFree(t), AbBound(t), AbLostKidney(t), etc
6.3.4 Run simulation
This involves the following:
• Update amount of Ab for production
• If PEG is making its way into blood, update amount PEG for this
• If Drug is making its way into blood, update amount Drug for this
• Update free Ab in interstitial fluid and blood
• Update amount of free Ab, free PEG, free Drug due to elimination by kidneys; update amount
of Ab, PEG, Drug due to Ab-PEG and Ab-Drug complexes eliminated by liver and spleen
(amount of Ab, PEG, Drug lost due to each type of elimination kept track of)
• Update number of Ab attached to each PEG molecule then update number of Ab attached to
PEGylated proteins
• Periodically plot progress, and periodically save values of terms of interest to be plotted later
6.4 Model equations
6.4.1 Ab
Ab production
d
dt
Abfreeplasma(t) =

kAb,prodreg when t ∈ [0, tRampStart)
kAb,prodramp when t ∈ [tRampStart, tRampEnd)
kAb,prodreg when t ∈ [tRampEnd, T f)
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Ab ISF-Plasma exchange
d
dt
(
[AbfreeISF (t)]− [Abfreeplasma(t)]
)
= kexchange ∗
(
[AbfreeISF (t)]− [Abfreeplasma(t)]
)
Ab elimination (Kidneys)
d
dt
Abfreeplasma(t) = −kAbFreeAbfreeplasma(t)
Ab elimination (Liver, Spleen)
d
dt
Abboundplasma(t) = −
(∑n=NmaxPEG
n=1 n ∗ PEGnelim(t) +
∑n=NmaxDrug
n=1 n ∗Drugnelim(t)
)
Ab binding/unbinding
PEGn +Abfree
(NSitesPEG − n)konAbfree
GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGBF GG
(n+ 1)koff
PEGn+1
Drugn +Abfree
(NSitesDrug − n)konAbfree
GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGBF GG
(n+ 1)koff
Drugn+1
6.4.2 PEG
PEG infusion
d
dt
PEG0(t) =

kPEG1 when t ∈ [0, t2ndInfusion)
kPEG2 when t ∈ [t2ndInfusion, tNoInfusion)
0 when t ∈ [tNoInfusion, T f)
PEG elimination (Kidneys)
d
dt
PEG0(t) = −k0PEGPEG0(t)
PEG elimination (Liver/Spleen)
d
dt
PEG1(t) = −k1PEGPEG1(t)
d
dt
PEG2
+
(t) = −k2+PEGPEG2
+
(t)
Ab binding/unbinding
PEGn +Abfree
(NSitesPEG − n)konAbfree
GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGBF GG
(n+ 1)koff
PEGn+1
179
6.4.3 Drug
Drug infusion
d
dt
Drug0(t) =

0 when t ∈ [0, t2ndInfusion)
kDrug2 when t ∈ [t2ndInfusion, tNoInfusion)
0 when t ∈ [tNoInfusion, Tf)
Drug elimination (Kidneys)
d
dt
Drug0(t) = −k0DrugDrug0(t)
Drug elimination (Liver/Spleen)
d
dt
Drug1(t) = −k1DrugDrug1(t)
d
dt
Drug2
+
(t) = −k2+DrugDrug2
+
(t)
Ab binding/unbinding
Drugn +Abfree
(NSitesDrug − n)konAbfree
GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGBF GG
(n+ 1)koff
Drugn+1
6.5 Model details
6.5.1 Representation of Ab, PEG, Drug in model
Ab, PEG, and Drug in the system are represented in nmol rather than ug/mL because it is
more straightforward to keep track of elimination of molecules rather than concentrations.
To compute the attachments and detachments of Ab to PEG and Drug, it is convenient to
represent PEG and Drug in the following manner:
PEG(t) = (PEG0(t)[nmol], PEG1(t)[nmol], ..., PEGNSitesPEG(t)[nmol])
Drug(t) = (Drug0(t)[nmol], Drug1(t)[nmol], ..., DrugNSitesDrug(t)[nmol])
where the subscript denotes the number of Ab attached.
Ab in the system are split into 2 categories: Free Ab and Bound Ab. They are calculated in the
following manner (using the notation above):
AbBound(t)[nmol] =
NSitesPEG∑
i=1
i ∗ PEGi(t)[nmol] +
NSitesDrug∑
j=1
j ∗Drugj(t)[nmol]
AbFree(t)[nmol] = AbTotSystem(t)[nmol]−AbBound(t)[nmol]
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6.5.2 Gradual insertion of PEG, Drug into blood
The full doses of PEG and Drug don’t make it to the blood immediately; rather, they are adminis-
tered and make their way into the blood gradually. This means that at t = Time2ndInfustionStarts,
we have that 0 [nmol] of Drug made it to the blood, while at t = TimeInfusionEnds the full dose
of Drug has entered the blood. Below is the ODE for the infusion of drug, along with the finite
difference representation for numerically solving it:
d
dt
Drug0(t) =

0 when t ∈ [0, t2ndInfusion)
kDrug2 when t ∈ [t2ndInfusion, tNoInfusion)
0 when t ∈ [tNoInfusion, Tf)
⇒ Drug0(t+ dt) =

Drug0(t) when t ∈ [0, t2ndInfusion)
Drug0(t) + kDrug2 dt when t ∈ [t2ndInfusion, tNoInfusion)
Drug0(t) when t ∈ [tNoInfusion, T f)
where, since the Drug is administered at a constant rate, such between t = Time2ndInfustionStarts
and t = TimeInfusionEnds the full dose of Drug has entered the blood, we have that kDrug2 =
DrugDose/LengthT ime2ndInfusion.
Similarly, for the infusion of free PEG we have the following:
d
dt
PEG0(t) =

kPEG1 when t ∈ [0, t2ndInfusion)
kPEG2 when t ∈ [t2ndInfusion, tNoInfusion)
0 when t ∈ [tNoInfusion, T f)
⇒ PEG0(t+ dt) =

PEG0(t) + kPEG1 dt when t ∈ [0, t2ndInfusion)
PEG0(t) + kPEG2 dt when t ∈ [t2ndInfusion, tNoInfusion)
PEG0(t) when t ∈ [tNoInfusion, T f)
where, similar to Drug, kPEG1 = PEGTot1stInfusion/LengthT ime1stInfusion and kPEG2 =
PEGTot2ndInfusion/LengthT ime2ndInfusion.
6.5.3 ISF-Blood Ab exchange
While only free Ab in the blood can attach to PEG and Drug and be eliminated by the kidney
or liver and spleen, there is a reservoir of free Ab in interstitial fluids. The movement of free Ab
between ISF and Blood is assumed to occur at a rate proportional to the difference in concentrations.
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Below is the derivation for how to update the concentrations, where k is the exchange rate (listed
parameter section above as InterstitialF luidBloodExchangeRate):
dCdiff/dt = k ∗ CdiffOld
⇒ CdiffNew − CdiffOld = k ∗ CdiffOld ∗ dt
where Cdiff = (ConcISF − ConcBlood)
⇒
(
CNewISF − CNewBlood
)
−
(
COldISF − COldBlood
)
= k ∗
(
COldISF − COldBlood
)
∗ dt
⇒
(
NNewISF
VISF
− N
New
Blood
VBlood
)
−
(
NOldISF
VISF
− N
Old
Blood
VBlood
)
= k ∗
(
NOldISF
VISF
− N
Old
Blood
VBlood
)
∗ dt
⇒ −
(
NOldISF
VISF
− N
New
ISF
VISF
)
−
(
NNewBlood
VBlood
− N
Old
Blood
VBlood
)
= k ∗
(
NOldISF
VISF
− N
Old
Blood
VBlood
)
∗ dt
⇒ −1
VISF
(
NOldISF −NNewISF
)
+
−1
VBlood
(
NNewBlood −NOldBlood
)
= k ∗
(
NOldISF
VISF
− N
Old
Blood
VBlood
)
∗ dt
where NOldISF −NNewISF = −NExchange = NNewBlood −NOldBlood
⇒ 1
VISF
(
−NExchange
)
+
1
VBlood
(
−NExchange
)
= −k ∗
(
NOldISF
VISF
− N
Old
Blood
VBlood
)
∗ dt
⇒ NExchange = 11
VISF
+
1
VBlood
∗ k ∗
(
NOldISF
VISF
− N
Old
Blood
VBlood
)
∗ dt
⇒ NExchange = k ∗ dt
VBlood + VISF
∗
(
VBlood ∗NOldISF − VISF ∗NOldBlood
)
which gives the following:
NNewISF = N
Old
ISF −NExchange
NNewBlood = N
Old
ISF +NExchange
where NISF and NBlood are the total number of free Ab in the interstitial fluid and blood.
6.5.4 Updating amounts of Ab, PEG, Drug due to elimination by kidneys or liver and
spleen
C(t) = C0e
−rt gives the amount C at time t given an initial amount C0 and a decay rate r.
Given the half-life t1/2 of a particle, we have the following:
1/2C0 = C0 ∗ e−r∗t1/2
⇒ 1/2 = e−r∗t1/2
⇒ ln(1/2) = −r ∗ t1/2
⇒ r = − ln(1/2)
t1/2
Hence, for each iteration we have the following:
C(t+ dt) = C(t)e−rdt
where C(t) is the amount at the start of the iteration (at time t), and C(t+ dt) is the amount at
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the end of the iteration (at time t+ dt).
So, in the model, we take in half-lives of free Ab, free PEG, free Drug, Ab-PEG complexes, and
Ab-Drug complexes, from which we then compute the following (using the above expression):
rAb, rPEG, rDrug, rPEGWithAb, rDrugWithAb
Below are the equations for updating the amount of all of the species due to elimination by the
kidneys or liver and spleen:
AbFree(t+ dt) = AbFree(t) ∗ e−rAbdt
PEG0(t+ dt) = PEG0(t) ∗ e−rPEGdt
Drug0(t+ dt) = Drug0(t) ∗ e−rDrugdt
PEGi(t+ dt) = PEGi(t) ∗ e−rPEGidt (where 0 < i ≤ NSitesPEG)
Drugj(t+ dt) = Drugj(t) ∗ e−rDrugidt (where 0 < j ≤ NSitesDrug)
AbBound(t+ dt) =
∑NSitesPEG
i=1 i ∗ PEGi(t+ dt) +
∑NSitesDrug
j=1 j ∗Drugj(t+ dt)
And from these we can compute the following terms of interest:
AbLostKidneysIter(t) = AbFree(t− dt)−AbFree(t)
AbLostLiverSpleenIter(t) = AbBound(t− dt)−AbBound(t)
AbLostKidneysTotal(t) = AbLostKidneysTotal(t− dt) +AbLostKidneysIter(t)
AbLostLiverSpleenTotal(t) = AbLostLiverSpleenTotal(t− dt) +AbLostLiverSpleenIter(t)
AbTotSystem(t) = AbFree(t) +AbBound(t)
= AbTotSystem(t− dt)− (AbLostKidneysIter(t) +AbLostLiverSpleenIter(t))
PEGLostKidneysIter(t) = PEG0(t− dt)− PEG0(t)
PEGLostLiverSpleenIter(t) =
NSitesPEG∑
i=1
PEGi(t− dt)−
NSitesPEG∑
i=1
PEGi(t)
PEGLostKidneysTotal(t) = PEGLostKidneysTotal(t− dt) + PEGLostKidneysIter(t)
PEGLostLiverSpleenTotal(t) = PEGLostLiverSpleenTotal(t−dt)+PEGLostLiverSpleenIter(t)
PEGTotSystem(t) =
NSitesPEG∑
i=0
PEGi(t)
= PEGTotSystem(t− dt)− (PEGLostKidneysIter(t) + PEGLostLiverSpleenIter(t))
DrugLostKidneysIter(t) = Drug0(t− dt)−Drug0(t)
DrugLostLiverSpleenIter(t) =
NSitesDrug∑
j=1
Drugj(t− dt)−
NSitesDrug∑
j=1
Drugj(t)
DrugLostKidneysTotal(t) = DrugLostKidneysTotal(t− dt) +DrugLostKidneysIter(t)
DrugLostLiverSpleenTotal(t) = DrugLostLiverSpleenTotal(t−dt)+DrugLostLiverSpleenIter(t)
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DrugTotSystem(t) =
NSitesDrug∑
j=0
Drugj(t)
= DrugTotSystem(t− dt)− (DrugLostKidneysIter(t) +DrugLostLiverSpleenIter(t))
Where we have the following initial values:
AbLostKidneysTotal(t = 0) = AbLostLiverSpleenTotal(t = 0) = 0
PEGLostKidneysTotal(t = 0) = PEGLostLiverSpleenTotal(t = 0) = 0
DrugLostKidneysTotal(t = 0) = DrugLostLiverSpleenTotal(t = 0) = 0
6.6 Results
The following are results of the simulations.
Figure 6.1: Comparison between the elimination of Drug at its regular half life and the accelerated
elimination of Drug when Ab are present. This is the case that the Ab-free Drug half life is 12.5
days.
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Figure 6.2: Comparison between the elimination of Drug at it’s regular half life, the accelerated
elimination of Drug when Ab are present, and the elimination of Drug with the treatment of PEG of
various molecular weights. This is the case that the Ab-free Drug half life is 12.5 days.
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(a) Plot of the amount of Free Ab, PEG-bound
Ab, and Drug-bound Ab in the blood as time
progresses. This is the case that PEG is 6 kDa
and the Ab-free Drug half life is 12.5 days.
(b) Plot of the amount of Free Ab, PEG-bound
Ab, and Drug-bound Ab in the blood as time
progresses. This is the case that PEG is 20 kDa
and the Ab-free Drug half life is 12.5 days.
(c) Plot of the amount of Free Ab, PEG-bound
Ab, and Drug-bound Ab in the blood as time
progresses. This is the case that PEG is 50 kDa
and the Ab-free Drug half life is 12.5 days.
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(a) Plot of the elimination routes of Ab, PEG,
and Drug. The elimination routes of Drug are
given for the case that there are no Ab, that there
are Ab but no PEG treatment, and that there
are Ab and the PEG treatment. This is the case
that PEG is 6 kDa and the Ab-free Drug half life
is 12.5 days.
(b) Plot of the elimination routes of Ab, PEG,
and Drug. The elimination routes of Drug are
given for the case that there are no Ab, that there
are Ab but no PEG treatment, and that there
are Ab and the PEG treatment. This is the case
that PEG is 20 kDa and the Ab-free Drug half
life is 12.5 days.
(c) Plot of the elimination routes of Ab, PEG, and
Drug. The elimination routes of Drug are given
for the case that there are no Ab, that there are
Ab but no PEG treatment, and that there are
Ab and the PEG treatment. This is the case that
PEG is 50 kDa and the Ab-free Drug half life is
12.5 days.
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Figure 6.5: The drug total drug exposure as time progresses for the case that there are no Ab, that
there are Ab but no PEG treatment, and that there are Ab and the PEG treatment for PEG or
molecular weights of 6 kDa, 20 kDa, and 50 kDa. This is the case that the Ab-free Drug half life is
12.5 days.
Figure 6.6: The drug total drug exposure at the end of the simulation for the case that there are no
Ab, that there are Ab but no PEG treatment, and that there are Ab and the PEG treatment for
PEG or molecular weights of 6 kDa, 20 kDa, and 50 kDa. This is the case that the Ab-free Drug
half life is 12.5 days.
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(a) The % of all of the drug in blood that have
n Ab attached at each point in time, where n =
0, 1, 2, 3, 4. This is the case that PEG is 6 kDa
and the Ab-free Drug half life is 12.5 days.
(b) The % of all of the drug in blood that have
n Ab attached at each point in time, where n =
0, 1, 2, 3, 4. This is the case that PEG is 20 kDa
and the Ab-free Drug half life is 12.5 days.
(c) The % of all of the drug in blood that have
n Ab attached at each point in time, where n =
0, 1, 2, 3, 4. This is the case that PEG is 50 kDa
and the Ab-free Drug half life is 12.5 days.
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(a) The % of all of the total drug dose that have
n Ab attached at each point in time, where n =
0, 1, 2, 3, 4. This is the case that PEG is 6 kDa
and the Ab-free Drug half life is 12.5 days.
(b) The % of all of the total drug dose that have
n Ab attached at each point in time, where n =
0, 1, 2, 3, 4. This is the case that PEG is 20 kDa
and the Ab-free Drug half life is 12.5 days.
(c) The % of all of the total drug dose that have
n Ab attached at each point in time, where n =
0, 1, 2, 3, 4. This is the case that PEG is 50 kDa
and the Ab-free Drug half life is 12.5 days.
190
(a) The % of all of the PEG in blood that have
n Ab attached at each point in time, where n =
0, 1, 2. This is the case that PEG is 6 kDa and
the Ab-free Drug half life is 12.5 days.
(b) The % of all of the PEG in blood that have
n Ab attached at each point in time, where n =
0, 1, 2, 3. This is the case that PEG is 20 kDa and
the Ab-free Drug half life is 12.5 days.
(c) The % of all of the PEG in blood that have
n Ab attached at each point in time, where n =
0, 1, 2, 3, 4. This is the case that PEG is 50 kDa
and the Ab-free Drug half life is 12.5 days.
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(a) The % of all of the total PEG dose that have
n Ab attached at each point in time, where n =
0, 1, 2. This is the case that PEG is 6 kDa and
the Ab-free Drug half life is 12.5 days.
(b) The % of all of the total PEG dose that have
n Ab attached at each point in time, where n =
0, 1, 2, 3. This is the case that PEG is 20 kDa and
the Ab-free Drug half life is 12.5 days.
(c) The % of all of the total PEG dose that have
n Ab attached at each point in time, where n =
0, 1, 2, 3, 4. This is the case that PEG is 50 kDa
and the Ab-free Drug half life is 12.5 days.
6.7 Conclusions and consequences
From these results, it appears that the free PEG treatment is very successful at minimizing the
influence of anti-PEG Ab on the PEGylated drug. We still hope to have fewer PEG with many Ab
attached in the plasma for extended periods of time. This project arose to be one component of
another project, so completion of this work means that we can begin to incorporate it into our other
model.
Drug treatments for cancer have several challenges. Given challenges unique to cancer, delivering
a desired amount of drug to a tumor from an infusion dose becomes even more important. A strategy
is to couple the nanoparticle drug with an active targeting element that will more efficiently deliver
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the nanoparticle to the tumor, since the targeting element can bind to specific cell surface receptors
at the tumor. The strategy we are proposing is to decouple the nanoparticle and the targeting
component so that we can deliver the targeting component Ab by injection prior to delivering the
nanoparticles (NP). We use Physiologically Based Pharmacokinetic (PBPK) models to keep track of
the concentrations of the Ab and the NP as they move organ to organ. We will then couple the
models given the binding kinetics between the Ab and NP. The blood compartment will include the
model described in this chapter. Because the penetration of NP through the stroma to the center
of a tumor is a particular challenge, we will also include a multiscale tumor model to give proper
treatment in determining the spatial distribution and penetration of NP into the tumor cells. With
this approach, we hope to be able to determine how much of a dose of drug makes it tumor cells.
We’ve already written the PBPK models for both the NP and the Ab. We need to see how the
changed blood compartment affects the PBPK. Before its inclusion, we felt our Ab PBPK model
didn’t fit the data well enough. The PBPK code was written to run in DataTank and then read
and plotted by MATLAB code. The system appears to be stiff, however, so even with an adaptive
Runge-Kutta routine we wrote it takes a while to run. So, the code was also written in MATLAB
and uses the ode15s solver. The PBPK appendix includes the equations and parameter values used
for the Ab PBPK model. The NP model is similar, so the equations are not included. Figs 6.11
and 6.12 show some results from running the models.
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Figure 6.11: Total amount of Ab for all compartments.
(a) Individual concentrations of doxorubicin in each
individual compartment
(b) Total concentrations of free and encapsulated dox-
orubicin in each organ
Figure 6.12: Concentrations of tracked doxorubicin after 96hr
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CHAPTER 7
Discussion
7.1 Excess cell surface during cell rounding
Our two-layer model was able to produce the highly folded surface observed of a cell after
rounding. In particular, the interesting BLiP structures were able to be recreated by pinning certain
points along the outer membrane layer to the inner contracting cortical layer and then minimizing
the curvature of the membrane. The structure was made even more realistic by making the sizes of
the BLiPs non-uniform. We applied this same two-layer 2d model to a 3d model, but with limited
success. First of all, the triangle mesh prohibits a great minimization of curvature. Furthermore, the
characteristic bulb shape of the BLiPs observed in the 2d model are impossible to create using the
current method formulation.
We’ve incorporated the elements of our model to be implemented in the immersed boundary
fluid solver software IBAMR. This allows us to control both the volume and surface area, and
hence maintain the excess ratio, which wasn’t the case before. While many of the same problems of
minimizing curvature of a trangle mesh still exist, a crude implementation may be possible using
beams. If so, then using IBAMR will allow us to perform simulations of a 3d cell starting in a spread
state and rounding to the compact rounded state. We are currently working with collaborators to
develop a complex fluid solver for IBAMR, and we’ve already created an indicator function that,
once we have the complex fluid solver, will allow us to place the cell in a viscoelastic fluid. We could
then look at the fluid dynamics inside and outside of a rounding cell. Again, our current method
formulation prevents us from getting the characteristic bulb-shaped BLiPs, but as a simulation to
observe the dynamics of a rounding cell, whose morphology is a crude approximation of the highly
folded surface observed, this appears to be a promising strategy.
7.2 Weak antibody-mucus binding to trap pathogens
We model the binding kinetics of codiffusing antibodies and HIV in cervicovaginal mucus and
semen. We are able to replicate the observed behavior of mucosal trapping by attaching many
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antibodies the HIV, which cooperatively tether the HIV to the mucus. By creating a reliable
model, we are able to vary some properties of the antibody, in particular the ratio of attachment to
detachment rates of the antibody to the mucus, in order to motivate the engineering of antibodies
that offer the best possible protection. We are able to demonstrate that the protection offered
by optimizing the properties of the antibody is equivalent to the protection offered by using a
concentration antibodies that is essentially impossible to achieve in the real world. Through our
simulations we are also able to demonstrate that trapping is a much more powerful strategy to
protect than neutralization (covering the binding sites that a virus uses to dock to cells), contrary to
what much of the community believes.
We’ve added fluid flows due to differences in osmolarity between the semen and mucus as well as
the drainage that occurs due to liquefaction of the semen. From these simulations, we see that the
protection is worsened overall by these two flows, but that the amount of protection that is offered
by optimizing the binding affinity of the antibodies to the mucins is significant.
7.3 Nanoparticle drug delivery treatment
We’ve developed a model that simulates the infusion and elimination of a PEGylated drug in the
blood, along with a simulation that also includes anti-PEG antibodies that attach to the PEG on
the PEGylated drug, which in turn accelerates the elimination of the PEGylated drug. In order to
see if it is a viable strategy to increase the drug exposure to that during the case without anti-PEG
antibodies, we’ve also simulated a treatment whereby a free PEG infusion is administered prior to
the drug infusion in order to attach enough anti-PEG antibodies to the free PEG that there aren’t
enough anti-PEG antibodies to significantly accelerate the elimination of the drug. The results of
our model suggests that this is a viable strategy, as the drug exposure is almost equal to the case
that there are no anti-PEG antibodies for large molecular weight free PEG.
The original aim of this research was to provide a more comprehensive treatment of the blood
compartment of a physiologically based pharmacokinetic (PBPK) model. Our group has already
made separate PBPK models for intact antibodies and a nanoparticle drug, and now that this model
is nearly complete, we can try to couple the PBPK models and incorporate the new model into the
blood compartment.
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APPENDIX A
PBPK MODEL FOR NANOPARTICLE DRUG DELIVERY
A.1 Equations for the model
The following are the equations to model the flow of Ab from one compartment to another. At
present, the organ "Other" isn’t included in this model, so all of those terms can be ignored.
A.1.1 Unbound fraction function
For all organs, the total concentrations of IgG in the endosomal space and the unbound fraction
(fu) of IgG are defined as the following:
CTotalEndo,Organ = C
Endogenous
Endo,Organ + C
7E3
Endo,Organ + C
IV IG
Endo,Organ (A.1)
fuOrgan = 1− 1
2× CTotalEndo,Organ
×
(
(Kd,Organ + nPtOrgan + C
Total
Endo,Organ)
−
√
(Kd,Organ + nPtOrgan + C
Total
Endo,Organ)
2 − 4× nPtOrgan × CTotalEndo,Organ
)
(A.2)
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A.1.2 Plasma
VPlasma
d
dt
CPlasma
=
(
(QLung − LLung)× CVLung
)
−
(
(LGI + LSpleen +QLiver +QHeart +QKidney +QSkin +QMuscle +QOther)× CPlasma
)
+
(
(1− σL,Lung)× LLung × CILung
)
+
(
(1− σL,GI)× LGI × CIGI
)
+
(
(1− σL,Spleen)× LSpleen × CISpleen
)
+
(
(1− σL,Liver)× LLiver × CILiver
)
+
(
(1− σL,Heart)× LHeart × CIHeart
)
+
(
(1− σL,Kidney)× LKidney × CIKidney
)
+
(
(1− σL,Skin)× LSkin × CISkin
)
+
(
(1− σL,Muscle)× LMuscle × CIMuscle
)
+
(
(1− σL,Other)× LOther × CIOther
)
(A.3)
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A.1.3 Lung
Vascular
V VLung
d
dt
CVLung
=
(
(QLiver − LLiver)× CVLiver
)
+
(
(QHeart − LHeart)× CVHeart
)
+
(
(QKidney − LKidney)× CVKidney
)
+
(
(QSkin − LSkin)× CVSkin
)
+
(
(QMuscle − LMuscle)× CVMuscle
)
+
(
(QOther − LOther)× CVOther
)
+
(
FR×R2Lung × (1− fuLung)× V ELung × CTotalEndo,Lung
)
−
(
(QLung − LLung)× CVLung
)
−
(
R1Lung × CVLung × V VLung
)
−
(
(1− σV,Lung)× LLung × CVLung
)
(A.4)
Endosome space
V ELung
d
dt
CTotalEndo,Lung
=
(
R1Lung × CVLung × V VLung
)
−
(
fuLung × CLLung × CTotalEndo,Lung
)
−
(
(1− fuLung)×R2Lung × V ELung × CTotalEndo,Lung
)
+
(
R1Lung × CILung × V ILung
)
(A.5)
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Interstitial space
V ILung
d
dt
CILung
=
(
(1− σV,Lung)× LLung × CVLung
)
+
(
(1− FR)×R2Lung × (1− fuLung)× V ELung × CTotalEndo,Lung
)
−
(
(1− σL,Lung)× LLung × CILung
)
−
(
R1Lung × CILung × V ILung
)
(A.6)
A.1.4 Liver
Vascular
V VLiver
d
dt
CVLiver
=
(
(QGI − LGI)× CVGI
)
+
(
(QSpleen − LSpleen)× CVSpleen
)
+
(
(QLiver −QGI −QSpleen + LGI + LSpleen)× CPlasma
)
+
(
FR×R2Liver × (1− fuLiver)× V ELiver × CTotalEndo,Liver
)
−
(
R1Liver × CVLiver × V VLiver
)
−
(
QLiver − LLiver)× CVLiver
)
−
(
(1− σV,Liver)× LLiver × CVLiver
)
(A.7)
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Endosome space
V ELiver
d
dt
CTotalEndo,Liver
=
(
R1Liver × CVLiver × V VLiver
)
−
(
fuLiver × CLLiver × CTotalEndo,Liver
)
−
(
(1− fuLiver)×R2Liver × V ELiver × CTotalEndo,Liver
)
+
(
R1Liver × CILiver × V ILiver
)
(A.8)
Interstitial space
V ILiver
d
dt
CILiver
=
(
(1− σV,Liver)× LLiver × CVLiver
)
+
(
(1− FR)×R2Liver × (1− fuLiver)× V ELiver × CTotalEndo,Liver
)
−
(
(1− σL,Liver)× LLiver × CILiver
)
−
(
R1Liver × CILiver × V ILiver
)
(A.9)
201
A.1.5 Other organs
Vascular
V VOrgan
d
dt
CVOrgan
=
(
QOrgan × CPlasma
)
+
(
FR×R2Organ × (1− fuOrgan)× V EOrgan × CTotalEndo,Organ
)
−
(
R1Organ × CVOrgan × V VOrgan
)
−
(
(1− σV,Organ)× LOrgan × CVOrgan
)
−
(
(QOrgan − LOrgan)× CVOrgan
)
(A.10)
Endosome space
V EOrgan
d
dt
CTotalEndo,Organ
=
(
R1Organ × CVOrgan × V VOrgan
)
−
(
fuOrgan × CLOrgan × CTotalEndo,Organ
)
−
(
(1− fuOrgan)×R2Organ × V EOrgan × CTotalEndo,Organ
)
+
(
R1Organ × CIOrgan × V IOrgan
)
(A.11)
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Interstitial space
V IOrgan
d
dt
CIOrgan
=
(
(1− σV,Organ)× LOrgan × CVOrgan
)
+
(
(1− FR)×R2Organ × (1− fuOrgan)× V EOrgan × CTotalEndo,Organ
)
−
(
(1− σL,Organ)× LOrgan × CIOrgan
)
−
(
R1Organ × CIOrgan × V IOrgan
)
(A.12)
A.2 Summary of equations
In order to see the balance of mass, we can summarize the changes in concentrations from the
equations to examine the directional flows. The summaries are given below, which makes clear the
patterns of flow and the expected rate of loss of mass from the system.
Flow between Plasma and All Organs (except lungs)
Out from plasma to organ (vascular): QOrgan × CPlasma
In to organ (vascular) from plasma: QOrgan × CPlasma
In to plasma from organ (interstitial): (1− σL,Organ)× LOrgan × CIOrgan
Out from organ (interstitial) to plasma: (1− σL,Organ)× LOrgan × CIOrgan
Flow between Plasma and Lungs
In to plasma from lungs (vascular): (QLung − LLung)× CVLung
Out from lung (vascular) to plasma: (QLung − LLung)× CVLung
Flow between Lungs and All Organs (except GI and Spleen)
In to lungs (vascular) from organ (vascular): (QOrgan − LOrgan)× CVOrgan
Out from organ (vascular) to lungs (vascular): (QOrgan − LOrgan)× CVOrgan
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Flow between Liver and GI and Spleen
In to liver (vascular) from GI (vascular): (QGI − LGI)× CVGI
Out from GI (vascular) to liver (vascular): (QGI − LGI)× CVGI
In to liver (vascular) from spleen (vascular): (QSpleen − LSpleen)× CVSpleen
Out from spleen (vascular) to liver (vascular): (QSpleen − LSpleen)× CVSpleen
Flow between Vascular, Endosome space, and Interstitial space of All Organs
In to vascular from endosome: FR×R2Organ × (1− fuOrgan)× V EOrgan × CTotalEndo,Organ
Out from vascular to endosome: R1Organ × V VOrgan × CVOrgan
Out from vascular to interstitial: (1− σV,Organ)× LOrgan × CVOrgan
In to interstitial from vascular: (1− σV,Organ)× LOrgan × CVOrgan
In to interstitial from endosome: (1− FR)×R2Organ × (1− fuOrgan)× V EOrgan × CTotalEndo,Organ
Out from interstitial to endosome: R1Organ × V IOrgan × CIOrgan
In to endosome from vascular: R1Organ × V VOrgan × CVOrgan
In to endosome from interstitial: R1Organ × V IOrgan × CIOrgan
Out from endosome to vascular: FR×R2Organ × (1− fuOrgan)× V EOrgan × CTotalEndo,Organ
Out from endosome to interstitial: (1− FR)×R2Organ × (1− fuOrgan)× V EOrgan × CTotalEndo,Organ
Flow not balanced
Out from organ (endosome): fuOrgan × CLOrgan × CTotalEndo,Organ
A.2.1 Total Ab
The amount of Ab can be determined from the following calculations:
CCompartmentOrgan =
AbCompartmentOrgan
V CompartmentOrgan
Which means that the total amount of Ab in a compartment is the following:
AbCompartmentOrgan = V
Compartment
Organ × CCompartmentOrgan
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Hence, we have that the amount of Ab in an organ is the following:
AbTotalOrgan =
(
V V ascularOrgan × CV ascularOrgan
)
+
(
V EndosomeOrgan × CEndosomeOrgan
)
+
(
V InterstitialOrgan × CInterstitialOrgan
)
And the total concentration in an organ is the following:
CTotalOrgan =
(
V V ascularOrgan × CV ascularOrgan
)
+
(
V EndosomeOrgan × CEndosomeOrgan
)
+
(
V InterstitialOrgan × CInterstitialOrgan
)
V V ascularOrgan + V
Endosome
Organ + V
Interstitial
Organ
That means that the total amount of Ab in the whole system is the following:
AbTotal =
∑
i
((
V V ascularOrgani ×CV ascularOrgani
)
+
(
V EndosomeOrgani ×CEndosomeOrgani
)
+
(
V InterstitialOrgani ×CInterstitialOrgani
))
A.3 Parameter values from literature
In this section the parameter values from literature are presented. These values are not in the
units used in the simulation, but rather they are listed as reported in literature. It should be noted
that for these parameters the values are for a mouse whose weight is 25g, while the experimental
data is from a mouse whose weight is 20g, so adjustments will be made later.
Parameter Plasma Volume Vascular Volume Interstitial Vol-
ume
Endosomal Vol-
ume
Units mL/min mL mL mL
Plasma 4.38 0.774 0 0
Lung 4.38 0.019 0.057 9.55× 10−4
GI 0.90 0.1 0.6 1.72× 10−4
Liver 1.10 0.095 0.19 4.75× 10−4
Spleen 0.05 0.01 0.02 5.0× 10−4
Heart 0.28 0.007 0.019 6.65× 10−4
Kidney 0.80 0.03 0.101 1.49× 10−4
Skin 1.21 0.2 0.999 1.47× 10−4
Muscle 0.80 0.15 1.032 3.96× 10−4
Table A.1: Volume parameter values for model
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Parameter Vascular reflec-
tion coefficient
Lymph reflec-
tion coefficient
Dissociation
constant
Organ clearance
Units – — nM mL/d/kg
Plasma 0.95 0.2 750 –
Lung 0.95 0.2 750 0.082
GI 0.95 0.2 750 1.48
Liver 0.95 0.2 750 0.41
Spleen 0.95 0.2 750 0.043
Heart 0.95 0.2 750 0.057
Kidney 0.95 0.2 750 0.13
Skin 0.95 0.2 750 1.26
Muscle 0.95 0.2 750 3.4
Table A.2: Parameter values for model
Parameter Value Units
R1 1.96 -
FR 0.715 -
R2 20.4 -
Table A.3: Parameter values for other terms in model
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Parameter FcRn den-
sity
Units mol/l
Lung 4.98× 10−5
GI 4.98× 10−5
Liver 4.98× 10−5
Spleen 4.98× 10−5
Heart 4.98× 10−5
Kidney 4.98× 10−5
Skin 4.98× 10−5
Muscle 4.98× 10−5
Table A.4: FcRn density in each organ
Parameter Adjustment
Factor
(AF )
Weight
of Organ
(WtOrgan)
Organ
Clear-
ance Rate
(CLobsOrgan)
Organ Clearance Rate
Units - g ml/d/kg ml/d
Lung 20 0.1 0.082 AF ×WtLung × CLobsLung
GI 20 1.5 1.48 AF ×WtGI × CLobsGI
Liver 20 1.3 0.41 AF ×WtLiver × CLobsLiver
Spleen 20 0.1 0.043 AF ×WtSpleen × CLobsSpleen
Heart 20 0.095 0.057 AF ×WtHeart × CLobsHeart
Kidney 20 0.34 0.13 AF ×WtKidney × CLobsKidney
Skin 20 2.9 1.26 AF ×WtSkin × CLobsSkin
Muscle 20 7.81 3.4 AF ×WtMuscle × CLobsMuscle
Table A.5: Organ clearance rates for each organ
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Parameter Percent
of Plasma
Flow
(PFOrgan)
Lymph Flow Rate
Units - l/d
Lung 2 % PFLung ×QLung
GI 2 % PFGI ×QGI
Liver 2 % PFLiver ×QLiver
Spleen 2 % PFSpleen ×QSpleen
Heart 2 % PFHeart ×QHeart
Kidney 2 % PFKidney ×QKidney
Skin 4 % PFSkin ×QSkin
Muscle 4 % PFMuscle ×QMuscle
Table A.6: Lymph flow rates for each organ
Parameter Value Units
WeightMouse 0.02 kg
WeightMouseParams 0.025 kg
WeightAb 146 kDa
DoseRate 8 mg/kg
Table A.7: Parameter values for other terms in model
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Parameter Concentration
Endogenous
Ab in Endo-
some
Concentration
IVIG Ab in
Endosome
Units mol/l mol/l
Lung 14600 0
GI 14600 0
Liver 14600 0
Spleen 14600 0
Heart 14600 0
Kidney 14600 0
Skin 14600 0
Muscle 14600 0
Table A.8: More parameter values for more terms in model
A.4 Parameter values used in the simulation
In this section the values used in the simulation are presented, in the units used in the simulation.
The unit conversions and other calculations used to convert the parameter values from literature to
those given in the table are listed below each table.
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Parameter QOrgan V VOrgan V
I
Organ V
E
Organ WtOrgan CLOrgan
Units L/day L L L kg L/day
Plasma – 6.1920e-4 – – – –
Lung 5.0458 1.5200e-5 4.5600e-5 7.6400e-7 1.00e-4 1.6400e-7
GI 1.0368 8.0000e-6 4.8000e-4 1.3760e-5 1.50e-3 4.4400e-5
Liver 1.2672 7.6000e-5 1.5200e-4 3.8000e-6 1.30e-3 1.0660e-5
Spleen 0.0576 8.0000e-6 1.6000e-5 4.0000e-7 1.00e-4 8.6000e-8
Heart 0.3226 5.6000e-6 1.5200e-5 5.3200e-7 9.50e-5 1.0830e-7
Kidney 0.9216 2.4000e-5 8.0800e-5 1.1920e-6 3.40e-4 8.8400e-7
Skin 1.3939 1.6000e-4 7.9920e-4 1.1760e-5 2.90e-3 7.3080e-5
Muscle 0.9216 1.2000e-4 8.2560e-4 3.1680e-5 7.81e-3 5.3108e-4
Table A.9: Parameter values that vary organ to organ
The following unit conversions were used:
QOrgan[mL/min] =
WeightMouse
WeightMouseParams
QOrgan[mL/min]
1
60[min]
1[hr]
24[hr]
1[day]
1[L]
1000[mL]
= QOrgan[L/day]
V VOrgan[mL] =
WeightMouse
WeightMouseParams
V VOrgan[mL]
1
1[L]
1000[mL]
= V VOrgan[L]
V IOrgan[mL] =
WeightMouse
WeightMouseParams
V IOrgan[mL]
1
1[L]
1000[mL]
= V IOrgan[L]
V EOrgan[mL] =
WeightMouse
WeightMouseParams
V EOrgan[mL]
1
1[L]
1000[mL]
= V EOrgan[L]
WtOrgan[g] =
WtOrgan[g]
1
1[kg]
1000[g]
= WtOrgan[kg]
CLOrgan[mL/day/kg] = AF ×WtOrgan[kg]CLOrgan[mL/day/kg]
1
1[L]
1000[mL]
= CLOrgan[L/day]
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Parameter σV,Organ σL,Organ Kd,Organ nPtOrgan C
Endogenous
Endo,Organ C
IV IG
Endo,Organ
Units – – nM nM mol/L mol/L
Plasma 0.95 0.2 750 – – –
Lung 0.95 0.2 750 12200 14600 0
GI 0.95 0.2 750 12200 14600 0
Liver 0.95 0.2 750 12200 14600 0
Spleen 0.95 0.2 750 12200 14600 0
Heart 0.95 0.2 750 12200 14600 0
Kidney 0.95 0.2 750 12200 14600 0
Skin 0.95 0.2 750 12200 14600 0
Muscle 0.95 0.2 750 12200 14600 0
Table A.10: Parameter values in organs that don’t vary
The following unit conversion was used:
nPtOrgan[mol/L] =
nPtOrgan[mol/L]
1
1[M ]
1[mol/L]
109nM
1M
= nPtOrgan[nM ]
Parameter R1 FR R2 WeightMouse WeightAb DoseRate DOSE IC
Units – – – kg kDa mg/kg n mol nM
1.96 0.715 20.4 0.02 146 8 1.09589 0
Table A.11: Parameter values that aren’t organ-dependent
The following calculation was used:
DOSE[mg] = DoseRate[mg/kg]×WeightMouse[kg]
DOSE[mg] =
DOSE[mg]
1
1[Da]
1.6605402e− 21[mg]
1[kDa]
1000[Da]
1[Ab]
WeightAb[kDa]
1[mol Ab]
6.022140857[Ab]
1e9[nmol Ab]
1[mol Ab]
= DOSE[nmol]
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Parameter Percent of Plasma
Flow (PFOrgan)
Lymph Flow Rate
Units - L/day
Lung 2 % 0.1009
GI 2 % 0.0207
Liver 2 % 0.0253
Spleen 2 % 0.0012
Heart 2 % 0.0065
Kidney 2 % 0.0184
Skin 4 % 0.0558
Muscle 4 % 0.0369
Table A.12: Lymph flow rates
The following calculation was used:
LOrgan[L/day] = PFOrgan ×QOrgan[L/day]
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Computer Parameter Parameter Value (nM)
X(1) CPlasma 1416
X(2) CVLung 0
X(3) CVGI 0
X(4) CVLiver 0
X(5) CVSpleen 0
X(6) CVHeart 0
X(7) CVKidney 0
X(8) CVSkin 0
X(9) CVMuscle 0
X(10) CILung 0
X(11) CIGI 0
X(12) CILiver 0
X(13) CISpleen 0
X(14) CIHeart 0
X(15) CIKidney 0
X(16) CISkin 0
X(17) CIMuscle 0
X(18) CELung 0
X(19) CEGI 0
X(20) CELiver 0
X(21) CESpleen 0
X(22) CEHeart 0
X(23) CEKidney 0
X(24) CESkin 0
X(25) CEMuscle 0
Table A.13: Initial concentration values
The following calculation was used:
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CPlasma[nM ] = DOSE[nmol]/V
V
P lasma[L]
A.5 Experimental results
The following are the experimental results:
Time Plasma Heart Lung Liver Spleen Muscle Skin GI Kidney
(Days) (nM) (nM) (nM) (nM) (nM) (nM) (nM) (nM) (nM)
1/24 1035 109 132 146 108 11 21 59 162
2/24 854 102 117 121 103 11 23 46 122
6/24 811 85 131 141 92 12 25 64 114
12/24 647 80 102 80 82 12 27 39 104
1 448 72 89 70 65 15 60 30 71
2 392 56 66 51 51 17 66 17 51
4 339 51 56 47 37 13 51 15 36
7 280 34 52 40 33 13 38 15 35
10 259 30 41 33 30 10 36 11 33
Table A.14: Concentrations (experimental data)
Time (Days) 1/24 2/24 6/24 12/24 1 2 4 7 2
Amount (nmol) 0.96 0.80 0.79 0.63 0.50 0.44 0.38 0.31 0.28
Table A.15: Total amount of Ab, calculated from experimental data and accepted values for volumes
of organs
A.6 Plots of intact Ab PBPK
The following are the results from running the intact Ab PBPK.
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Figure A.1: Total amount of Ab for all compartments.
A.6.1 Linear scale
In the following plots, the results of the simulation are in blue, while the data is in red. The
same time points were plotted for in order to compare the simulation with the data.
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(a) Concentrations of Ab in GI–model compared
to data
(b) Concentrations Ab in heart–model compared
to data
(c) Concentrations of Ab in kidney–model com-
pared to data
(d) Concentrations of Ab in liver–model compared
to data
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(a) Concentrations of Ab in lung–model compared
to data
(b) Concentrations of Ab in muscles–model com-
pared to data
(c) Concentrations of Ab in plasma–model com-
pared to data
(d) Concentrations of Ab in skin–model compared
to data
(e) Concentrations of Ab in spleen–model com-
pared to data
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Figure A.4: Total amount of Ab in whole system–model compared to data–linear scale.
In the above plot, it is clear that the behavior the total Ab in the system is very different
between the data and the simulation. Observing the behavior of the data and the matrix form of
the equations, it seems that even upon fitting certain parameters for a best fit (which was done in
this research), it seems impossible to capture the behavior of the data. Hence, we are not confident
that the PBPK is correct it its current state.
A.6.2 Log scale
In the following plots, the results of the simulation are in blue, while the data is in red. The
same time points were plotted for in order to compare the simulation with the data. The y-axis is in
log-scale.
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(a) Concentrations of Ab in GI–model compared
to data
(b) Concentrations Ab in heart–model compared
to data
(c) Concentrations of Ab in kidney–model com-
pared to data
(d) Concentrations of Ab in liver–model compared
to data
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(a) Concentrations of Ab in lung–model compared
to data
(b) Concentrations of Ab in muscles–model com-
pared to data
(c) Concentrations of Ab in plasma–model com-
pared to data
(d) Concentrations of Ab in skin–model compared
to data
(e) Concentrations of Ab in spleen–model com-
pared to data
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Figure A.7: Total amount of Ab in whole system–model compared to data–log scale
A.7 Nanoparticle PBPK
As mentioned before, a PBPK model for the intact Ab was developed along with a PBPK model
for the NP. This section shows results of the PBPK for doxorubicin. The simulation was done using
DataTank, where the outputs were then written to text files and plotted using MATLAB.
Fig A.8 shows the DataTank outputs of the PBPK doxorubicin model. Fig A.10a shows output
of both free and encapsulated doxorubicin in each compartment, which includes interstitial fluid
and cellular compartments for the organs. Fig A.10b shows the total concentration of doxorubicin
broken down by organ rather than compartment.
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(a) Individual concentrations of doxorubicin
in each individual compartment as output by
DataTank
(b) Total concentrations of free and encapsulated
doxorubicin in each organ as output by DataTank
Figure A.8: Concentrations of tracked doxorubicin after 96hr as output by DataTank
In order to visualize the data in other ways, the outputs from DataTank were written to text
files, then read and plotted using MATLAB. Fig A.9 shows the same data plotted by both DataTank
(Fig A.9a) and MATLAB (Fig A.9b), where Fig A.9a is the same figure as Fig A.10a.
(a) Individual concentrations of doxorubicin
in each individual compartment as output by
DataTank
(b) Individual concentrations of doxorubicin in each
individual compartment–computed by DataTank and
plotted by MATLAB
Figure A.9: Concentrations in DataTank and MATLAB
Fig A.10 uses the same data that produced Fig A.8, and plots the time points. In addition
to Fig A.10, the changes in concentrations as time evolves was visualized by a movie of updated
bar graphs like that in Fig A.9b. Notice that the concentration of the NP in all compartments
decreases fairly quickly. Fig A.11 shows the initial and final concentrations of the NP in all of the
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compartments if different input values are used. The NP appears to stay in the body longer with
these input values.
(a) Individual concentrations of doxorubicin in
each individual compartment
(b) Total concentrations of free and encapsulated
doxorubicin in each organ
Figure A.10: Concentrations of tracked doxorubicin after 96hr
(a) Individual concentrations of doxorubicin in
each individual compartment when t=0hr
(b) Individual concentrations of doxorubicin in each
individual compartment when t=096hr
Figure A.11: Different inputs were used in order to see if concentrations of NP can be maintained
longer.
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APPENDIX B
LEFT/RIGHT ALGORITHM
B.1 Conditions for algorithm
This document describes an algorithm we’ve delveloped that will find the optimum value for
particular functions. It is useful because of its simplicity for understanding and implementation and
because of its speed vs other algorithms in certain situations. It is best used in situations in which
the function isn’t known but some certain properties of the function are known. It is also beneficial
because a minimum rate of convergence is guaranteed, which is not the case for gradient descent
methods. We have used it for finding x such that f(x) ∈ [ytarget − , ytarget + ] for some  > 0; i.e.,
we used it to find some x such that f(x) ≈ ytarget. (In practice, we usually just find an x such that
xopt ∈ [x− δ, x+ δ] where f(xopt) = ytarget and δ > 0.) Below are the requirements on the function
for the algorithm to work.
Let there be a 1d function f that has a minimum value f(xopt) such that f is monotonically
strictly decreasing to the left of xopt and monotonically strictly increasing to the right of xopt. The
following algorithm will find xopt to an arbitrary level of precision.
B.1.1 Some notes
Obviously, this algorithm will work (with some adjustments) for finding xopt corresponding to the
maximum value of the function if instead the function is monotonically increasing to the left of the
maximum and monotonically decreasing to the right of the maximum. It should also be noted that
the algorithm doesn’t require compactness nor continuity on f . The algorithm can work in some
instances with monotonicity rather than strict monotonicity (and, similarly, without a unique xopt),
but not always, where some adjustments can be made to help increase the likelihood of solving.
B.1.2 The conditions
• f : [xmin, xmax] 7→ R, −∞ < xmin < xmax <∞
• ∃xopt ∈ [xmin, xmax] such that the following hold:
1. f(xa) > f(xb)∀xa < xb where xa, xb ∈ [xmin, xopt)
2. f(xa) < f(xb)∀xa < xb where xa, xb ∈ (xopt, xmax]
Figure B.1 shows some plots of example functions that the algorithm will work for.
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(a) This is just a parabola, and the algorithm
will find the minimum (0,0).
(b) For this function, the minimum is at
(0,0), which is the left-most point, so not at
an intermediary point between the domain
limits. Still, the minimum will be found
using the algorithm.
(c) This is a plot of an actual situation I
was finding the minimum value for. Each
simulation takes several minutes and gives
an output value of flux, and the value that
gives the minimum was of interest.
(d) This plot is an example of a situation in
which the minimization function is trying
to find an input that gives a target output.
The minimum value of the black curve is de-
sired, where the black curve is the difference
between the red (target output) and blue
(actual output) curves.
Figure B.1: Some example functions that the algorithm will work for.
B.2 Basic process
This algorithm works by having a left limit xL, a right limit xR, where the minimum value xopt ∈
(xL, xR), and each iteration the distance d(xL, xR) decreases; i.e., di+1 < di, where dj = x
j
R − xjL is
the distance between the x-values at the jth iteration. By each iteration shrinking the x-interval
that the minimum values lies in, the minimum value is determined to an arbitrary level of precision.
In order to shrink the interval, an intermediary point (xM , f(xM )) and a test point (xT , f(xT ))
are used such that xM , xT ∈ (xL, xR), where it is guaranteed that f(xM ) < f(xL), f(xM ) < f(xR),
f(xT ) < f(xL), f(xT ) < f(xR). At the each iteration, either the left-most point (xL, f(xL)) or the
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right-most point (xR, f(xR)) is removed, leaving only three points, (xM , f(xM )), (xT , f(xT )), and
the point which wasn’t removed, which is either (xL, f(xL)) or (xR, f(xR)). These three points
are renamed to be the left-most ((xL, f(xL)), the intermediary (xM , f(xL)), and the right-most
(xR, f(xL)) organized by the value of their x−coordinates. The test point is then determined based
on the new assignments of these three points, and the next iteration begins.
The point (xT , f(xT )) needs to be chosen in a way that the interval is guaranteed to be able
shrunk to an arbitrary length. This can be achieved if xT alternates its definition each iteration
to being between xL and xM and being between xM and xR. That is, each iteration xT alternates
between being to the left of xM and being to the right of xM . (The proof of the guarantee that the
interval can be shrunk to an arbitrary length is in the next section of this document.) The definition
of xiT (the x-coordinate of the test point at the i
th iteration) is the following:
xiT =

xiR − xiM
2
if i is even
xiM − xiL
2
if i is odd
B.3 Proof that algorithm will work
Let’s try to find an x such that d(x, xopt) ≤ 2δ for some δ > 0, where f(xopt) = yopt; that is, let’s
find an x arbitrarily close to the point xopt that optimizes the function f .
Let’s start by assuming the following conditions for the function are met.
• f : [xmin, xmax] 7→ R, −∞ < xmin < xmax <∞
• ∃xopt ∈ [xmin, xmax] such that the following hold:
1. f(xa) > f(xb)∀xa < xb where xa, xb ∈ [xmin, xopt)
2. f(xa) < f(xb)∀xa < xb where xa, xb ∈ (xopt, xmax]
Let us initialize the algorithm with the following values, including a point outside of the domain
which will be removed after the first iteration (without loss of generality, let’s make this the right-most
point):
xL = xmin ⇒ fL = f(xL) = f(xmin)
xM = xmax ⇒ fM = f(xM ) = f(xmax)
without loss of generality, let xR = xmax + δ and without loss of generality let fR =∞
Let’s define xT =
xiM − xiL
2
and fT = f(xT ).
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Notice that, by our assumptions, xopt ∈ [xL, xR]. Hence, xopt ∈ [xL, xT ) or xopt ∈ [xT , xM ] or
xopt ∈ (xM , xR] (but actually not the latter case by design for the first iteration). Notice that if
xopt /∈ [xL, xT ), then it must be the case that xopt ∈ [xT , xR]; similarly, if xopt /∈ (xM , xR], then
it must be the case that xopt ∈ [xL, xM ]. Let’s look at some consequences of the monotonicity
requirements in order to show that we can determine at each iteration that either xopt /∈ [xL, xT )
or xopt /∈ (xM , xR] (or, since each iteration it switches from xT < xM to xM < xT or vice versa,
in the case xM < xT it is that we can determine at each iteration that either xopt /∈ [xL, xM ) or
xopt /∈ (xT , xR]).
Without loss of generality, let’s look at an iteration with xL < xT < xM < xR (rather than
an iteration with xL < xM < xT < xR). We know that xopt ∈ [xL, xT ) or xopt ∈ [xT , xM ] or
xopt ∈ (xM , xR]. If we have that fT ≤ fM , then it cannot be the case that xopt ∈ (xM , xR]. To see
this, let’s assume that xopt ∈ (xM , xR]. Then, by monotonicity, f(xa) > f(xb)∀xa < xb < xopt. Since
xT < xM < xopt, we have that fT > fM , which is a contradiction. Hence, if fT ≤ fM , then it must
be the case that xopt /∈ (xM , xR]. Similarly, if fM ≤ fT , then it must be the case that xopt /∈ [xL, xT ).
Since it must always be the case that fT ≤ fM or fM ≤ fT , then at every iteration we are able
to eliminate either [xL, xT ) or (xM , xR] from the domain where xopt can lie, and we know which
interval to remove by only determining whether fT ≤ fM or fM ≤ fT .
At this point we have shown that at each iteration we can decrease the domain that xopt can be
found in, but we have not shown that this domain can be reduced to [x− δ, x+ δ] for some arbitrary
δ > 0. Let’s show that for every two iterations the size of the domain is reduced by at least half,
meaning that to get d(x, xopt) ≤ 2δ for some δ > 0, the number n of iterations required will be at
most n =
2ln
(
2δ
xmax − xmin
)
ln(1/2)
iterations.
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B.3.1 Proof bounding interval at least halved every other iteration
Figure B.2: Before first iteration.
To prove it we will use induction. Let’s show that in general after two iterations the size of the
domain is reduced by at least half. Let’s have the domain be [L1, R1], with M1 as the intermediary
point (see Figure B.2 shows the domain before running the first iteration). In general, at iteration i
there are 4 points: Li, Ti,Mi, Ri, where Ti is either the midpoint of Li and Mi or the midpoint of
Mi and Ri, depending on whether the iteration is in the "left" regime or the "right" regime. That
means that each iteration there are 3 intervals: [Li, Ti], [Ti,Mi], and [Mi, Ri] in the left regime, and
[Li,Mi], [Mi, Ti], and [Ti, Ri] in the right regime. Each iteration we remove either the left-most
interval or the right-most interval. Notice that that means that after 2 iterations there are only
4 possible interval-removal operations: right-most followed by right-most, right-most followed by
left-most, left-most followed by left-most, and left-most followed by right-most. In order to show
that after 2 iterations the interval is reduced by least half, what we aim to show is that for all 4 of
these possible interval-removal operations we have that d(Li+2, Ri+2) ≤ 1/2d(Li, Ri).
Without loss of generality, for this proof let’s assume we’re in the "left" regime, so that Ti is the
midpoint of Li and Mi. Let’s define lj = d(Lj , Rj) and let dj = d(Mj , Rj when in the left regime
and dj = d(Lj ,Mj when in the right regime (so it is the length of the interval that is not bisected
by the point Tj).
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Before we go through the proof of each interval-removal case, let’s find the definition of a few
lengths that we’ll use:
d(Ri, Li) = li
d(Ri,Mi) = di
d(Mi, Li) = li − di
d(Mi, Ti) = d(Ti, Li) = 1/2d(Mi, Li) = 1/2(li − di)
d(Ri, Ti) = 1/2(li + di)
CASE 1: the removal of the right-most followed by the removal of the right-most See
Figure B.3 for the removal of intervals for this case, where in the figure i = 1.
(a) Bounding interval and subintervals before the
first subinterval is removed.
(b) Bounding interval and subintervals after right-
most interval is removed.
(c) Bounding interval and subintervals after right-
most interval is removed and then new right-most
interval is removed.
Figure B.3: Interval removal process for case 1
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li+2
= d(Li+2, Ri+2) = d(Li+1, Ti+1) = d(Li+1,Mi+1) + d(Mi+1, Ti+1)
= d(Li+1,Mi+1) + 1/2d(Mi+1, Ri+1) = d(Li, Ti) + 1/2d(Ti,Mi) = (li − di) + 1/2 (1/2(li − di))
= 3/4(li − di)
Therefore,
li+2 ≤ 1/2li ⇐⇒ 3/4(li − di) ≤ 1/2li ⇐⇒ li − di ≤ 2/3li ⇐⇒ 1/3li ≤ di
CASE 2: the removal of the right-most followed by the removal of the left-most See
Figure B.4 for the removal of intervals for this case, where in the figure i = 1.
(a) Bounding interval and subintervals before the
first subinterval is removed.
(b) Bounding interval and subintervals after right-
most interval is removed.
(c) Bounding interval and subintervals after right-
most interval is removed and then new left-most
interval is removed.
Figure B.4: Interval removal process for case 2
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li+2
= d(Li+2, Ri+2) = d(Mi+1, Ri+1) = d(Ti,Mi)
= 1/2(li − di)
Therefore,
li+2 ≤ 1/2li ⇐⇒ 1/2(li − di) ≤ 1/2li ⇐⇒ li − di ≤ li ⇐⇒ di ≥ 0
CASE 3: the removal of the left-most followed by the removal of the left-most See
Figure B.5 for the removal of intervals for this case, where in the figure i = 1.
(a) Bounding interval and subintervals before the
first subinterval is removed.
(b) Bounding interval and subintervals after left-most
interval is removed.
(c) Bounding interval and subintervals after left-most
interval is removed and then new left-most interval
is removed.
Figure B.5: Interval removal process for case 3
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li+2
= d(Li+2, Ri+2) = d(Mi+1, Ri+1) = d(Mi, Ri)
= di
Therefore,
li+2 ≤ 1/2li ⇐⇒ di ≤ 1/2li
CASE 4: the removal of the left-most followed by the removal of the left-most See
Figure B.6 for the removal of intervals for this case, where in the figure i = 1.
(a) Bounding interval and subintervals before the
first subinterval is removed.
(b) Bounding interval and subintervals after left-most
interval is removed.
(c) Bounding interval and subintervals after left-most
interval is removed and then new right-most interval
is removed.
Figure B.6: Interval removal process for case 4
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li+2
= d(Li+2, Ri+2) = d(Li+1, Ti+1) = d(Li+1,Mi+1) + d(Mi+1, Ti+1)
= d(Li+1,Mi+1) + 1/2d(Mi+1, Ri+1) = d(Ti,Mi) + 1/2d(Mi, Ri) = 1/2(li − di) + 1/2di
= 1/2li
Therefore,
li+2 ≤ 1/2li
Summary of cases So, from all of these, we have the following:
CASE 1: li+2 ≤ 1/2li ⇐⇒ 1/3li ≤ di
CASE 2: li+2 ≤ 1/2li ⇐⇒ di ≥ 0
CASE 3: li+2 ≤ 1/2li ⇐⇒ di) ≤ 1/2li
CASE 4: li+2 ≤ 1/2li∀li
Which means that, ∀ cases, li+2 ≤ 1/2li ⇐⇒ 1/3li ≤ di ≤ 1/2li
Proof of base case To prove by induction we must show the base case.
Either we can initialize so that d1 it satisfies 1/3l1 ≤ d1 ≤ 1/2l1, or we can show that regardless
of the relationship between l1 and d1 we will have that 1/3l3 ≤ d3 ≤ 1/2l3. Let’s look at all of the
cases to see if it can be shown.
CASE 1 (See Figure B.3 for the removal of intervals for this case):
d3 = d(M3, R3) = d(M2, T2) = 1/2d(M2, R2) = 1/2d(T1,M1) = 1/2 (1/2(l1 − d1)) = 1/4(l1 − d1)
From above:
l3 = 3/4(l1 − d1) = 3d3
⇒ d3 = 1/3l3
CASE 2 (See Figure B.4 for the removal of intervals for this case):
d3 = d(M3, R3) = d(T2, R2) = 1/2d(M2, R2) = 1/2d(T1,M1) = 1/2 (1/2(l1 − d1)) = 1/4(l1 − d1)
From above:
l3 = 1/2(l1 − d1) = 2d3
⇒ d3 = 1/2l3
CASE 3 (See Figure B.5 for the removal of intervals for this case):
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d3 = d(M3, R3) = d(T2, R2) = 1/2d(M2, R2) = 1/2d(M1, R1) = 1/2d1
From above:
l3 = d1 = 2d3
⇒ d3 = 1/2l3
CASE 4 (See Figure B.6 for the removal of intervals for this case):
l3 = d(M3, R3) = d(M2, T2) = 1/2d(M2, R2) = 1/2d(M1, R1) = 1/2d1
From above:
l3 ≤ 1/2l1
So, for cases 1-3, regardless of the relationship between l1 and d1, we have that 1/3l3 ≤ d3 ≤ 1/2l3,
and we know that 1/3li ≤ di ≤ 1/2li guarantees that li+2 ≤ 1/2li. Hence, regardless of the size of
d1, as long as the algorithm enters case 1, 2, or 3 at some iteration n, then the conditions will be
met such that li+2 ≤ 1/2li ∀i ≥ n. However, we already know that case 4 guarantees that li+2 ≤ li
regardless of di, so even for case 4 the conditions are met at the first iteration. Thus, we have shown
inductively that li+2 ≤ 1/2li ∀i (for any l1, d1).
B.4 Similar algorithms
In general, this algorithm is guaranteeing that for every 2 function calls the interval bound is
guaranteed to be reduced by half. This algorithm achieves this by using 4 data points, so 3 intervals,
and removing 1 interval per iteration. It makes one new function call per iteration, reducing the
interval by at least half after two completed iterations. This is the best case of the generalized
algorithm. Let’s briefly look at the generalized algorithm.
For the first investigation into the generalized algorithms, let’s look at an interval [xmin, xmax],
which is broken up into N equally-sized subintervals, where N is even; i.e., [xmin, xmax] = [xmin =
x1, x2]∪[x2, x3]∪· · ·∪[xN−1, xN ]∪[xN , xN+1 = xmax] (where the repeated inclusion of each xj will be
important later). Hence, there are N +1 data points, where N +1 is odd. Each iteration subintervals
will be removed and the new interval will be divided into new subintervals. Let li = d(xi1, xiN+1)
be the length of the interval prior to the ith iteration. This procedure will show that li+1 = 2/Nli,
but each iteration will require N − 2 function calls–so worse than the rate of interval reduction per
function call as the Left-Right algorithm described in this chapter. There is a bit more overhead for
this method, but there are also cases that allow for li+1 = 1/Nli with a probability of occurrence
2
N+1 , although in this case the next iteration will require N − 1 function calls. This will be discussed
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more later.
For this method, let’s start at iteration i, where f(xij) has been calculated ∀j. The minimum
function value must be determined; i.e., we must identify xij such that f(x
i
j) ≤ f(xik) ∀k ∈
{1, · · · , N + 1}. If j 6= 1, N + 1, then we remove all intervals except intervals [xij−1, xij ], [xij−1, xij+1],
because it must be the case (due to monotonicity) that the minimum value of the function must lie in
one of these intervals. The interval [xij−1, x
i
j+1] will now be renamed to [x
i+1
1 , x
i+1
N+1] and divided into
N equally-sized subintervals. At this point, f(xi+1j ) needs to be calculated ∀j 6= 1, N + 1, N/2, where
we don’t need to calculate f(xi+1j ) because f(x
i+1
1 ) = f(x
i
j−1), f(x
i+1
N+1) = f(x
i
j+1) f(x
i+1
N/2) = f(x
i
j),
which were calculated in the last iteration. Hence, of the N equally-sized subintervals at the start of
iteration i only 2 remain, and of the N + 1 values all but 3 will need to be calculated to start the
next iteration, so we have a reduction in size of 2/N with N − 2 function calls.
However, in this we calculation we assumed that j 6= 1, N + 1. If it is the case that j = 1, then
due to monotonicity the minimum value of the function in the interval [xi1, xi2], so all other intervals
can be removed; if it is the case that j = N + 1, then due to monotonicity the minimum value of
the function in the interval [xiN , x
i
N+1], so all other intervals can be removed. In either event, the
interval will be renamed to [xi+11 , x
i+1
N+1] and divided into N equally-sized subintervals. At this point,
f(xi+1j ) needs to be calculated ∀j 6= 1, N + 1, where we don’t need to calculate f(xi+1j ) because
f(xi+11 ) = f(x
i
j−1), f(x
i+1
N+1) = f(x
i
j+1), which were calculated in the last iteration. Hence, of the
N equally-sized subintervals at the start of iteration i only 1 remains, and of the N + 1 values all
but 2 will need to be calculated to start the next iteration, so we have a reduction in size of 1/N
with N − 1 function calls.
In order to combine these two cases, we have the following reductions in interval size and number
of function calls to achieve it:
Expected Size Reduction = P (2/N) ∗ (2/N) + P (1/N) ∗ (1/N)
Expected Function Calls = P (N − 2) ∗ (N − 2) + P (N − 1) ∗ (N − 1)
If we assume that the minimum function value is equally likely to exist at any x value, then we
have the following:
Expected Size Reduction = P (2/N) ∗ (2/N) + P (1/N) ∗ (1/N)
235
=
N + 1− 2
N + 1
2
N
+
2
N + 1
1
N
=
2N
N(N + 1)
=
2
N + 1
Expected Function Calls = P (N − 2) ∗ (N − 2) + P (N − 1) ∗ (N − 1)
=
N + 1− 2
N + 1
(N − 2) + 2
N + 1
(N − 1) = (N − 2 + 2)(N − 1)
N + 1
=
N(N − 1)
N + 1
Notice that
2
N + 1
<
2
N
, so there is a slight improvement in reduction of interval size due to the
chance of removing all but 1 interval rather than all but 2. However, also notice that
N(N − 1)
N + 1
=
N2 −N
N + 1
>
N2 −N − 2
N + 1
=
(N + 1)(N − 2)
N + 1
= N − 2, so this improvement comes at a cost of more
function calls. However, notice the following:
FuncCalls/Reduction (no improvement) =
N − 2
2
N
=
N(N − 2)
2
FuncCalls/Reduction (with improvement) =
(
N(N − 1)
N + 1
)
(
2
N + 1
) = N(N − 1)
N + 1
N + 1
2
=
N(N − 1)
2
And
N(N − 2)
2
<
N(N − 1)
2
, so overall the improvement in reduction of the interval size is worth
the slight extra cost in function calls.
Importantly, though, for N > 2, we have that FuncCalls/Reduction (with improvement) =
N(N − 1)
2
>
2(2− 1)
2
= 1, so the ratio function calls to reduction in interval size is greater than 1,
and that is what we get with the Left/Right algorithm. As N increases the ratio gets worse, so the
smaller N the better.
Notice that a similar process can be performed for the case that N is odd, but there is no middle
point to be reused each iteration if the intervals are split up to be equally-spaced, so there will be
N − 1 function evaluations every iteration rather than N − 2 as was done in most events when N is
even. If the intervals aren’t to be equally-spaced, then the point xij can be reused, as it was in the
case that N is even, but a decision must be made where to place the remaining points, because there
are an odd number of remaining points to be distributed between xij−1 and x
i
j+1, so either more will
be on the left of xij or more on the right. Alternating left and right is a strategy that guarantees
that the intervals can shrink to an arbitrary size. This is exactly the process that was done for the
Left/Right Algorithm, where it is the special case that N = 3.
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APPENDIX C
FURTHER CONSIDERATIONS ON BLIPS
C.1 Introduction
We’re suggesting that the shape of the surface of a cell pinned to the cortical layer will be
the one with the least amount of bending energy. Thus, in order to find the shape of the cell we
try to minimize the bending energy. The following is a discussion of bending energy (BE) of cells
with various excess ratios (ER). We will use the following definition of BE: BE=
∫
contour κ
2(s)ds ≈∑i=k
i=1
|x′iy′′i − y′ix′′i |
(x′2i + y
′2
i )
3/2
(x′2i + y
′2
i )
1/2 =
∑i=k
i=1
|x′iy′′i − y′ix′′i |
x′2i + y
′2
i
. The excess ratio of a 2d cell with a volume
V and perimeter P is given by ER =
P
2
√
piV
(since it’s the ratio P/Pcircle, where Pcircle is the
perimeter of the circle that encloses the same volume of the cell).
C.2 Area and excess ratio
After running the minimization model described in Kapustina et al. [9] using DataTank, the
configuration of points is taken in to calculate the bending energy, as well as the area and perimeter.
Notice that the area inside the outer layer is not preserved (and in fact won’t be known ahead
of time), so the different number of BLiPs and excess ratios will yield contours of different sizes.
Consequently, even the final excess ratios will not be preserved as the system evolves (and in fact
the final ER won’t be known ahead of time). We’ll now discuss ER in more detail.
C.2.1 The technical definition for the Excess Ratio (ER)
ER =
Pcontour
Pcircle
where Pcontour is the perimeter of the outer layer and Pcircle is the perimeter
of the circle that has the same area as is contained within the outer layer. Notice, though, that
the area contained within the outer layer depends on how small the inner layer is. Consequently, a
decision needs to be made as to the size of the inner layer. Obviously, the inner layer can’t contain
the same volume as the outer layer nor have the same perimeter. We chose to make the inner layer
have a perimeter Pinner = 2 ∗ pi, and let the perimeter of the outer layer Pouter = ER ∗ Pinner. In
other words, we made a choice to assume that the inner layer was the base shape that the outer
layer was an excess of. Since the outer layer contains more area than the base case (per design), the
ER must be recalculated at the end of the simulation using ER =
Pcontour
Pcircle
. Even if we conserved
the area and perimeter of the outer layer, such as when we used IBAMR, a decision still must be
made about the size of the inner layer.
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C.3 Normalizing with "droplets"
We also need to decide a way to get the size of the cell in order to compare it to other cells.
This is important because objects of the same shape but different size have different curvatures. We
investigated many different ways to normalize, including scaling to the same area or perimeter, as
well as to the same area or perimeter of BLiPs. One way to compare different cells is to normalize
each object with a given ER to the base case of a shape with the same ER but having no BLiPs.
That is, we assume that there are no contact points connecting the outer layer to the inner layer
and instead just evolve the outer layer conserving area and perimeter and minimizing curvature.
Then, we have a "base" amount of energy for a given excess and can investigate how many times
larger the energy is for the various numbers of BLiPs. Here are the "droplet" base cases (no BLiPs)
followed by the results from these runs.
"Droplets"
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(a) ER=1.5 (b) ER=2
(c) ER=3 (d) ER=4
(e) ER=5 (f) ER=6
C.4 Tension and bending
In order to visualize the conflict between the perimeter preservation penalty and the curvature
penalty, the tension and bending of the final object is looked at. Code was written that takes
as inputs the BLiP number and excess factor, then reads in the corresponding data (coordinates)
and calculates the "tension" or "bending energy" of the outer layer. The "tension" code finds the
distance between adjacent points, then compares this distance to the average distance (Lbar). If
the distance is less than Lbar, then the points are considered compressed; if the distance is greater
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than Lbar, then the points are considered stretched. The amount of "compression" or "stretching"
is then plotted as a heat-valued square at the location exactly between the adjacent points being
measured. The "bending energy" code calculates the curvature and plots that value as heat-value at
the location of the point. Figs C.2 and C.3 are some examples.
Figure C.2: "stretching" and "compressing" with 20 BLiPs and an excess of 6
Figure C.3: "bending" with 20 BLiPs and an excess of 6
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C.5 Unequal BLiP sizes
In Kapustina et al. 2016 [9], each of the BLiPs in the Hamiltonian model were assumed to be
the same size. We have done a lot of work looking at when that is not the case.
C.5.1 Choosing the different spacings between pinning points
The arc lengths of the BLiPs in the discretized model can be determined by counting the number
of points between special pinning points. Generating a cell with a random distribution of BLiP sizes
can be accomplished by randomly spacing the special pinning points apart. The appendix on the
"random" distribution of special pinning points discusses methods for doing this.
After choosing the special pinning points that will create BLiPs of different sizes, there are a few
different ways to reach the steady state. The different ways concern how to space the attachment
points on the inner cortex where the special pinning points on the membrane will connect to. The
first way is to make sure that the attachment points are equally spaced, even though the BLiPs are
not equally spaced, as in seen in Fig C.4. In a cell rounding situation, this approach implies that
there is some reconstruction that occurs in the cortical layer. This sounds reasonable, yet there
doesn’t seem to be any reason for the attachment points to reorganize to be equally-spaced. Another
way is to make the distance between the attachment points in the cortex to be proportional to the
distance between the pinning points on the membrane, as is seen in Fig C.5. For this approach, cell
rounding implies that there isn’t any reconstruction, and the contracting cortical layer pulls the
membrane in. The final way is to pin the outer layer to the inner layer, but not to any specific point
on the inner layer; rather, the minimizing curvature of the BLiPs will determine the location of the
special pinning points on the cortical layer. This seems to be the most realistic in terms of what
is being modeled. Unsurprisingly, our results show that the steady state for the approach without
attaching to a specific point has the smallest bending energy, and that this state is closer to the
evenly-spaced scheme in Fig C.4. This investigation has helped informed strategies for making the
3d model.
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Figure C.4: Unequally-sized BLiPs with the distance between attachment points on the cortical
layer equally-spaced.
Figure C.5: Unequally-sized BLiPs with the distance between attachment points on the cortical
layer spaced proportional to BLiP sizes.
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APPENDIX D
RANDOM DISTRIBUTION OF PINNING POINTS
D.1 Probabilistic situation
Suppose there are k marbles and N cups to put them in (where k ≥ N). What is the distribution
of number of marbles in a cup if the k marbles are randomly placed in the N cups, with a requirement
that there must be at least n marbles in each cup (where n ≤ k/N)?
Obviously, the final distribution of number of marbles in each cup depends on what is meant by
"randomly placed" in the framing of this question.
When solving this numerically, each of the k marbles can be treated individually, choosing which
of the N cups to place it in (without loss of generality draw from a uniform distribution, so each
cup has an equal likelihood of being chosen), and once each of the k marbles has been placed a
check can be performed to make sure that each of the N cups has at least n marbles. If each of
the N cups does not have at least n marbles, then the process can be repeated until there is a
successful placement. The whole process can be repeated to get many successful placements in order
to get some sense of the distribution of the final number of marbles in each cup. However, when
n ≈ k/N > 1, then it may take many tries before a successful placement is achieved, especially when
k is large (since n ≈ k/N means that there are very few acceptable possible successful placements,
and k large means that there are a large number of total possible placements).
An alternative approach is to force a successful placement. This can be done by starting out
placing n marbles in each of the N cups, and then randomly assigning the remaining k − n ∗ N
marbles in the N cups. However, is this method of placement equivalent to the other? If not, which
method gives a more "random" placement? (The answer to the latter question depends on the
definition of "random," but a discussion of this is offered after showing the results.)
D.2 Results
The following are some results after 1e4 successful trials (placements) for each of the methods.
It should be noted that reporting how many occurrences of a cup with exactly m marbles is not a
perfect measure of "randomness" because a single placement can have multiple instances of a cup
with m marbles, but regardless of what one is looking for in a "random placement," the distributions
are very different, and one can glean from them what a single placement looks like.
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(a) In this trial, N = 40 and n = 7, k =
1600−N .
(b) In this trial, N = 40 and n = 7, k =
1600−N .
(c) In this trial, N = 20 and n = 27, k =
1600−N .
(d) In this trial, N = 20 and n = 27, k =
1600−N .
(e) In this trial, N = 20 and n = 40, k =
1600−N .
(f) In this trial, N = 20 and n = 40, k =
1600−N .
Figure D.1: Distributions of number of marbles in each cup given different n, N , and k. x axis:
Number of marbles in a cup; y axis: Total number of occurrences of a cup with x marbles after 1e4
successful placements. The method used on the left is to repeatedly undergo random placements
until a successful placement is found; the method used on the right is to place n marbles in each of
the N cups and then randomly place the remaining k − n ∗N marbles afterward.
It should be mentioned that the construction of Figure D.1e on a MacBook Pro several hours to
run in order to get 1e4 successful placements.
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D.3 Actual description
The framing of the question of the distribution of the number of balls per cup is an easy one to
understand. The motivation of this question comes from a problem of discretizing a circle with k
points, then randomly selecting N of them. This object will then be stretched uniformly so that the
distance between each pair of adjacent points are equal, but the new perimeter will be P = f ∗ P0,
where f is the stretching factor, and P0 is the original perimeter. The N points will be pinned to
N uniformly-spread points on a circle with perimeter P0, and each line connecting adjacent points
on the stretched object must lie outside of the circle with perimeter P0. Hence, since the spacing
between adjacent points is equal, there must be a certain number of non-special points between the
N special points to ensure that the total perimeter of the stretched object is P , that the spacing
between each pair of adjacent points is equal, and that all lines connecting adjacent points lie outside
of the circle with perimeter P0. The number of points n that must be between the N special points
when the perimeter of the stretched object is f times a circle with perimeter P0 can be given by
n = ceil((sin(pi/N))/(f ∗ sin(pi/k))).
Figure 2 shows the output of getting a single successful placement using each method.
(a) The method used in this figure is to
repeatedly undergo random placements until
a successful placement is found. In this trial,
N = 40 and f = 6, k = 1600 (k is number
of points around circle).
(b) The method used in this figure is to
place n points between each of the N special
points and then randomly place the remain-
ing k− n ∗N points afterward. In this trial,
N = 40 and f = 6, k = 1600 (k is number
of points around circle).
Figure D.2: Example circles. Red are the "special" points; Blue are the "non-special" points
It’s very clear that the two methods are not equivalent. From the distributions seen in Figure D.1,
we’d expect to see many more occurances of small spacings, and, as a consequence of having the
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N intervals add to a perimeter P , we would also expect to see instances of much larger spacings.
If it is desirable to have "random" spacings between the "special" points, it seems that what is
desired is for the space between adjacent "special" points to be as non-uniform as possible. When
looking at Figure D.2, it is not obvious that the spacings are different, while in Figure D.2a it is
very obvious. So, if the task is to find a "random" spacing between points, it seems that the method
used to produce Figure 2a is better. However, this method becomes prohibitively computationally
expensive when n ≈ k/N > 1 and k is large. Because of this, an analytical way to calculate the
distribution would be preferred.
246
REFERENCES
[1] K. Jacobson, O. Mouritsen, and R. Anderson, “Lipid rafts: at a crossroad between cell biology
and physics,” Nat Cell Biol, vol. 9, 2007.
[2] M. Sheetz, J. Sable, and H.-G. Dobereiner, “Continuous membrane-cytoskeleton adhesion
requires continuous accommodation to lipid and cytoskeleton dynamics,” Annual Review of
Biophysics and Biomolecular Structure, vol. 35, 2006.
[3] C. Morris and U. Homann, “Cell surface area regulation and membrane tension,” The Journal
of Membrane Biology, vol. 179, 2001.
[4] E. Sackmann, “Membrane bending energy concept of vesicle- and cell-shapes and shape-
transitions,” FEBS Letters, vol. 346, 1994.
[5] H. McMahon and J. Gallop, “Membrane curvature and mechanisms of dynamic cell membrane
remodelling,” Nature, vol. 438, 2005.
[6] R. Lipowsky, “The conformation of membranes,” Nature, vol. 349, 1991.
[7] A. Kusumi and Y. Sako, “Cell surface organization by the membrane skeleton,” Current Opinion
in Cell Biology, vol. 8, 1996.
[8] A. Kusumi, K. Suzuki, R. Kasai, K. Ritchie, and T. Fujiwara, “Hierarchical mesoscale domain
organization of the plasma membrane,” Trends in Biochemical Sciences, vol. 36, 2011.
[9] M. Kapustina, T. Elston, and J. K, “Compression and dilation of the membrane-cortex layer
generates rapid changes in cell shape,” Journal of Cell Biology, vol. 200, 2013.
[10] L. Figard and A. Sokac, “A membrane reservoir at the cell surface,” BioArchitecture, vol. 4,
2014.
[11] C. Erickson and J. Trinkaus, “Microvilli and blebs as sources of reserve surface membrane
during cell spreading,” Experimental Cell Research, vol. 99, 1976.
[12] K. Porter, D. Prescott, and J. Frye, “Changes in surface morphology of chinese hamster ovary
cells during the cell cycle,” The Journal of Cell Biology, vol. 57, 1973.
[13] G. Salbreux, J. Joanny, J. Prost, and P. Pullarkat, “Shape oscillations of non-adhering fibroblast
cells,” Physical Biology, vol. 4, 2007.
[14] J. i. A. Houk, Andrew R, C. O. Mejean, R. Boltyanskiy, E. R. Dufresne, and et al, “Membrane
tension maintains cell polarity by confining signals to the leading edge during neutrophil
migration,” Cell, vol. 148, 2012.
[15] W. Strychalski and R. Guy, “A computational model of bleb formation,” Mathematical Medicine
and Biology-a Journal of the Ima, vol. 30, 2013.
[16] E. Paluch, M. Piel, J. Prost, M. Bornens, and C. Sykes, “Cortical actomyosin breakage triggers
shape oscillations in cells and cell fragments,” Biophysical Journal, vol. 89, 2005.
[17] D. Kabaso, R. Shlomovitz, K. Schloen, and G. N. Stradal, T, “Theoretical model for cellular
shapes driven by protrusive and adhesive forces,” PLoS Comput Biol, vol. 7, 2011.
247
[18] J. Cahn and J. Hilliard, “Free energy of a nonuniform system .1. interfacial free energy,” Journal
of Chemical Physics, vol. 28, 1958.
[19] Q. Du, C. Liu, and X. Wang, “Simulating the deformation of vesicle membranes under elastic
bending energy in three dimensions,” Journal of Computational Physics, vol. 212, 2006.
[20] X. Yang, V. Mironov, and Q. Wang, “Modeling fusion of cellular aggregates in biofabrication
using phase field theories,” Journal of Theoretical Biology, vol. 303, 2012.
[21] L. Chen, “Phase-field models for microstructure evolution,” Annual Review of Materials
Research, vol. 32, 2002.
[22] M. Stewart, J. Helenius, Y. Toyoda, S. Ramanathan, D. Muller, and et al., “Hydrostatic
pressure and the actomyosin cortex drive mitotic cell rounding,” Nature, vol. 469, 2011.
[23] B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and et al., Molecular Biology of the
Cell, 4th edition. New York: Garland Science, 2002.
[24] G. Charras, C. Hu, M. Coughlin, and T. Mitchison, “Reassembly of contractile actin cortex in
cell blebs,” J Cell Biol, vol. 175, 2006.
[25] P. Canham, “The minimum energy of bending as a possible explanation of the biconcave shape
of the human red blood cell,” Journal of Theoretical Biology, vol. 26, 1970.
[26] W. Helfrich, “Elastic properties of lipid bilayers: theory and possible experiments,” Z Natur-
forsch C, vol. 28, 1973.
[27] E. Evans, “Minimum energy analysis of membrane deformation applied to pipet aspiration and
surface adhesion of red blood cells,” Biophysical Journal, vol. 30, 1980.
[28] R. Phillips, J. Kondev, J. Theriot, and N. Orme, Physical Biology of the Cell. New York:
Garland Science, 2013.
[29] D. Boal, Mechanics of the Cell. Cambridge, UK: Cambridge University Press, 2001.
[30] C. Cunningham, “Actin polymerization and intracellular solvent flow in cell surface blebbing,”
J Cell Biol, vol. 129, 1995.
[31] J. Joanny, F. Julicher, K. Kruse, and J. Prost, “Hydrodynamic theory for multi-component
active polar gels,” New Journal of Physics, vol. 9, 2007.
[32] J. Tinevez, U. Schulze, G. Salbreux, J. Roensch, J. Joanny, and et al., “Role of cortical tension
in bleb growth,” Proc Natl Acad Sci U S A, vol. 106, 2009.
[33] M. Bovellan, Y. Romeo, M. Biro, A. Boden, P. Chugh, and et al., “Cellular control of cortical
actin nucleation,” Curr Biol, vol. 24, 2014.
[34] Q. Wang, X. Yang, D. Adalsteinsson, T. Elston, and e. a. Jacobson, K, Computational and
Modeling Strategies for Cell Motility. US: Springer, 2012.
[35] J. Cahn, “Free energy of a nonuniform system .2. thermodynamic basis,” Journal of Chemical
Physics, vol. 30, 1959.
[36] Q. Du, C. Liu, and W. X, “A phase field approach in the numerical study of the elastic bending
energy for vesicle membranes,” Journal of Computational Physics, vol. 198, 2004.
248
[37] Q. Du, C. Liu, R. Ryham, and X. Wang, “A phase field formulation of the willmore problem,”
Nonlinearity, vol. 18, 2005.
[38] P. G. de Gennes and J. Prost, The Physics of Liquid Crystals. Oxford University Press.
[39] Y. Sun and C. Beckermann, “Sharp interface tracking using the phase-field equation,” Journal
of Computational Physics, vol. 220, 2007.
[40] W. H. Grover, A. K. Bryan, M. Diez-Silva, J. . M. H. S. Suresh, and S. R. Manalis, “Measuring
single-cell density,” PNAS, vol. 108, no. 27, pp. 10992–10996, 2011.
[41] H. Karcher, J. Lammerding, H. Huang, R. T. Lee, R. D. Kamma, and M. R. Kaazempur-Mofrad,
“A three dimensional viscoelastic model for cell deformation with experimental verification,”
Biophysical Journal, vol. 85, 2003.
[42] R. Simson, E. Wallraff, J. Faix, J. Niewohner, G. Gerisch, and E. Sackmann, “Membrane
bending modulus and adhesion energy of wild-type and mutant cells of dictyostelium lacking
talin or cortexillins.,” Biophysical Journal, vol. 74, 1998.
[43] J. Etienne, J. Fouchard, D. Mitrossilis, N. Bu
, P. Durand-Smet, and A. Asnacios, “Cells as liquid motors: mechanosensitivity emerges from
collecive dynamics of actomyosin cortex,” PNAS, vol. 112, no. 9, p. 27402745, 2015.
[44] A. V. Zakharov, M. N. Tsvetkova, and V. G. Korsakov, “Elastic properties of liquid crystals,”
Physics of the Solid State, vol. 44, no. 9, pp. 1795–1801, 2002.
[45] B. Klus, U. A. Laudyn, M. A. Karpierz, and B. Sahraoui, “All optical measurement of elastic
constants in nematic liquid crystals,” Optics Express, vol. 22, no. 24, pp. 0357–30266, 2014.
[46] J. Shen and X. Yang, “Numerical approximation of allen-cahn and cahn-hilliard equations,”
Discrete and Continuous Dynamical Systems Series B, vol. 28, no. 4, p. 16691691, 2010.
[47] J. L. Guermond, P. Minev, and J. Shen, “An overview of projection methods for incompressible
flows,” Comput. Methods Appl. Mech. Engrg., vol. 195, 2006.
[48] J. Shen and X. Yang, “A phase-field model and its numerical approximation for two-phase
incompressible flows with different densities and viscositites,” SIAM Journal of Scienti
c Computing, vol. 32, 2010.
[49] F. Boyer and C. Lapuerta., “Study of a three component cahn-hilliard flow model,” ESAIM:
Mathematical Modeling and Numerical Analysis, vol. 40, no. 4, p. 653687, 2006.
[50] J. Hoberock and N. Bell, “Thrust: a parallel template library,” preprint, 2010.
[51] N. Bell and M. Garland, “Cusp: Generic parallel algorithms for sparse matrix and graph
computations,” preprint, 2012.
[52] M. Kapustina, D. Tsygankov, J. Zhao, T. Wessler, X. Yang, A. Chen, N. Roach, T. C. Elston,
Q. Wang, K. Jacobson, and M. G. Forest, “Modeling the excess cell surface stored in a complex
morphology of bleb-like protrusions,” PLoS Comput Biol, vol. 12, no. 3, p. e1004841, 2016.
[53] A. Casadevall and L. A. Pirofski, “A new synthesis for antibody-mediated immunity,” Nat.
Immunol., vol. 13, no. 1, pp. 21–28, 2012.
249
[54] B. Corthesy, “Role of secretory immunoglobulin a and secretory component in the protection
of mucosal surfaces,” Future Microbiol., vol. 5, no. 5, pp. 817–829, 2010.
[55] P. A. Kozlowski and M. R. Neutra, “The role of mucosal immunity in prevention of hiv
transmission,” Curr. Mol. Med., vol. 3, no. 3, pp. 217–228, 2003.
[56] D. R. Burton and J. R. Mascola, “Antibody responses to envelope glycoproteins in hiv-1
infection,” Nat. Immunol., vol. 16, no. 6, pp. 571–576, 2015.
[57] M. J. van Gils and R. W. Sanders, “Broadly neutralizing antibodies against hiv-1: templates
for a vaccine,” Virology, vol. 435, no. 1, pp. 46–56, 2013.
[58] J. R. Dunkelberger and W. C. Song, “Complement and its role in innate and adaptive immune
responses,” Cell Res., vol. 20, no. 1, pp. 34–50, 2010.
[59] M. Huber, W. C. Olson, and A. Trkola, “Antibodies for hiv treatment and prevention: window
of opportunity?,” Curr. Top. Microbiol. Immunol., vol. 317, 2008.
[60] M. Kilian and M. W. Russell, “Function of mucosal immunoglobulins,” Handbook of Mucosal
Immunology, 1994.
[61] K. J. Whaley, L. Zeitlin, R. A. Barratt, T. E. Hoen, and R. A. Cone, “Passive immunization of
the vagina protects mice against vaginal transmission of genital herpes infections,” J. Infect.
Dis., vol. 169, no. 3, pp. 647–649, 1994.
[62] L. Zeitlin, K. J. Whaley, P. P. Sanna, T. R. Moench, R. Bastidas, A. De Logu, R. A. Williamson,
D. R. Burton, and R. A. Cone, “Topically applied human recombinant monoclonal igg1 antibody
and its fab and f(ab’)2 fragments protect mice from vaginal transmission of hsv-2,” Virology,
vol. 225, no. 1, pp. 213–215, 1996.
[63] R. S. Veazey, R. J. Shattock, M. Pope, J. C. Kirijan, J. Jones, Q. Hu, T. Ketas, P. A. Marx,
P. J. Klasse, D. R. Burton, and J. P. Moore, “Prevention of virus transmission to macaque
monkeys by a vaginally applied monoclonal antibody to hiv-1 gp120,” Nat. Med., vol. 9, no. 3,
pp. 343–346, 2003.
[64] J. R. Mascola, G. Stiegler, T. C. VanCott, H. Katinger, C. B. Carpenter, C. E. Hanson,
H. Beary, D. Hayes, S. S. Frankel, D. L. Birx, and M. G. Lewis, “Protection of macaques
against vaginal transmission of a pathogenic hiv-1/siv chimeric virus by passive infusion of
neutralizing antibodies,” Nat. Med., vol. 6, no. 2, pp. 207–210, 2000.
[65] E. J. Chipperfield and B. A. Evans, “Effect of local infection and oral contraception on
immunoglobulin levels in cervical mucus,” Infect. Immun., vol. 11, no. 2, pp. 215–221, 1975.
[66] S. J. Usala, F. O. Usala, R. Haciski, J. A. Holt, and G. F. Schumacher, “Igg and iga content of
vaginal fluid during the menstrual cycle,” J. Reprod. Med., vol. 34, no. 4, pp. 292–294, 1989.
[67] Y. Y. Wang, A. Kannan, K. L. Nunn, M. Murphy, D. B. Subramani, T. Moench, R. Cone,
and S. K. Lai, “Igg in cervicovaginal mucus traps hsv and prevents vaginal herpes infections,”
Mucosal Immunol., vol. 7, no. 5, pp. 1036–1044, 2014.
[68] S. K. Lai, Y. Y. Wang, K. Hida, R. Cone, and J. Hanes, “Nanoparticles reveal that human
cervicovaginal mucus is riddled with pores larger than viruses,” Proc. Natl. Acad. Sci. U. S.
A., vol. 107, no. 2, pp. 598–603, 2010.
250
[69] S. K. Lai, K. Hida, S. Shukair, Y. Y. Wang, A. Figueiredo, R. Cone, T. J. Hope, and J. Hanes,
“Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human
cervicovaginal mucus,” J. Virol., vol. 83, no. 21, pp. 11196–11200, 2009.
[70] K. L. Nunn, Y. Y. Wang, D. Harit, M. S. Humphrys, B. Ma, R. Cone, J. Ravel, and S. K. Lai,
“Enhanced trapping of hiv-1 by human cervicovaginal mucus is associated with Lactobacillus
crispatus-dominant microbiota,” mBio, vol. 6, no. 5, pp. e01084–15, 2015.
[71] S. A. Shukair, S. A. Allen, G. C. Cianci, D. J. Stieh, M. R. Anderson, S. M. Baig, C. J. Gioia,
E. J. Spongberg, S. M. Kauffman, M. D. McRaven, H. Y. Lakougna, C. Hammond, P. F.
Kiser, and T. J. Hope, “Human cervicovaginal mucus contains an activity that hinders hiv-1
movement,” Mucosal Immunol., vol. 6, no. 2, pp. 427–434, 2013.
[72] W. M. Saltzman, M. L. Radomsky, K. J. Whaley, and R. A. Cone, “Antibody diffusion in
human cervical mucus,” Biophys. J., vol. 66, no. 2 Part 1, pp. 508–515, 1994.
[73] S. S. Olmsted, J. L. Padgett, A. I. Yudin, K. J. Whaley, T. R. Moench, and R. A. Cone,
“Diffusion of macromolecules and virus-like particles in human cervical mucus,” Biophys. J.,
vol. 81, no. 4, pp. 1930–1937, 2001.
[74] S. A. McKinley, A. Chen, F. Shi, S. Wang, P. J. Mucha, M. G. Forest, and S. K. Lai, “Modeling
neutralization kinetics of hiv by broadly neutralizing monoclonal antibodies in genital secretions
coating the cervicovaginal mucosa,” PLoS One, vol. 9, no. 6, p. e100598, 2014.
[75] F. Klein, H. Mouquet, P. Dosenovic, J. F. Scheid, L. Scharf, and M. C. Nussenzweig, “Antibodies
in hiv-1 vaccine development and therapy,” Science, vol. 341, no. 6151, pp. 1199–204, 2013.
[76] K. J. Whaley and K. H. Mayer, “Strategies for preventing mucosal cellassociated hiv transmis-
sion,” J. Infect. Dis., vol. 210, no. Suppl. 3, pp. S674–S680, 2014.
[77] A. Chen, S. A. McKinley, S. Wang, F. Shi, P. J. Mucha, M. G. Forest, and S. K. Lai,
“Transient antibody-mucin interactions produce a dynamic molecular shield against viral
invasion,” Biophys. J., vol. 106, no. 9, pp. 2028–2036, 2014.
[78] M. v. Smoluchowski, “Versuch einer mathematischen theorie der koagulationskinetik kolloider
loosungen,” Z. Phys. Chem., vol. 92, 1917.
[79] J. K. Sherwood, L. Zeitlin, K. J. Whaley, R. A. Cone, and M. Saltzman, “Controlled release
of antibodies for long-term topical passive immunoprotection of female mice against genital
herpes,” Nat. Biotechnol., vol. 14, no. 4, pp. 468–471, 1996.
[80] K. Ramessar, T. Rademacher, M. Sack, J. Stadlmann, D. Platis, G. Stiegler, N. Labrou,
F. Altmann, J. Ma, E. Stoger, T. Capell, and P. Christou, “Cost-effective production of a
vaginal protein microbicide to prevent hiv transmission,” Proc. Natl. Acad. Sci. U. S. A.,
vol. 105, no. 10, pp. 3727–3732, 2008.
[81] K. J. Whaley, A. Hiatt, and L. Zeitlin, “Emerging antibody products and nicotiana manufac-
turing,” Hum. Vaccines, vol. 7, no. 3, pp. 349–356, 2011.
[82] H. F. Liu, J. Ma, C. Winter, and R. Bayer, “Recovery and purification process development
for monoclonal antibody production,” mAbs, vol. 2, no. 5, pp. 480–499, 2010.
251
[83] A. L. Zydney, “Continuous downstream processing for high value biological products–a review,”
Biotechnol. Bioeng., 2015.
[84] S. Santra, G. D. Tomaras, R. Warrier, N. I. Nicely, H. X. Liao, J. Pollara, P. Liu, S. M. Alam,
R. Zhang, S. L. Cocklin, X. Shen, R. Duffy, S. M. Xia, R. J. Schutte, C. W. Pemble Iv, S. M.
Dennison, H. Li, V. i. K. Chao, A., A. Evans, K. Klein, A. Kumar, J. Robinson, G. Landucci,
D. N. Forthal, D. C. Montefiori, J. Kaewkungwal, S. Nitayaphan, P. Pitisuttithum, S. Rerks-
Ngarm, M. L. Robb, N. L. Michael, J. H. Kim, K. A. Soderberg, E. E. Giorgi, L. Blair, B. T.
Korber, C. Moog, R. J. Shattock, N. L. Letvin, J. E. Schmitz, M. A. Moody, F. Gao, G. Ferrari,
G. M. Shaw, and B. F. Haynes, “Human non-neutralizing hiv-1 envelope monoclonal antibodies
limit the number of founder viruses during shiv mucosal infection in rhesus macaques,” PLoS
Pathog., vol. 11, no. 8, p. e1005042, 2015.
[85] S. Rerks-Ngarm, P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal, J. Chiu, R. Paris,
N. Premsri, C. Namwat, M. de Souza, E. Adams, M. Benenson, S. Gurunathan, J. Tartaglia,
J. G. McNeil, D. P. Francis, D. Stablein, D. L. Birx, S. Chunsuttiwat, C. Khamboonruang,
P. Thongcharoen, M. L. Robb, N. L. Michael, P. Kunasol, , and J. H. Kim, “Vaccination with
alvac and aidsvax to prevent hiv-1 infection in thailand,” N. Engl. J. Med., vol. 361, no. 23,
pp. 2209–2220, 2009.
[86] P. L. Jamison and P. H. Gebhard, “Penis size increase between flaccid and erect states: an
analysis of the kinsey data,” J. Sex Res., vol. 24, no. 1, pp. 177–183, 1988.
[87] S. K. Lai, D. E. O’Hanlon, S. Harrold, S. T. Man, Y. Y. Wang, R. Cone, and J. Hanes, “Rapid
transport of large polymeric nanoparticles in fresh undiluted human mucus,” Proc. Natl. Acad.
Sci. U. S. A., vol. 104, no. 5, pp. 1482–1487, 2007.
[88] P. Gupta, J. Mellors, L. Kingsley, S. Riddler, M. K. Singh, S. Schreiber, M. Cronin, and C. R.
Rinaldo, “High viral load in semen of human immunodeficiency virus type 1-infected men at
all stages of disease and its reduction by therapy with protease and nonnucleoside reverse
transcriptase inhibitors,” J. Virol., vol. 71, no. 8, pp. 6271–6275, 1997.
[89] N. Rehan, A. J. Sobrero, and J. W. Fertig, “The semen of fertile men: statistical analysis of
1300 men,” Fertil. Steril., vol. 26, no. 6, pp. 492–502, 1975.
[90] P. Zhu, J. Liu, J. Bess, J., E. Chertova, J. D. Lifson, H. Grise, G. A. Ofek, K. A. Taylor,
and K. H. Roux, “Distribution and three-dimensional structure of aids virus envelope spikes,”
Nature, vol. 441, no. 7095, pp. 847–852, 2006.
[91] P. B. Pendergrass, M. Belovicz, and C. A. Reeves, “Surface area of the human vagina as
measured from vinyl polysiloxane casts,” Gynecol. Obstet. Invest., vol. 55, no. 2, pp. 110–113,
2003.
[92] A. Stone and C. J. Gamble, “The quantity of vaginal fluid,” Am. J. Obstet. Gynecol., vol. 78,
no. 2, pp. 379–381, 1959.
[93] D. H. Owen and D. F. Katz, “A vaginal fluid simulant,” Contraception, vol. 59, no. 2, pp. 91–95,
1999.
[94] H. Chakraborty, P. K. Sen, R. W. Helms, P. L. Vernazza, S. A. Fiscus, J. J. Eron, B. K.
Patterson, R. W. Coombs, J. N. Krieger, and M. S. Cohen, “Viral burden in genital secretions
determines male-to-female sexual transmission of hiv-1: a probabilistic empiric model,” AIDS,
vol. 15, no. 5, pp. 621–627, 2001.
252
[95] A. R. Geonnotti and D. F. Katz, “Dynamics of hiv neutralization by a microbicide formulation
layer: biophysical fundamentals and transport theory,” Biophys. J., vol. 91, no. 6, pp. 2121–2130,
2006.
[96] B. E. Lai, M. H. Henderson, J. J. Peters, D. K. Walmer, and D. F. Katz, “Transport theory
for hiv diffusion through in vivo distributions of topical microbicide gels,” Biophys. J., vol. 97,
no. 9, pp. 2379–2387, 2009.
[97] J. F. Scheid, H. Mouquet, B. Ueberheide, R. Diskin, F. Klein, T. Y. Oliveira, J. Pietzsch,
D. Fenyo, A. Abadir, K. Velinzon, A. Hurley, S. Myung, F. Boulad, P. Poignard, D. R. Burton,
F. Pereyra, D. D. Ho, B. D. Walker, M. S. Seaman, P. J. Bjorkman, B. T. Chait, and M. C.
Nussenzweig, “Sequence and structural convergence of broad and potent hiv antibodies that
mimic cd4 binding,” Science, vol. 333, no. 6049, pp. 1633–1637, 2011.
[98] C. Magnus and R. R. Regoes, “Estimating the stoichiometry of hiv neutralization,” PLoS
Comput. Biol., vol. 6, no. 3, p. e1000713, 2010.
[99] X. Yang, S. Kurteva, S. Lee, and J. Sodroski, “Stoichiometry of antibody neutralization of
human immunodeficiency virus type 1,” J. Virol., vol. 79, no. 6, pp. 3500–3508, 2005.
[100] K. Schonning, O. Lund, O. S. Lund, and J. E. Hansen, “Stoichiometry of monoclonal antibody
neutralization of t-cell line-adapted human immunodeficiency virus type 1,” J. Virol., vol. 73,
no. 10, pp. 8364–8370, 1999.
[101] L. McLain and N. J. Dimmock, “Single- and multi-hit kinetics of immunoglobulin g neutral-
ization of human immunodeficiency virus type 1 by monoclonal antibodies,” J. Gen. Virol.,
vol. 75, no. Part 6, pp. 1457–1460, 1994.
[102] J. R. Norris, Markov Chains, Issue 2008. Cambridge, UK: Cambridge University Press, 1998.
[103] S. K. Lai, Y. Y. Wang, and J. Hanes, “Mucus-penetrating nanoparticles for drug and gene
delivery to mucosal tissues,” Advanced drug delivery reviews, vol. 61, no. 2, pp. 157–71, 2009.
[104] T. Wessler, A. Chen, S. A. McKinley, R. Cone, M. G. Forest, and S. K. Lai, “Using computa-
tional modeling to optimize the design of antibodies that trap viruses in mucus,” ACS Infect.
Dis., vol. 2, no. 1, pp. 82–92, 2016.
[105] K. T. Barnhart, A. Izquierdo, E. S. Pretorius, D. M. Shera, M. Shabbout, and A. Shaunik,
“Baseline dimensions of the human vagina,” Human Reproduction, vol. 21, no. 6, pp. 1618–1622,
2006.
253
